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 Preface iii 
Preface 
In this dissertation, I am pleased to present to you my work “Resection-dependent canonical 
non-homologous end-joining induces genomic rearrangements” wherein I will introduce you to 
a novel DNA repair pathway, which endangers the genomic integrity. 
This dissertation was generated under the supervision of Prof. Dr. M. Löbrich at the Technische 
Universität Darmstadt (Technical University Darmstadt), Germany in his Radiation Research 
and DNA repair working group. The laboratory work of this dissertation was performed from 
July 2013 until October 2016 at Technische Universität Darmstadt and from October 2015 to 
March 2016 at MD Anderson Cancer Center, Houston, Texas, USA in the Department of 
Experimental Radiation Oncology under the supervision of J. Chen, PhD. 
The declaration of authorship can be found at the very end of this thesis (Ehrenwörtliche 
Erklärung). Any data obtained in collaboration or by undergraduate students under my 
supervision are explicitly declared as such in the according figure legends. This thesis generally 
uses an impersonal style of writing. 
Parts of this dissertation were published in the peer-reviewed journal articles Barton et al. 
(2014) “Polo-like kinase 3 regulates CtIP during DNA double-strand break repair in G1” in The 
Journal of Cell Biology and Biehs et al. (2017) “DNA double-strand break resection occurs 
during non-homologous end-joining in G1 but is distinct to resection during homologous 
recombination in G2” in Molecular Cell. Figures involving data included in one of these 
publications are named in the according figure legends. 
The structure of this dissertation mostly adheres to the classical structure of a thesis from the 
biological sciences. However, some results are discussed within the results section of this thesis 
instead of the discussion section to make it easier for the reader to follow the reasoning behind 
the experimental design. In addition, the materials and methods section can be found after the 
discussion section to not disrupt the flow. Furthermore, the lists of abbreviations, figures, and 
tables are located after the references to enable all materials supporting the comprehension of 
the content to be combined in one place.  
I hope you enjoy reading this dissertation as much as I enjoyed researching this topic. 
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1. Summary 
DNA double-strand breaks (DSBs) are the main threat to genomic integrity. The majority of 
DSBs are repaired by canonical non-homologous end-joining (c-NHEJ), where the two DSB 
ends are rejoined with minimal processing. Some studies suggest that the rejoining of DSBs by 
c-NHEJ can be error-prone by causing sequence alterations and/or the misrejoining of two 
separate DSBs. Such genomic rearrangements are a driving force in carcinogenesis. However, 
it remains an ongoing discussion as to how such rearrangements arise, as other studies associate 
genomic rearrangements with alternative end-joining (alt-EJ) and factors favoring resection. 
During alt-EJ the involvement of resection results in the loss of genetic information. However, 
there is evidence that alt-EJ mechanisms only play a role in human cells, which are deficient 
for certain repair proteins. This is the case in combination with genetic defects or in tumor cells. 
Thus, it remains unclear how mutagenic end-joining, which results in genomic rearrangements, 
operates and is regulated in wild-type human cells. 
To answer this question, mutagenic end-joining repair was investigated in this study by 
combining a reporter assay with other molecular biological assays. This reporter assay monitors 
the misrejoining of two 3.2 kilobase distant DSB ends under the loss of the intervening 
fragment. In addition, the sequence alterations at the misrejoined break sites were analyzed 
and overall repair was investigated. Furthermore, two approaches were taken to understand 
the circumstances under which error-prone end-joining is employed in wild-type human cells: 
the misrejoining of DSBs was compared between different reporter assays and the interactions 
of proteins involved in this pathway were analyzed.  
The results of this study show that distant DSB ends are misrejoined by a hitherto undescribed 
slow repair mechanism, which is specific for the G1 phase of the cell cycle. These misrejoined 
break sites are frequently associated with sequence alterations, especially small deletions (less 
than 50 nucleotides). These deletions are the result of limited resection. Surprisingly, the DSB 
ends remain protected by the key c-NHEJ factor KU during this undescribed repair mechanism. 
This feature distinguishes this end-joining process from all previously described pathways 
involving resection. Indeed, the absence of factors such as KU or the anti-resection factor 53BP1 
results in increased genomic rearrangements by alt-EJ. Hence, in this novel repair pathway, c-
NHEJ factors are pivotal in ensuring resection remains limited. 
Resection-dependent c-NHEJ is initiated by the activation of the resection factor CtIP. This is 
achieved through damage-inducible phosphorylation by the kinase PLK3 at Ser327, Thr847, 
and probably additional sites. Subsequently, the phosphorylation of CtIP at Ser327 results in its 
interaction with the pro-resection factor BRCA1. Similar to its role in S/G2 phase, the BRCA1-
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CtIP interaction seems to be important to overcome the resection barrier posed by 53BP1. 
Resection is executed by the exonuclease EXO1. Although EXD2 and MRE11 are also involved, 
the endonuclease function of MRE11 is dispensable for this repair pathway, indicating that 
resection is conducted from the DSB end. This is a key step limiting resection since the 
endonucleolytic cut by MRE11 overcomes the protected or blocked DSB ends during other 
resection processes to generate large single-stranded DNA overhangs. Thus, the initiation and 
execution of resection in this novel pathway is finely tuned to ensure that resection remains 
limited.  
Strikingly, the impairment of factors involved in the initiation or execution of resection does 
not result in unrepaired DSBs. This indicates that a repair pathway switch occurs in their 
absence. Although the absence of this novel error-prone repair pathway results in less genomic 
rearrangements, the remaining rearrangements are associated with worse sequence alterations, 
including longer deletions. Importantly, the limited resection process during resection-
dependent c-NHEJ produces short single-stranded DNA regions, which form intermediate 
structures. These structures need to be resolved by the endonuclease activity of ARTEMIS, 
which is dependent on its interaction with the key c-NHEJ component DNA-PKcs. Thus, once 
resection has taken place, both ARTEMIS and DNA-PKcs are indispensable for repair 
completion. 
The break sites are mostly misrejoined using microhomologies, and thus require the single-
stranded DNA gaps to be filled-in by polymerases. POL, which is typically associated with 
microhomologies, acts in this novel repair pathway, but the c-NHEJ-associated polymerases 
POL/ are also involved. The ligation step is conducted by the c-NHEJ ligase LIG4 and not by 
LIG1/3, which ligate DSB ends during alt-EJ. To summarize, despite its error-prone 
characteristics, this novel repair pathway restricts the loss of genetic information to a minimum. 
This is accomplished by rejoining the break sites using microhomologies, by keeping resection 
limited with the help of c-NHEJ factors, and by preventing an endonucleolytic cut by MRE11. 
In conclusion, this study characterizes a novel G1-specific mutagenic resection-dependent c-
NHEJ pathway in human cells. In addition, this study shows how protein-protein interactions 
influence the choice to utilize this DSB repair pathway. The occurrence of resection in 
combination with c-NHEJ factors is a unique feature of this repair pathway and was hitherto 
thought to be mutually exclusive. Furthermore, the discovery of this pathway clarifies the role 
of alt-EJ as a type of backup mechanisms to compensate for missing repair proteins. Hence, in 
the ongoing discussion of how genomic rearrangements arise, this novel repair pathway unifies 
the contradicting observations of other studies.   
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1.1. Zusammenfassung 
DNA Doppelstrangbrüche (DSBs) sind die größte Gefahr für die genomische Integrität. Die 
Mehrheit aller DSBs wird durch die kanonische nicht-homologe Endverknüpfung (c-NHEJ) 
repariert, bei der die beiden Bruchenden nach minimaler Prozessierung miteinander verknüpft 
werden. Manche Studien suggerieren, dass c-NHEJ durch Sequenzmodifikationen und/oder die 
Fehlverknüpfung zweier separater DSBs fehlerbehaftet sein kann. Solche genomische 
Umlagerungen sind eine treibende Kraft der Karzinogenese. Allerdings bleibt die Entstehung 
dieser Umlagerungen ungewiss, denn andere Studien assoziieren genomische Umlagerungen 
mit alternativer Endverknüpfung (alt-EJ) und resektionsfördernden Faktoren. Die Beteiligung 
von Resektion führt während des alt-EJ zu dem Verlust genetischer Informationen. Jedoch gibt 
es Hinweise, dass alt-EJ in humanen Zellen nur eine Rolle spielt, wenn diese nicht über 
bestimmte Reparaturproteine verfügen. Dies ist bei Gendefekten und in Tumorzellen der Fall. 
Daher bleibt unklar, wie in humanen Wildtyp-Zellen mutagene Endverknüpfung, welche zu 
genomischen Umlagerungen führt, stattfindet und reguliert wird.  
Um diese Frage zu beantworten, wurde die mutagene Endverknüpfungsreparatur in dieser 
Studie mittels eines Reporter-Assays in Kombination mit anderen molekularbiologischen 
Analysemethoden untersucht. Dieser Reporter-Assay misst die Fehlverknüpfung zweier 
3,2 Kilobasen entfernter DSB-Enden, die durch den Verlust des dazwischenliegenden 
Fragmentes entsteht. Zusätzlich wurden die Sequenzveränderungen an den fehlverknüpften 
Bruchstellen analysiert und die Gesamtreparatur untersucht. Außerdem wurden zwei Ansätze 
gewählt, um zu verstehen unter welchen Bedingungen fehlerbehaftete Endverknüpfung in 
humanen Wildtyp-Zellen stattfindet: die Fehlverknüpfung von DSBs wurde zwischen 
verschiedenen Reporter-Assays verglichen und Interaktionen von Proteinen, die in diesem 
Reparaturweg beteiligt sind, wurden analysiert.  
Die Ergebnisse dieser Studie zeigen, dass voneinander entfernt liegende DSB-Enden durch 
einen bisher unbeschriebenen langsamen Reparaturmechanismus fehlverknüpft werden, der 
spezifisch für die G1 Phase des Zellzyklus ist. Die fehlverknüpften Bruchstellen sind häufig mit 
Sequenzveränderungen assoziiert, vor allem mit kurzen Deletionen (unter 50 Nukleotide). 
Diese Deletionen resultieren aus limitierter Resektion. Überraschenderweise werden die DSB-
Enden in diesem unbeschriebenen Reparaturweg durch KU geschützt, einem Kernfaktor des c-
NHEJ. Dieses Merkmal unterscheidet diesen Endverknüpfungsprozess von allen zuvor 
beschriebenen Reparaturwegen, bei denen Resektion involviert ist. Tatsächlich führt die 
Abwesenheit von KU oder des Antiresektionsfaktors 53BP1 zu vermehrten genomischen 
Umlagerungen durch alt-EJ. Daher sind c-NHEJ-Faktoren ausschlaggebend in diesem neuen 
Reparaturweg, um zu gewährleisten, dass die Resektion limitiert bleibt. 
Resektionsabhängiges c-NHEJ wird durch die Aktivierung des Resektionsfaktors CtIP initiiert. 
Dies wird mittels Phosphorylierung durch die Kinase PLK3 an Ser327, Thr849 und vermutlich 
weiteren Stellen erreicht. Darauffolgend interagiert das an Ser327-phosphorylierte CtIP mit 
dem Pro-Resektionsfaktor BRCA1. Vergleichbar zu seiner Rolle in der S/G2 Phase, scheint die 
BRCA1-CtIP Interaktion wichtig zu sein, um die 53BP1-Resektionsbarriere zu überwinden. Die 
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Resektion wird von der Exonuklease EXO1 durchgeführt. Obwohl EXD2 und MRE11 auch 
involviert sind, ist die Endonukleasefunktion von MRE11 entbehrlich für diesen Reparaturweg, 
was daraufhin deutet, dass die Resektion vom DSB-Ende durchgeführt wird. Dies ist ein 
entscheidender Schritt um die Resektion zu limitieren, denn der endonukleolytische Schnitt 
durch MRE11 überwindet in anderen Resektionsprozessen geschützte oder blockierte DSB-
Enden und generiert so große einzelsträngige DNA-Überhänge. Folglich ist die Initiierung und 
Durchführung der Resektion in diesem neuen Reparaturweg fein abgestimmt um 
sicherzustellen, dass die Resektion limitiert bleibt. 
Bemerkenswerterweise führt die Beeinträchtigung von Faktoren, die an der Initiierung oder 
Durchführung der Resektion beteiligt sind, nicht zu unreparierten DSBs. Dies deutet darauf hin, 
dass ohne diese Faktoren ein Wechsel des Reparaturweges stattfindet. Obwohl die Abwesenheit 
dieses neuen fehlerbehafteten Reparaturwegs in weniger genomischen Umlagerungen 
resultiert, sind die verbleibenden Umlagerungen mit schlimmeren Sequenzmodifikationen 
verbunden, inklusive längeren Deletionen. Der limitierte Resektionsprozess in diesem neuen 
Reparaturweg führt zu kurzen einzelsträngigen Bereichen, die intermediäre Strukturen 
ausbilden. Diese Strukturen müssen durch die Endonukleaseaktivität von ARTEMIS aufgelöst 
werden, was von ihrer Interaktion mit DNA-PKcs abhängig ist, einer Kernkomponente des c-
NHEJ. Folglich sind ARTEMIS und DNA-PKcs unentbehrlich sobald Resektion stattgefunden 
hat. 
Die Bruchstellen werden zumeist unter der Verwendung von Mikrohomologien verknüpft und 
erfordern daher das Auffüllen der einzelsträngigen DNA-Bereiche durch Polymerasen. POL, 
welche mit Mikrohomologien in Verbindung gebracht wird, agiert in diesem Reparaturweg aber 
auch die c-NHEJ-assoziierten Polymerasen POL/ sind involviert. Der Ligationsschritt wird 
von der c-NHEJ Ligase LIG4 durchgeführt und nicht von LIG1/3, welche DSB-Enden während 
alt-EJ ligieren. Zusammengefasst beschränkt dieser neue Reparaturweg trotz seiner 
fehlerbehafteten Charakteristiken den Verlust von genetischen Informationen an 
fehlverknüpften Bruchenden auf ein Minimum. Dies wird erreicht durch die Verknüpfung der 
Bruchstellen unter der Verwendung von Mikrohomologien, durch die Limitierung der Resektion 
mithilfe von c-NHEJ Faktoren, sowie mittels der Verhinderung eines endonukleolytischen 
Schnitts durch MRE11. 
Zusammengefasst charakterisiert diese Studie einen neuen, G1-spezifischen, mutagenen, 
resektionsabhängigen c-NHEJ Weg in humanen Zellen. Zusätzlich zeigt die Studie, wie Protein-
Protein Interaktionen die Entscheidung beeinflussen, diesen DSB-Reparaturweg zu benutzen. 
Die Kombination von Resektion und c-NHEJ-Faktoren ist ein einzigartiges Merkmal dieses 
Reparaturwegs, da bisher angenommen wurde, dass sich diese Prozesse gegenseitig 
ausschließen. Darüber hinaus verdeutlicht die Entdeckung dieses Reparaturweges, dass alt-EJ 
eine Ansammlung von Backup-Mechanismen ist, um für fehlende Reparaturproteine zu 
kompensieren. Folglich vereint dieser neue Reparaturweg in der fortlaufenden Diskussion wie 
genomischen Umlagerungen entstehen, die widersprüchlichen Beobachtungen anderer 
Studien.  
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2. Introduction 
Deoxyribonucleic acid (DNA) is the carrier of genetic information in all living organisms. 
Endogenous cellular processes and exogenous sources damage the DNA on a daily basis. Thus, 
it is of utmost importance for any organism to protect and maintain its genetic information. 
Failure to do so endangers genomic integrity, which may result in carcinogenesis 143. Therefore, 
it is a never-ending quest in biological research to understand the cellular mechanisms that 
preserve the genome. In addition to the basic research argument to investigate and understand 
these mechanisms, the knowledge gained in this field has clinical relevance to understand 
tumor development and to improve cancer treatment possibilities.  
2.1. DNA damage response 
DNA is a polymer, which consists of a sugar-phosphate backbone and the four bases adenine, 
thymidine, guanine, and cytosine. It is built from units called nucleotides (nt) and its double 
helix structure is organized around histone octamers (consisting of two copies each of the 
histones H2A, H2B, H3, and H4) 363. The arrangement of 147 nt around a histone octamer is 
called a nucleosome. Nucleosomes form the chromatin, which can be packed in an extended 
(euchromatin) or condensed (heterochromatin) form 190. DNA can be damaged by a multitude 
of endogenous and exogenous factors. Intracellular processes, which can result in DNA damage 
include free radicals in the cell, meiosis, V(D)J recombination, class switch recombination 
(CSR), and the collapse of replication forks, while external influences include 
chemotherapeutics, ionizing radiation, and carcinogenic substances 143,146. DNA can be 
damaged in a variety of ways, including base mismatches, bulky adducts, abasic sites, single-
strand breaks (SSBs), double-strand breaks (DSBs), and inter- and intrastrand crosslinks 
39,146,248. 
2.1.1. Post-translational modifications 
In response to DNA damage, cells react with a variety of measures, which are largely regulated 
by post-translational modifications of proteins. These modifications include phosphorylation, 
ubiquitination, SUMOylation, neddylation, methylation, acetylation, and PARylation of specific 
amino acids in a certain protein to induce the recruitment, activation, inhibition, degradation, 
and/or interaction of factors 50,55,307,345. PARylation, which is also called poly ADP-ribosylation, 
is catalyzed by PARPs (poly (ADP-ribose) polymerases) to rapidly attach ADP-ribose to the 
carboxyl group of acidic amino acids following DNA damage induction 404. In contrast, 
phosphorylation is executed by kinases and involves the addition of a phosphate group to the 
amino acids serine (Ser, S), threonine (Thr, T), or tyrosine (Tyr, Y). Kinases associated with the 
DNA damage response typically target Ser or Thr followed by a glutamine (Gln, Q) after DNA 
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damage induction 261. Several proteins involved in the DNA damage response have a BRCT 
(BRCA1 C-terminal) domain, which enables the proteins to specifically bind to phosphorylated 
amino acids. Ubiquitination involves the linkage of the small protein ubiquitin to lysine (Lys, 
K) residues in a three-step process involving E1, E2, and E3 ubiquitin ligases, while 
SUMOylation uses SUMO (small ubiquitin-like modifier) and neddylation uses NEDD8 
(ubiquitin-like protein NEDD8) 50,56,307. Both methylation and acetylation typically occur at Lys 
residues and involve the addition of a methyl or acetyl group, respectively 316. In concert, these 
modifications induce a highly-controlled interplay of proteins to initiate and regulate DNA 
repair, cell cycle control, senescence, and apoptosis 39,44,50,55,60,217,307,345. 
2.1.2. Cell cycle control 
The reaction to certain types of DNA damage is dependent on the cell cycle phase, and thus it 
is important to understand the regulation of the cell cycle by cyclin complexes, consisting of 
regulatory cyclins and CDKs (cyclin-dependent kinases, Figure 2.1) 314. The cell cycle consists 
of gap phase 1 (G1), synthesis (S), gap phase 2 (G2), and mitosis. In G1, complexes of CyclinD 
with either CDK4 or 6 phosphorylate Rb (retinoblastoma protein) resulting in the release of E2F 
(E2F transcription factor 1) 87. This initiates a positive feedback loop in which CyclinE is 
upregulated 101,225,406. Subsequently, CyclinE/CDK2 complexes begin to form leading to the 
transition to S phase by the recruitment of replication factors. This complex is dependent on 
active CDC25A, which activates it by dephosphorylation 101,221,246. CyclinA/CDK2 takes over 
during S phase and is replaced by the CyclinB/CDK1 complex in G2 phase 118,221. This complex 
is also called mitosis promoting factor since dephosphorylation removes its inhibitory function 
and results in the initiation of cell division 118. Importantly, due to a high degree of similarity 
between their active sites, CDK1 can take over for CDK2 340.  
 
Figure 2.1 Cell cycle regulation 
Simplified model of the cell cycle regulation by cyclins and CDKs. The cell cycle consists of 4 phases. In G1, 
CyclinD/CDK4/6 dominate and phosphorylate Rb, resulting in the release of E2F and the crossing of the restriction 
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point. CyclinE/CDK2 is upregulated and the cells can enter S phase where CyclinA/CDK2 prevails. The CyclinB/CDK1 
complex must be dephosphorylated for the cells to be able to enter mitosis. The cell cycle is controlled and can be 
arrested at several points (red circles). Based on Satyanarayana and Kaldis (2009); Bretones et al. (2015). 
Checkpoints are able to block the progression of the cell cycle to ensure the integrity of the 
genome, full DNA replication, and accurate chromosome segregation. The cell cycle can be 
disrupted in early G1 phase, during G1/S transition, intra-S, during G2/M transition, and in 
mitosis (Figure 2.1) 349,433. 
2.1.3. DNA repair 
DNA repair is executed by a multitude of repair mechanisms, which specifically address certain 
types of DNA damage. Error-free or high-fidelity repair mechanisms include base excision 
repair, nucleotide excision repair, and mismatch repair, which repair base mismatches, abasic 
sites, bulky adducts, SSBs, and other varieties of minor DNA damage 39,403. Compared to these 
high-fidelity mechanisms, other DNA repair pathways deal with DNA damage that is more 
difficult to repair, namely DSBs and inter- and intrastrand crosslinks. However, the cell has 
developed specific mechanisms to recognize and deal with even the most dangerous DNA 
damage, namely the DSB (chapter 2.2). In addition to highly effective DNA repair pathways 
that maintain genetic information, cells also employ error-prone mechanisms, which are 
associated with loss of genetic information and thus play a key role in the initiation of 
carcinogenesis 51,161,413. The impairment of genes encoding proteins involved in DNA repair 
pathways can favor mutagenic events and enhance the possibility of carcinogenesis and tumor 
progression 143. In fact, the combination of defective genes and the use of error-prone repair 
mechanisms allows cancer cells to accumulate DNA damage and enhance their genomic 
instability to develop further mutations 134,193. Indeed, targeting these molecular mechanisms is 
a growing and promising field in cancer treatment 248.  
2.2. Double-strand break repair 
The most severe type of DNA damage is the DSB because it endangers genome stability by 
impairing the genetic information on both DNA strands 297. On average, 10 DSBs arise 
endogenously each day in a human body 242. There are several mechanisms to repair DSBs and 
the pathway choice is dependent on the cell cycle phase, the chromatin status, and the 
complexity of the DSB. The different DSB repair pathways vary in their speed and accuracy. 
How these DSB repair mechanisms are orchestrated is of specific interest. 
2.2.1. DSB Recognition 
First, DSBs need to be recognized (Figure 2.2). Central to the recognition of DNA DSBs are the 
MRN (MRE11 (meiotic recombination 11), RAD50 (radiation repair protein 50), and NBS 1 
(Nijmegen breakage syndrome 1)) complex and the KU (KU70 (XRCC6, X-ray repair cross-
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complementing protein 6) and KU80 (XRCC5, X-ray repair cross-complementing protein 5)) 
heterodimer 95,303,342,431. The rapid recruitment of MRE11 and NBS1 to the DSB ends is 
dependent on PARP1 158. MRN and KU hold the DSBs together 95,188 and recruit the PIKKs 
(phosphatidylinositol 3-kinase-related kinases) ATM (ataxia telangiectasia mutated) and DNA-
PKcs (DNA-dependent protein kinase catalytic subunit), respectively 65,119,311. Together 
KU70/80 and DNA-PKcs form the DNA-PK (DNA-dependent protein kinase) holoenzyme 188. 
Contrary to former assumptions 79,125, it has only recently been shown that MRE11 and KU do 
not affect the recruitment of each other to DSBs with KU binding directly to the DSB end and 
MRN associating with the side 11,64,74,184,435. A model was proposed suggesting that large 
complexes of DNA-PK and MRN/ATM assemble at the DSBs right after damage induction 
wherein DNA-PKcs regulates ATM activity through phosphorylation 435. ATM is activated via an 
interaction with NBS1 but implemented by autophosphorylation 21,119,342. The active PIKKs are 
able to phosphorylate the histone variant H2AX at Ser139 to form H2AX (Figure 2.2) 58,368,398. 
Mechanistically, this is caused by a positive feedback loop, allowing the H2AX signal to spread 
1 to 2 megabase pairs (Mbp) 17,329,386. In the presence of single-stranded DNA (ssDNA), the PIKK 
ATR (ATM- and Rad3-related) can also conduct this phosphorylation. Next, ATM and MRN 
recruit MDC1 (mediator of DNA damage checkpoint protein 1) to bind to H2AX 211,367 and 
together they recruit RNF8 (E3 ubiquitin protein ligase RING finger protein 8). In concert with 
UBC13 (ubiquitin conjugating enzyme E2 N) and HERC2 (HECT and RLD domain-containing 
E3 ubiquitin protein ligase 2) RNF8 ubiquitinates histone H2A and its variants 8,31,174. This 
allows the binding of another ubiquitin protein ligase, RNF168, to ubiquitinated H2A type 
histones, which then interacts with UBC13 and amplifies the RNF8-dependent ubiquitination 
8,14,110. This chain of interactions builds the binding platform for several proteins involved in 
DNA repair, including BRCA1 (breast cancer susceptibility protein 1) 55,393. Importantly, BRCA1 
also forms a complex involving MRN, which is exclusive to S/G2 phase 78. 
Just like BRCA1, 53BP1 (tumor suppressor p53-binding protein 1) is recruited to the DSB by 
several mechanisms. First, its BRCT2 domain binds directly to H2AX 23. Second, ubiquitination 
of H2A at Lys15 allows 53BP1-binding via its ubiquitin-dependent recruitment (UDR) motif 
3,301. In addition, 53BP1 binds to Lys20 dimethylated histone H4 (H4 Lys20me2) via its Tudor 
domain, which is facilitated through several mechanisms: one such mechanism is the ubiquitin-
dependent removal of L3MBTL1 (lethal (3) malignant brain tumor-like protein) from H4 
Lys20me2 by VCP (valosin-containing protein) 3,301. VCP is a factor that targets ubiquitinated 
proteins to segregate them from binding partners or cellular structures 45. In fact, H4 Lys20me2 
guides 53BP1 to pre-replicative chromatin 308. Moreover, the methyl-histone-binding Tudor 
domain enables 53BP1 to interact constitutively with chromatin in the absence of DNA damage, 
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which is a weak interaction compared to the damage-inducible localization of 53BP1 at the DSB 
30,49,179,430. Recently, TIRR (Tudor interacting DNA repair regulator) was discovered to interact 
with the Tudor domain of 53BP1 restricting the access of 53BP1 to chromatin prior to DNA 
damage 112. RNF168 ubiquitinates and ATM phosphorylates 53BP1 to control its downstream 
response to DSBs 43,127. The phosphorylation is required for 53BP1 to interact with RIF1 (RAP1-
interacting factor homolog) and PTIP (PAXIP1, PAX interacting protein 1) 96,127,186,353,369. The 
interaction with RIF1 disrupts the TIRR-53BP1 complex and allows for proper 53BP1 
localization to the chromatin 112. In S/G2 phase of the cell cycle, 53BP1 is dephosphorylated by 
PP4C (Ser/Thr-protein phosphatase 4 catalytic subunit) if timely DSB repair does not occur 
186,353. This is promoted by BRCA1 in concert with BARD1 (BRCA1-associated RING domain 
protein 1) to disrupt the phosphorylation-dependent 53BP1 interaction with RIF1 and PTIP 
(Figure 2.2) 96,127,186,353. Another important factor to abort RIF1-binding to 53BP1 is SCAI 
(suppressor of cancer cell invasion) 185. Therefore, the late downstream signaling of the DSB 
recognition differs in G1 phase compared to S/G2, which has an impact on the DSB repair 
pathway choice 178,353. 
 
Figure 2.2 DSB recognition 
Simplified model for the DSB recognition. The DSB is recognized by the KU heterodimer and the MRN complex. KU 
recruits DNA-PKcs and MRN recruits ATM. DNA-PKcs regulates the ATM activity. The two kinases phosphorylate the 
histone variant H2AX, which expands via a positive feedback loop. MRN and ATM recruit MDC1 to bind to H2AX, 
which then recruits RNF8. RNF168 binds to RNF8-dependent ubiquitin chains and subsequently builds the platform 
for many downstream factors. 53BP1 binds to methylated and ubiquitinated histones as well as H2AX. In S/G2 
phase, BRCA1-BARD1 promotes 53BP1 dephosphorylation. Based on van Attikum and Gasser (2009); Panier and 
Boulton (2014); Brown and Jackson (2015); Feng et al. (2015); Shibata (2017). 
2.2.2. Homologous recombination (HR) 
Homologous recombination (HR) is a high-fidelity DSB repair pathway because it utilizes 
homologous sequences as a template for repair. In human cells, HR is limited to S/G2 phase of 
the cell cycle since it requires the presence of the sister chromatid to use as a matrix for DNA 
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synthesis 138,200. DSB repair by HR is conducted in a slow process and is associated with the 
remodeling of the chromatin 34,147,204,288. HR repair is the preferred repair pathway for DSBs 
resulting from replication errors such as stalled replication forks, complex DSBs from high-LET 
(linear energy transfer) irradiation, DSBs in H3 Lys36me3-decorated transcriptionally active 
regions, and DSBs in heterochromatic regions identified by H3 Lys9me3 and H4 Lys20me 
13,17,74,75,140,147,202,288,312. HR can be divided into three sections: the degradation of one DNA 
strand to generate large regions of ssDNA, the strand invasion of the sister chromatid by the 
generated 3′ ssDNA tail, and the template DNA synthesis and subsequent dissolution/resolution 
of HR intermediates 262,337. The degradation of one DNA strand is executed by a process called 
resection in which the hydrolysis of the phosphodiester bond (the linkage between two 
nucleotides) is catalyzed by nucleases 249. Overcoming the barriers opposing resection in a 
regulated manner is crucial for efficient HR. 
Central to the initiation of HR is the binding of the MRN complex to the DSB and subsequent 
recruitment of ATM (Figure 2.3) 95,189. Due to its limitation to S/G2 phase, HR is initiated in a 
cell cycle-dependent manner. As mentioned in chapter 2.2.1, BRCA1 promotes the 
dephosphorylation of ATM-phosphorylated 53BP1 if timely DSB repair does not occur, and thus 
disrupts 53BP1s interaction with RIF1 and PTIP 96,127,178,186,353. This is possible due to the cell 
cycle-dependent formation of the BRCA1-C complex, which consists of the MRN complex, CtIP 
(CtBP-interacting protein), BRCA1, and BARD1 78,183,295. The formation of this complex is 
dependent on the interaction of BRCA1 with CtIP, which requires the constitutive activation of 
CtIP by phosphorylation at Ser327 through the S/G2-specific CDK2/CyclinA complex (Figures 
2.1, 2.3) 428. Furthermore, CtIP is activated upon damage induction by SIRT6 (sirtuin-6)-
dependent deacetylation 75,201 and the SUMOylation of CtIP by CBX4 (E3 SUMO-protein ligase 
chromobox 4) is required for the recruitment of CtIP to damaged DNA 360. The speed of 
resection is impaired in the absence of BRCA1 or if the BRCA1-CtIP interaction is blocked 93. 
Terminating RIF1-binding to 53BP1 allows BRCA1 to antagonize the anti-resection function of 
53BP1, a process that is not yet fully understood. However, it has been shown that BRCA1-
BARD1 ubiquitinates H2A Lys217 to allow SMARCAD1 (SWI/SNF-related matrix-associated 
actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1)-binding, which 
results in the repositioning of nucleosomes including the bound 53BP1 (Figure 2.3) 89,105. The 
repositioning of 53BP1 is further promoted by SETDB1 (SET domain bifurcated 1), HP1 (CBX5, 
chromobox protein homolog 5), and SUV39 (suppressor of variegation 3-9 homolog 1) 9. 
Nevertheless, 53BP1 also contributes to the remodeling of the chromatin during HR by tethering 
ATM at DSBs, which is known to phosphorylate and thus inactivate the heterochromatin 
building factor KAP1 (KRAB domain associated protein 1) 141,204. An additional barrier to 
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prevent resection is posed by RAP80 (BRCA1-A complex subunit RAP80). To overcome this 
barrier, BRCA1 primes 53BP1 to allow POH1 (26S proteasome non-ATPase regulatory 
subunit 14) access to remove RAP80 203,283. Moreover, the autophosphorylation of DNA-PKcs, a 
key step during DSB repair by end-joining (see next chapter 2.2.3), is attenuated by BRCA1 in 
a cell cycle-dependent manner and thus promotes repair by HR 100. 
End resection during HR is conducted bi-directionally in two steps, short-range and long-range 
resection (Figure 2.3) 135,354. The key factor for short-range resection is MRE11 with its single-
stranded endonuclease activity and its double-stranded 3′ to 5′ exonuclease activity 304,383. 
Resection is initiated by the MRN complex in concert with CtIP phosphorylated at Thr847 via 
the endonuclease function of MRE11, which induces a nick internal to the DSB 75,177,339. 
Subsequently, short-range resection takes place in a 3′ to 5′ direction towards the DSB through 
the exonuclease function of MRE11, which was assumed to create 50 to 300 base pair (bp) 
regions of ssDNA due to studies in the Saccharomyces cerevisiae system 61,93,233,274. However, 
Anand et al. (2016) revealed that the endonucleolytic cut is preferentially initiated roughly 
20 nt away from the 5′ terminus in the human system. Moreover, they showed that Thr847-
phosphorylated CtIP and NBS1 have structural roles to promote DNA cleavage by the nuclease 
activity of MRE11 and the ATPase activity of RAD50, while the endonuclease activity of CtIP is 
dispensable. Furthermore, they observed that a second MRN-phosphorylated CtIP (pCtIP) 
complex can subsequently bind to induce an additional cut, which would allow 3′ to 5′ resection 
in a stepwise manner even beyond 20 nt. 3′ to 5′ resection is accelerated through the 3′ to 5′ 
exonuclease activity of EXD2 (exonuclease 3′-5′ domain-containing protein 2), a CtIP-
interacting protein 53.  
The resulting ssDNA is coated with RPA (replication protein A) for stability and to prevent the 
formation of secondary structures 37. RPA is a heterotrimeric protein complex which binds the 
ssDNA in multiple steps 41: the initial binding requires a ssDNA region of 8 to 10 nt while the 
stable binding of an RPA molecule is only possible at roughly 30 nt of ssDNA 42. Another 
important step to ensure accurate resection is the removal of the KU heterodimer. It is not 
entirely clear when exactly KU is removed; however, multiple studies indicate that KU removal 
requires short-range resection and needs to be executed before long-range resection can take 
place 74,75,128,184. The removal of KU is not completely understood either, but it seems to entail 
a combination of KU phosphorylation, KU ubiquitination, and subsequent removal of KU from 
the DSB. Indeed, it was proposed that multiple mechanisms act simultaneously 74. KU70 is 
phosphorylated by S/G2-specific CyclinA/CDK1/2 at Thr455 (Figure 2.1) 81,128. A connection 
between KU70 phosphorylation and DNA end resection was only recently found. In a structural-
based approach, Lee et al. (2016) showed that phosphorylation of KU70 at the adjacent pillar 
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and bridge region (which is vital for the ring-like structure of the KU heterodimer around the 
DNA) induces a conformational change to allow KU dissociation by a lowered binding affinity, 
which they observed to be necessary for accurate DNA end resection. In addition, 3′ to 5′ 
resection has been shown to facilitate KU release where MRE11 exonuclease activity creates a 
DNA flap, which needs to be cleaved by the endonuclease activity of CtIP 74,75,224. Other studies 
focus on the importance of the ubiquitination of KU for its removal from DSB ends. Ismail et al. 
(2015) showed that RNF138, which binds to ssDNA or resected dsDNA (double-stranded DNA) 
overhangs, ubiquitinates KU80 to promote the removal of the KU heterodimer. Ubiquitinated 
KU is targeted and removed from the DNA by VCP 45. 
To create large regions of 3′ ssDNA tails, long-range resection is conducted from the MRE11-
induced nick in a 5′ to 3′ direction by EXO1 (exonuclease 1)/BLM (Bloom syndrome protein) 
and/or BLM/DNA2 (DNA replication ATP-dependent helicase/nuclease DNA2)/WRN (Werner 
syndrome ATP-dependent helicase, Figure 2.3) 67,287,382. The MRN complex continues to play an 
important role by recruiting 5′ to 3′ resection factors 371. In addition, the recruitment of EXO1 
and BLM is promoted by the ATM-mediated phosphorylation of CtIP, which is only possible 
after CtIP is already hyper-phosphorylated following DNA damage induction by CDK complexes 
397. EXO1 has 5′ to 3′ dsDNA exonuclease activity, endonuclease activity on 5′ flaps 227,230, and 
is phosphorylated at Ser639, Thr732, and Ser815 by S/G2-specific CDK complexes 128,349. 
Several studies indicate that full EXO1 activity requires stimulation by factors such as MRE11, 
CtIP, BRCA1 and/or additional unknown proteins 62,121,169,170,373,381,382. In fact, it has been shown 
that EXO1 is removed from ssDNA by RPA if it is not supported 282. The current working model 
suggests an initial stimulation of EXO1 activity by the MRN complex and/or its interaction 
partners, which is then assumed by BLM for the majority of the 5′ to 3′ resection process 16. BLM 
and WRN are both RecQ helicases, which unwind dsDNA, including secondary structures, by 
translocating along ssDNA in a 3′ to 5′ direction 92,352. In addition to EXO1-dependent resection, 
5′ to 3′ resection is also conducted with either BLM and/or WRN in concert with DNA2 16,371. 
RPA stimulates the unwinding of the DNA by the helicases and binds the unwound 3′ strand to 
protect it from digestion 16. DNA2 has endonuclease activity and thus RPA directs the DNA2 
nuclease activity towards the degradation of the 5′ strand in a stepwise endonucleolytic 
digestion 16,240,282.  
The finely-tuned resection process generates 2 to 4 kilobases (kb) of ssDNA in each direction of 
the DSB with a reduced nucleosome occupancy within 1 kb of the DSB 17,434. Therefore, another 
important part of the resection process is the limitation of the resection length. Indeed, HR is 
impaired in 53BP1-depleted cells where hyper-resection takes place 203,204,292. Central to the 
suppression of excessive resection is the BRCA1-A complex with the core components BRCA1, 
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ABRAXAS (BRCA1-A complex subunit Abraxas 1), RAP80, BRCC36 (BRCA1/BRCA2-containing 
complex subunit 36), and BARD1 (Figure 2.3) 66,162,283,395. Importantly, while the assembly is 
hierarchical, the BRCA1-A complex is dynamic, as the components undergo changes in their 
internal protein-protein interactions 167. The BRCA1-A complex is formed downstream of the 
H2AX pathway (Figure 2.2) and is therefore assembled at a slower rate than the pro-resection 
BRCA1-C complex, which it competes with to limit resection 83,283,295. For the BRCA1-A complex 
to prevail, it seems to be essential that the BRCA1-C complex is disrupted. This might be 
achieved by the degradation and/or inactivation of CtIP through several mechanisms. CtIP 
inactivation is achieved through its constitutive acetylation by an unknown Lys 
acetyltransferase 75,201 and may also be influenced by its neddylation 199. Despite the role of the 
ATM-dependent phosphorylation of CtIP in recruiting long-range resection factors, hyper-
phosphorylation of CtIP has also been associated with the dissociation of the BRCA1-CtIP 
interaction in response to damage induction 238,281. This includes CtIP phosphorylation at 
Ser276 and Thr315 by S/G2-specific CDK complexes following the initiation of resection, 
resulting in PIN1 (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1)-binding to CtIP, 
which leads to the ubiquitination and subsequent degradation of CtIP 366. In another 
mechanism, long-range resection is limited by HELB (DNA helicase B), which is recruited to 
ssDNA in an RPA-dependent manner 380. Importantly, HELB is phosphorylated in S/G2 by CDK2 
complexes leading to its nuclear export and consequent low HELB concentrations in the 
nucleus. In contrast, nuclear HELB concentrations are high during G1 phase, which counteracts 
long-range resection and thus also makes HELB an important factor in DSB repair pathway 
choice 380. 
The next step in HR requires a complex of BRCA1/BRCA2/PALB2 (partner and localizer of 
BRCA2), which is regulated by ATR-activated CHK1 (checkpoint kinase 1) and ATM-activated 
CHK2 (checkpoint kinase 2) 19. Interestingly, the assembly of the complex is cell cycle-
dependent and key in limiting HR to S/G2 phase 299. The BRCA1/BRCA2/PALB2 complex 
interacts with RAD51 (DNA repair protein RAD51 homolog 1) and is responsible for placing it 
on the ssDNA under RPA displacement 77,306,374. Importantly, if KU is not removed at this stage, 
RPA cannot exchange with RAD51 74. RAD51 forms a nucleoprotein filament, which is pivotal 
for the strand invasion of the sister chromatid and the subsequent homology search 208,337,407. 
Finally, the DNA strand is elongated by DNA polymerases, HR intermediates are dissolved or 
resolved by helicases and nucleases, and the DNA ends are ligated 168,262. 
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Figure 2.3 Homologous recombination (HR) 
Simplified model for bidirectional resection during HR. Resection barriers are overcome in a cell cycle-dependent 
manner by BARD1/BRCA1/CtIP-pS327, which involves the displacement of 53BP1. Resection is initiated by an 
endonucleolytic cut internal to the DSB end by MRN/CtIP-pT847. From that nick, short-range resection is conducted 
by the 3′ to 5′ exonuclease activities of MRE11 and EXD2, while long-range resection is executed by the 5′ to 3′ 
exonuclease activity of EXO1 or the 3′ to 5′ helicase activity of BLM or WRN in concert with the endonuclease activity 
of DNA2. KU is removed from the DSB ends and RPA protects the generated ssDNA. Resection is limited by the 
BRCA1-A complex. Based on Coleman and Greenberg (2011); Ohta et al. (2011); Savage and Harkin (2015); Hustedt 
and Durocher (2017). 
2.2.3. Canonical non-homologous end-joining (c-NHEJ) 
DSB end-joining repair is the joining of the two DSB ends. In contrast to HR, end-joining is 
active in all cell cycle phases. However, different end-joining mechanisms exist and the 
deployment of each mechanism is dependent on the structure of the break ends, the chromatin 
status, and the availability of repair factors. Canonical non-homologous end-joining (c-NHEJ) 
is responsible for the repair of the majority of DSBs. It is a simple rejoining of the DNA ends, 
which is sufficient to repair regular DSBs quickly. In a simplified model, KU70 and KU80 protect 
the DSB ends and together with the catalytic subunit DNA-PKcs, form DNA-PK to hold the break 
ends together 85,188. The XRCC4 (X-ray repair cross-complementing protein 4)/XLF (XRCC4-like 
factor, also Cernunnos)/LIG4 (DNA ligase 4)/PAXX (paralog of XRCC4 and XLF) complex then 
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joins the ends 6,191,290,345. However, there is much more detail worth mentioning in the c-NHEJ 
process.  
The KU70/80 heterodimer is rapidly recruited to DSBs and binds the DNA ends under the 
formation of a ring-like structure (Figure 2.4) 394. KU prevents nucleolytic degradation of the 
DNA ends and recruits and interacts with an array of NHEJ proteins 151,239,362. KU recruits and 
interacts with DNA-PKcs to form the DNA-PK holoenzyme 188. For DNA-PKcs to bind, KU 
translocates from the DSB end inwards for a distance of roughly 10 bp, which equals one helical 
turn 271,321,424. The two DNA-PK molecules at the DSB ends form a long-range complex and thus 
keep the break ends in proximity 103,149,231. KU also interacts with PAXX, which promotes KU 
accumulation at DSB ends 244,290. Additionally, KU80 rapidly recruits BRCA1 to the DSB in G1 
phase and this interaction is required for the stabilization of KU80 at the break end and precise 
joining of the ends 197,336,405. Concurrently, BRCA1 interacts with the MRN complex to suppress 
the nuclease activity of MRE11 in G1 phase through its interaction with NBS1 336,412 and DNA-
PKcs phosphorylates ATM to inhibit its activity 435. Both mechanisms channel repair towards c-
NHEJ. Another factor rapidly recruited to DSBs is PARP1. Although KU and PARP1 compete to 
bind to the broken DNA ends and KU limits but does not prevent PARP1 recruitment to the 
DSBs, PARP1 regulates and promotes c-NHEJ by a number of mechanisms 79,275,401. PARP1 acts 
at DSBs in the presence of KU and contributes to DSB repair via c-NHEJ by rapid chromatin 
expansion in concert with CHD2 (chromodomain-helicase-DNA-binding protein 2), which 
coincides with the efficient distribution of XRCC4 250. PARP further regulates efficient NHEJ 
through the retention of KU at the DSBs, which is realized by the KU70 PAR-interacting motif 
90. Finally, PARP1 stimulates DNA-PKcs kinase activity and can form a complex with DNA-PK to 
influence the DNA-PK conformational change required for c-NHEJ 85,334,361,404.  
KU also recruits the XRCC4/LIG4 complex and XLF (Figure 2.4) 6,150,191,259,263,379,422. DNA-PKcs 
enhances the recruitment of XRCC4 and XLF and in return, XRCC4/LIG4 potentiates the 
association of KU with DNA-PKcs 85,113. Additionally, LIG4 recognizes the PAR chains by PARP1, 
which further mediates the rapid recruitment of the LIG4 complex 404. XRCC4 and XLF interact 
directly 6 and XLF/XRCC4/LIG4 form a filament along the DNA 323. The XRCC4/XLF/LIG4 
filaments on both DSB ends align in a side-by-side position to then pair the DSB ends in an end-
to-end configuration 54,187,323. While KU and DNA-PKcs are both required for the connection of 
the DNA ends in the aforementioned long-range complex, the end-to-end alignment of the DSB 
ends marks the beginning of the second phase of c-NHEJ 149. Within seconds of the formation 
of the long-range complex, the ends are brought together into a short-range complex. This 
transition is dependent on the catalytic activities of DNA-PK and XLF/XRCC4 149,323. The 
interaction of two DNA-PK molecules in combination with the stimulating contact of DNA-PKcs 
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with the DNA induces the autophosphorylation of DNA-PK, which disrupts the DNA-PK complex 
(Figure 2.4) 40,108,267,271. It is not entirely clear how this disruption and subsequent release of 
the complex is orchestrated with the later steps of c-NHEJ 109. However, it has been shown that 
autophosphorylation leads to an immediate conformational change and releases DNA-PKcs 
from the break ends 267,388. Structural analyses have observed that DNA-PK also exists in a form 
where DNA-PKcs does not interact with the DNA but is loosely bound to the “arm” of KU80 409. 
Therefore, despite its release, DNA-PKcs might remain at the DSB ends due to this interaction. 
Another model proposes that the autophosphorylation of DNA-PKcs at two described clusters is 
conducted in multiple steps 285. In such a model, the autophosphorylation of the cluster adjacent 
to the putative DNA-binding domain (PQR) is conducted first and promotes the NHEJ process, 
while the autophosphorylation of the clustered ABCDE site causes the release of DNA-PKcs 
285,409. In any case, the intermolecular autophosphorylation of DNA-PKcs is required to relieve 
the physical block at the end ligation step, which is imposed by DNA-PKcs localization to the 
DSB ends 198. 
Before ligation can occur, most DSB ends need to be modified (Figure 2.4) 71. A variety of 
factors is involved in the processing and gap filling prior to ligation 109. The extent to which the 
DSB ends are processed prior to DNA-PKcs release is not completely understood. However, one 
nuclease involved in the alteration of the DSB ends is ARTEMIS, which is recruited and interacts 
with DNA-PKcs following the phosphorylation of DNA-PKcs by ATM 198. The DNA-PKcs 
phosphorylation sites on which the recruitment of ARTEMIS is dependent, are distinct and 
phosphorylated prior to the aforementioned DNA-PKcs intermolecular autophosphorylation 
sites 198. Of note, DNA-PKcs autophosphorylation can occur at these sites in the absence of ATM. 
ARTEMIS is known to process common DNA substrates such as blunt ends, 3′ overhangs, 5′ 
overhangs, and is the only vertebrate endonuclease capable of opening hairpins 70,114,251. It has 
been suggested, that ARTEMIS uses three contact points on its DNA substrates under the 
formation of a hairpin-like structure 70. The first contact point is located on the 5′ to 3′ strand 
at the ssDNA/dsDNA transition, the second is directly across from the first on the 3′ to 5′ strand, 
and the third contact point with the catalytic site is located an equivalent distance of 1 nt in the 
5′ direction from the second contact point 70. Consequently, an endonucleolytic cut by ARTEMIS 
mostly creates a 3′ overhang but can also create a blunt end. With the formation of the 
aforementioned short-range complex, the DSB ends are bridged by the XRCC4/XLF/LIG4 
filament (Figure 2.4) 54,323. The assembly, activity, and retention of the XRCC4/XLF/LIG4 
complex is promoted by APLF (aprataxin and PNK-like factor) to accelerate the ligation process 
151,333. The processing of the DSB ends probably continues beyond the release of DNA-PKcs. 
ARTEMIS also interacts with LIG4, suggesting that ARTEMIS might further contribute to the 
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processing of the DNA ends with its 5′ to 3′ exonuclease activity, which is suppressed by its 
interaction with DNA-PKcs 151,182,270. Other nucleases proposed to be involved in the processing 
step are MRE11 and APLF, which both have a 3′ to 5′ exonuclease activity 322,378,404. 
Furthermore, WRN interacts directly with KU and promotes c-NHEJ via its helicase and 3′ to 5′ 
exonuclease activity (Figure 2.4) 88,298,350.  
In addition, gap-filling is required at non-complementary termini during c-NHEJ 151. Two 
polymerases are connected to c-NHEJ, namely POL (DNA polymerase lambda) and POLµ 
(DNA-directed DNA/RNA polymerase mu) 63,124,253,293,388,420. POL is associated with high-
fidelity repair. This polymerase connects clean 3′ to 5′ gaps of a paired terminus and conducts 
error-free NHEJ by accurate gap-filling 420. POLµ is involved in the end-bridging of non-
complementary DNA ends as it occurs in V(D)J recombination (see chapter 2.2.5). Furthermore, 
POLµ has no proofreading activity, is known for its template-independent DNA synthesis and 
high frequency of 1 bp deletions resulting in a frameshift 293,420. The template-independent 
addition of nucleotides leans heavily towards the addition of thymidine 152,153. Finally, ligation 
of the “clean” DSB ends can take place via the LIG4 complex (Figure 2.4). Importantly, LIG4 is 
capable of ligating nicks and compatible 4 nt overhangs on its own but requires XRCC4 to ligate 
ssDNA or long 3′ and/or 5′ overhangs, which is only possible when the DNA end consists of 
more than one thymidine 152,153. LIG4/XRCC4 can also ligate DSB ends that share 2 bp of 
microhomology (MH; which are identical short sequences of base pairs terminal or internal to 
both sides of the DSB) and/or have 1 nt gaps, which is further stimulated by XLF 242. In the 
presence of KU, the XRCC4/XLF/LIG4 complex additionally ligates blunt ends and at low 
efficiencies, even incompatible DNA ends 152,153,242. The trapped KU is ubiquitinated for the 
disassembly of the NHEJ machinery after or near completion of the c-NHEJ repair process 
(Figure 2.4) 268. Two E3 ubiquitin ligases have been proposed to conduct this ubiquitination 
during c-NHEJ, RNF8 and the SCF (Skp, Cullin, F-box containing) complex 126,317,318. The 
ubiquitination of KU is promoted by its neddylation 56. Finally, the ubiquitinated KU80 is 
recognized and removed by VCP 45. 
The complexity, location, and structure of the break ends greatly dictates which factors are 
involved in the c-NHEJ process and the outcome of repair 72,145,302,370. When the two DSBs are 
“clean” without any modification, even DNA-PKcs is not required for c-NHEJ repair 71,326. 
Indeed, biochemical studies have shown that the KU-DNA-PKcs complex formation is highly 
dependent on the structure of the DNA ends and preferentially forms on dsDNA with a 3′ or 5′ 
poly-pyrimidine ssDNA extension 320. Although it has been shown that translocations (which 
are interchromosomal genomic rearrangements) in human cells arise from c-NHEJ, it is an 
ongoing discussion as to how error-prone c-NHEJ truly is 33,142,302. 
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Figure 2.4 Canonical non-homologous end-joining (c-NHEJ) 
Simplified model of c-NHEJ. The KU70/80 heterodimer rapidly binds to the DSB ends under formation of a ring-like 
structure and recruits DNA-PKcs, XRCC4/LIG4, and XLF. KU translocates inwards to allow DNA-PKcs-binding. 
XRCC4/LIG4/XLF builds a filament along the DNA. These filaments on both sides of the DSB interact with each other 
to initiate the alignment of the DSB ends in an end-to-end configuration. The catalytic activity of DNA-PKcs activates 
ARTEMIS and together with the catalytic activity of XRCC4/LIG4 brings the break ends together from a long-range 
to a short-range complex. The DNA-PK autophosphorylation disposes of DNA-PKcs and the XRCC4/LIG4/XLF 
filament bridges the two DSB ends. Of note, here this is displayed in two steps but is more likely a fluent process. 
PAXX is bound to KU and is required for the efficiency of the ligation complex. The DSB ends are processed by 
nucleases and gaps are filled by polymerases. After ligation, KU is disposed of by ubiquitination. Based on Grundy et 
al. (2014); Williams et al. (2014); Reid et al. (2015); Graham et al. (2016); Chang et al. (2017). 
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2.2.4. Error-prone end-joining 
As mentioned in chapter 2.1.3, error-prone repair mechanisms are considered to be a driving 
force in carcinogenesis 51,161,413. Additionally, cancer cells are frequently mutated in genes 
encoding proteins involved in repair or cell cycle control and exploit error-prone repair 
mechanisms 134,143,193. Just like c-NHEJ, error-prone end-joining mechanisms consist of three 
steps: the recognition of the DSB, the processing of the break ends, and the ligation 131. 
However, error-prone DSB repair utilizes other factors compared to c-NHEJ, which results in 
the frequent occurrence of deletions and/or insertions of base pairs 106,260,265,322. Deletions arise 
by resection and the subsequent misrejoining of DNA regions adjacent, near, or distant from 
the DSB ends. Error-prone end-joining mechanisms are associated with all sizes of deletions but 
many studies have observed a significant number of deletion sizes above 50 and up to several 
hundred nucleotides 257,401,414. As described in chapter 2.2.3, DSBs are also processed during c-
NHEJ. However, this processing is believed to result in losses of only up to 4 nt 226,265,322.  
Microhomology-mediated end-joining (MMEJ) 
One error-prone end-joining mechanism is microhomology-mediated end-joining (MMEJ). This 
pathway rejoins DSBs using microhomologies (MHs), which are identical short sequences of 
base pairs terminal or internal to both sides of the DSB 38,102,207. As mentioned in chapter 2.2.3, 
small MHs (some studies have observed up to 5 nt MHs) at the rejoined break end are also 
observed in c-NHEJ 226,265,302,322. Therefore, the definition of MMEJ in regard to the size of a MH 
varies in different studies. Some working groups refer to MHs of up to 25 nt with a minimum 
of 5 nt 106,226,265. Recent investigations revealed that MMEJ-mediated rejoining in human cells 
can be conducted with as little as 1 nt of MH, but the preferred length used by the involved 
polymerase is at least 3 nt 38,207,346,347. 
To initiate MMEJ, multiple domains of PARP1 bind to DNA, which results in interdomain 
contact that rapidly activates PARP1 via an intramolecular mechanism (Figure 2.5) 223. The 
subsequent PARP1 automodification builds a scaffold to recruit further factors such as the MRN 
complex 346,375,404. MRN bridges the DSB ends to keep the breaks in proximity 146,431. Resection 
during MMEJ is predominantly thought to be conducted by MRN in complex with CtIP, which 
initiates a nick internal to the DSB end and then conducts resection in a 3′ to 5′ direction towards 
the break end, resulting in 3′ overhangs 38,346,410. However, contradictory studies report that 
EXO1 and/or BLM/DNA2 execute resection in the 5′ to 3′ direction 260. It is unclear if there is a 
decision between these two types of resection or if both exist simultaneously as is the case for 
S. cerevisiae 347. In any case, resection is delayed in cells lacking MRE11 and CtIP, but can still 
occur via EXO1 347. Resection creates ssDNA and thus unveils sequences of MHs, which are 
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annealed for rejoining 38,102,207,347. The repair is influenced by the location of the MHs (Figure 
2.5, example with the MH located terminal to one DSB end and internal to the other). It has 
been proposed that resection is executed to the point that a suitable MH is uncovered, which 
could determine which proteins conduct resection and how limited resection is during MMEJ 
207,346. Importantly, the binding of ssDNA by RPA prevents the annealing of MHs and therefore, 
RPA is considered to be a major factor antagonizing MMEJ 264. 
The annealing of the MH can create unpaired ssDNA and leaves DNA gaps, which need to be 
filled (Figure 2.5). During MMEJ, gaps are filled by POL (DNA polymerase theta). Importantly, 
distinctions have been made between MMEJ and a pathway specifically described as POL-
mediated end-joining 178,414. POL is a low-fidelity polymerase, which can bypass abasic sites 
and other lesions 171. Its polymerase activity is template-independent and extends single-
stranded 3′ ends of DNA 171. In MMEJ, POL binds to the 5′ terminus phosphate of the opposing 
DNA end to extend the annealed 3′ overhang under the displacement of the 5′ strand 207. The 
central role of POL in MMEJ explains the preferred rejoining under the usage of at least 3 nt, 
as the stability of the annealed intermediate is enhanced with MHs starting at this size, and 
thus promotes the repair by POL 38,414. Due to unique contact points in its active site, POL can 
tightly grasp the 3′ terminus, which allows the extension of the DNA even with such short-
paired primers 410. Wyatt et al. (2016) showed that MHs between 4 and 6 nt were most 
frequently observed in rejoined DNA sequences after POL-mediated repair. Additionally, POL 
is frequently observed to cause templated insertions 171,410. This is suggested to be caused by 
POL performing mismatch extension of the 3′ overhangs from unpaired ssDNA regions 207. 
The heterodimer XPF (ERCC4, ERCC excision repair 4, endonuclease catalytic subunit)/ERCC1 
(ERCC excision repair 1, endonuclease non-catalytic subunit) has been associated with the 
removal of the 5′ flaps generated by POL (Figure 2.5) 346,347. Nevertheless, the involvement of 
additional nucleases remains uncertain (Figure 2.5) 38,347. In addition, certain 3′ overhangs 
created by unpaired ssDNA might be processed by nucleases before the nucleotide extension by 
POL takes place 38. Finally, ligation is conducted by the LIG3 (DNA ligase 3)/XRCC1 (X-ray 
repair cross-complementing protein 1) complex 102,116,346. The recruitment of XRCC1 is 
dependent on binding to PARP1-generated PARs 404 and it has been suggested that LIG1 (DNA 
ligase 1) can carry out ligation in the absence of LIG3 38,346,347.  
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Figure 2.5 Microhomology-mediated end-joining (MMEJ) 
Simplified model of MMEJ as an alt-EJ process with a terminal-internal MH. PARP1 binds the DSB ends and builds 
the scaffold for the recruitment of other proteins. Limited resection takes place by MRN together with CtIP, which 
first introduces a nick and then resects in the 3′ to 5′ direction. EXO1-mediated resection might also play a role, 
either at the DSB ends or at the location of the MRN-CtIP-induced nick to conduct resection in the 5′ to 3′ direction. 
Unveiled MHs are annealed and POL binds to the 5′ terminus phosphate of the opposing DNA strand to extend the 
DNA from the 3′ end under the displacement of the 5′ strand. The flaps are removed by nucleases and ligation occurs 
via XRCC1/LIG3. Based on Decottignies (2013); Mashimo et al. (2013); Kent et al. (2015); Sfeir and Symington 
(2015); Wei and Yu (2016); Wyatt et al. (2016); Seol et al. (2017). 
The question is under which conditions is MMEJ performed? It remains uncertain whether 
MMEJ-mediated DSB repair is a backup for abrogated repair pathways to ensure survival or if 
it has a role in wild-type (WT) human cells 347. Moreover, it is unclear whether every 
microhomology-mediated rejoining is executed as outlined in Figure 2.5. The best indication of 
a role for MMEJ in a WT situation is its participation in certain repair events during class switch 
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recombination (see chapter 2.2.5) 131,226,289,421. Further, POL-mediated repair has been 
observed in WT cells with predominantly short deletions below 50 nt and in KU-deficient cells 
in combination with deletions up to several hundred nucleotides 414. Another clue for MMEJ in 
WT cells has been provided by experiments conducted in Caenorhabditis elegans by Koole et al. 
(2014). Here, POL was shown to be essential for the repair of replication-induced DSBs at G-
quadruplex structures caused by difficult to replicate regions of tandem guanines. Remarkably, 
the loss of small patches of DNA and the usage of MHs for rejoining in POL-mediated repair 
prevented a profound loss of sequences surrounding these G-quadruplex structures, and thus 
evaded genomic havoc. In addition, MMEJ has been associated with poor NHEJ substrates and 
with resection when it takes place during G1 phase of the cell cycle 414. Converse to a possible 
role for MMEJ in a WT situation, it has been shown that although MMEJ and HR share the 
initial end-resection step 384, a number of HR factors, including BRCA1, suppress MMEJ 7,399. 
Furthermore, repair by MMEJ has been associated with abrogated c-NHEJ, aborted HR in 
tumors with mutated BRCA1/2, and with hyper-resection, as it takes place in cells deficient for 
KU or 53BP1 178,181,414. Surprisingly, Pfister et al. (2014) revealed that a reduction in CtIP 
protein does not prevent MMEJ, but increases it compared to HR in G2 phase. An increase in 
MMEJ has also been observed following the impairment of HR-related long-range resection 
factors 399. In addition, POL overexpression has been associated with poor survival in breast 
and colon cancer patients due to an increased capability of the cancer cells to deal with high 
levels of DSBs by the usage of error-prone DSB repair 232.  
Alternative end-joining (alt-EJ) 
A term generally associated with all types of error-prone end-joining is alternative end-joining 
(alt-EJ) 181. Although the involvement of MMEJ in a WT situation remains unclear, cells 
deficient for certain proteins can use MMEJ as a backup mechanism and therefore, MMEJ can 
be alt-EJ. However, not all alt-EJ is conducted using MHs. Furthermore, it has been proposed 
that alt-EJ is distinct from MMEJ and requires additional factors such as WRN, ligation by LIG1, 
and explicitly does not use XRCC1 102,116,359. Mansour et al. (2010) found a requirement for 
PARP1 in KU-deficient cells, but contradictory to other findings 414, did not observe rejoining 
using MHs. In any case, alt-EJ, either with or without microhomology-mediated rejoining, has 
been frequently observed as a backup mechanism in non-WT situations. In addition, several HR 
factors and c-NHEJ factors have been shown to suppress alt-EJ 7,256. Therefore, alt-EJ has also 
been called KU- and XRCC4/LIG4-independent end-joining 357. Despite this, overexpression of 
EXO1 reduces the frequency of repair by c-NHEJ and enhances mutagenic DSB repair resulting 
in increased deletions and insertions 260. Furthermore, while the increased resection in KU-
deficient cells has been observed to be EXO1-dependent 382, resection in 53BP1-deficient cells 
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is not 22. An additional factor that generally seems to be required in alt-EJ is the nuclease 
ARTEMIS 278. However, the function of ARTEMIS might differ compared to its role in c-NHEJ, 
as neither DNA-PKcs nor LIG4 would be available as interaction partners. In conclusion, the alt-
EJ mechanisms seem to differ depending on which factors of regular DSB repair proteins are 
missing or are overexpressed. Therefore, alt-EJ might be a backup strategy and not a dedicated 
pathway 116. Other factors influencing the use of alt-EJ are the cell line and the species. It has 
been shown that alt-EJ plays a more important role in mice than humans 313, which could be 
caused by the 50-fold higher amounts of DNA-PK in human cells 130.  
2.2.5. End-joining in genetic recombination 
In addition to the importance of end-joining in repairing DSBs by c-NHEJ and error-prone end-
joining mechanisms, end-joining has a special role in T and B lymphocytes, which belong to the 
adaptive immune system. The focus of the immune response is generating antibody diversity. 
Antibodies (also called immunoglobulin) in human cells consist of a heavy and light chain, each 
containing a variable and a constant region. The variable region provides the antibody its 
specificity for antigen-binding 28. Two important pathways in genetic recombination are V(D)J 
(variable, diversity, joining) recombination and class switch recombination (CSR). Both 
pathways begin with the endogenous induction of DSBs at defined positions in a controlled and 
highly-regulated manner. The factors involved in the response and repair of these DSBs heavily 
overlap with the damage response and end-joining machineries. Therefore, patients with 
inherited mutations in genes encoding proteins involved in the repair machinery (e.g. 
ARTEMIS), have a defective immune system in addition to their radio-sensitivity 194. As the aim 
of these genetic recombination pathways is antibody diversity, they employ repair factors to 
purposely misrejoin DSB ends to create new sequences. 
V(D)J recombination 
The diverse assembly of the variable region of immunoglobulin and T cell receptor genes in 
developing B and T cells is conducted by V(D)J recombination 26,115. It is also called antigen 
receptor gene rearrangement and is responsible for providing a highly-diverse set of antigen 
receptors 115,139. In the heavy chain variable region, exons are assembled from V, D, and J 
segments, while light chain exons are assembled from V and J segments 26. V(D)J recombination 
is initiated during G1 phase by the binding of lymphoid-specific RAG1/2 (recombination 
activating gene) in concert with HMG1 (high mobility group 1) at highly-conserved 
recombination signal sequences 139,391. RAG1/2 generates DSBs under the formation of hairpins 
at the coding ends, while blunt ends are formed at the intervening gene segment, which is then 
excised as a circular DNA fragment 391. The DSB is recognized by the c-NHEJ heterodimer 
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KU70/80. KU recruits the catalytic subunit DNA-PKcs, which interacts with ARTEMIS to open 
the hairpin structures of the coding ends 251. TdT (terminal deoxynucleotidyl transferase), a 
lymphoid-specific protein, increases the diversity by incorporating non-templated nucleotides 
255. The ligation step is executed by the XLF/XRCC4/LIG4 complex 180,391. Additional proteins 
have been described as functioning in V(D)J recombination, namely H2AX, ATM, the MRN 
complex, and PARP1 423. While H2AX, ATM, and the MRN complex contribute to the 
stabilization of the broken DNA ends, the interaction of PARP1 and DNA-PKcs facilitates the 
genomic integrity during V(D)J recombination 165,277,404,423. In addition to its stabilizing role, 
H2AX prevents the processing of hairpin-sealed coding ends by any nuclease other than 
ARTEMIS 164. Surprisingly, Helmink et al. (2011) observed that in the absence of H2AX, CtIP 
can efficiently promote the hairpin opening. In addition, TOPBP1 and 53BP1 are critical factors 
in V(D)J recombination 157,212,416. Indeed, Difilippantonio et al. (2008) show that the loss of 
53BP1 impairs the joining of distant V-DJ segments, which exhibit extensive degraded coding 
ends, thus demonstrating the role of 53BP1 in maintaining genomic stability during the joining 
of long-range DSB ends.  
Class switch recombination (CSR) 
The immunoglobulin gene diversification of mature B cells is conducted by CSR and somatic 
hypermutation. CSR is an alteration, which allows expression of an antibody with the same 
antigen-binding specificity, but switches the antibody class by recombination of the heavy chain 
constant region 4,115. The efficient and specific activation of CSR in B cells is dependent on 
cytokines from T cells 115,254. AID (activation-induced cytidine deaminase) induces lesions at 
large guanine- and cytosine-rich switch regions of repetitive DNA sequences by deamination of 
cytosine 4,115,365. AID is a lymphoid-specific protein. In fibroblast cell lines, the expression of AID 
induces CSR, preferentially in actively-transcribed regions 115,296,425. The lesions induced by AID 
are converted into SSBs by the base excision repair pathway in which the backbone of the DNA 
is disrupted by the removal of the damaged base 196,365. The formation of DSBs results from 
either two close SSBs or requires the EXO1-dependent mismatch repair pathway 24,364,365. Thus, 
single-stranded overhangs are generated by EXO1 processing during the induction of the DSB, 
which either need to be excised or filled-in to generate ends suitable for the end-joining process 
137,309,364,365,419. Several DNA polymerases have been implicated in the DNA synthesis process to 
fill those gaps, including POL 419. The DSBs induced in two of the switch regions are distant 
and therefore, CSR is a complex form of DSB repair 4. Similar to V(D)J recombination, the 
intervening fragment is excised as a circular fragment. ATM, H2AX, and the MRN complex 
contribute to the stabilization of the broken DNA ends but in contrast to V(D)J recombination, 
ATM and MRN are not sufficient to hold the DSB ends together, and thus H2AX is essential for 
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the stabilization process in CSR 423. Furthermore, together with MDC1 and ATR, these factors 
facilitate CSR and in their absence show varying levels of impact on the overall levels of CSR 
215.  
Another essential part of CSR is the modification of histones to position the switch regions near 
each other prior to DSB induction, which places them within the same chromosomal loop 365. 
Several specific histone modifications have been identified as promoting CSR 235. Interestingly, 
PTIP plays a role in long-range chromatin interactions and promotes the chromatin changes 
that are critical for CSR 97,344. 53BP1 (the interaction partner of PTIP) plays a central role in 
CSR by performing an anchoring role required for the long-range synapsis 4,157. 53BP1 explicitly 
favors long-range CSR by protecting the DNA ends from excessive resection and preventing 
short-range rejoining, which would result in intra-switch region recombination 47,324. The 
protection of DNA ends from resection by 53BP1 is independent of the distance of the DSBs. 
However, the distance between the DSBs is essential for 53BP1-dependent facilitation of the 
joining of distant intrachromosomal DSB ends and corresponds to the dissemination of the 
H2AX signal 48. RIF1, another 53BP1-interacting protein, also promotes CSR 392. Furthermore, 
DSB repair during CSR involves the c-NHEJ factors KU70/80, DNA-PKcs, and the 
XLF/XRCC4/LIG4 complex 4,46,254,391. The absence of ARTEMIS reduces the overall amount of 
CSR 328,330,331. Even cells lacking XRCC4/LIG4, XLF, or KU can still perform a fraction of CSR, 
but under the enhanced usage of MHs for rejoining 131,160,234. This indicates a switch to 
alternative repair mechanisms in the absence of c-NHEJ factors during CSR. This repair pathway 
switch is dependent on CtIP 226. The absence of 53BP1 also promotes microhomology-mediated 
alternative rejoining processes in CSR 47,57,107. However, even in a WT situation, some junctions 
use MHs for rejoining distant DSBs, which is also dependent on CtIP 226,289,421. As the switch 
region is full of repetitive sequences, microhomology-mediated rejoining of the DSBs could be 
promoted. Therefore, CSR could be the physiological cause for repair pathways using MHs 131.  
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2.3. Aim of this study  
DSB repair by end-joining has the potential to be error-prone due to sequence alterations and/or 
the misrejoining of two DSB ends, which causes genomic rearrangements. Thus, error-prone 
end-joining endangers genomic stability by promoting carcinogenesis and tumor progression 
51,99,134,161,193,413. However, the use of error-prone end-joining is poorly understood in WT human 
cells. While some studies show that c-NHEJ causes interchromosomal genomic rearrangements 
in WT human cells 142,302,357, other studies link the formation of intrachromosomal genomic 
rearrangements to resection, which results in sequence alterations during alt-EJ 148,322. 
However, in human cells, alt-EJ mechanisms are suggested to be restricted to cells deficient for 
certain repair proteins, which is the case for genetic defects or as frequently observed in tumor 
cells 22,143,181. Thus, it remains unclear how error-prone end-joining, resulting in 
intrachromosomal genomic rearrangements, operates in WT human cells and how that pathway 
compares to alt-EJ. 
To investigate mutagenic end-joining in this study, a reporter assay (in which two DSBs get 
induced in an intrachromosomal-integrated reporter construct) was utilized and combined with 
other molecular biological assays to investigate: (i) if DSBs are repaired in this assay, by 
analyzing the overall repair capability after DSB induction; (ii) if the two DSBs are misrejoined 
after the loss of the intervening fragment, by monitoring intrachromosomal genomic 
rearrangements; (iii) if the misrejoined break sites feature sequence alterations; and (iv) how 
the structure of other reporter constructs influences the misrejoining of DSBs. This was 
complemented by the investigation of protein-protein interactions to characterize: (1) the 
circumstances under which error-prone end-joining is utilized in WT human cells; (2) which 
factors are involved in this type of error-prone end-joining; (3) does error-prone end-joining in 
WT human cells involve resection (like alt-EJ)? (4) If so, how is it initiated and (5) how does it 
operate? Moreover, (6) how does this repair pathway compare to other DSB repair mechanisms; 
and (7) is there a benefit for the cell to use this pathway, taking into account its mutagenic 
character? 
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3. Results 
The purpose of this study was the investigation of how distant endonuclease-induced DNA DSBs 
are misrepaired by an error-prone end-joining mechanism and to characterize the newly-
discovered underlying repair pathway. The first chapter of the results section introduces the 
assays and analyses performed in this study, the second chapter focuses on end-joining factors 
involved in this error-prone repair mechanism, and the third chapter uncovers how this repair 
mechanism is initiated and executed. 
3.1. The end-joining reporter system in GC92 cells and associated assays 
The center of this study was the end-joining reporter system in GC92 cells 155,322 (Figure 3.1 A). 
GC92 cells are SV40-transformed GM639 human fibroblasts, which contain an 
intrachromosomal-integrated reporter construct. This construct consists of a promoter region, 
several genes encoding surface reporter proteins, and two cohesive recognition sites for the 
endonuclease I-SceI, which are 3.2 kb apart. The endonucleolytic cleavage by I-SceI at its 
recognition site induces a DSB. The accurate repair of an I-SceI-induced DSB cannot be 
distinguished from the situation prior to the damage induction. However, the two I-SceI-
induced DSBs can be misrejoined if they are present at the same time. Misrejoining occurs by 
the inversion or loss of the intervening fragment (of note, inversion events are rare and were 
not further investigated in this study). The misrejoining of the distant DSB ends results in the 
expression of the CD4 reporter gene, and thus CD4-positive cells represent and enable the 
quantification of misrepair events in GC92 cells (Figures 3.1 A, B). Furthermore, sequence 
analysis of the misrejoined site provides information about repair-associated alterations of the 
DNA sequence adjacent to the break site. The reporter assay provides information about GC92 
cells in which misrepair took place, but not about the overall repair of I-SceI-induced DSBs. To 
assess the overall repair of the I-SceI-induced DSBs, the GC92 reporter assay was combined 
with the H2AX foci assay, which uses the histone modification H2AX as a marker to visualize 
DSBs (Figures 3.1 A, C). The first part of this results section focuses on introducing the assays 
and their analyses in detail. 
 28 
 
Figure 3.1 Misrepair and overall repair of distant I-SceI-induced DSBs can be assessed by the 
combination of the GC92 reporter assay with the H2AX foci assay 
(A) The end-joining reporter system in GC92 cells and associated assays. The end-joining reporter assay in GC92 
SV40-transformed human fibroblast cells contains two 3.2 kb distant I-SceI endonuclease recognition sites, where 
DSBs can be induced by I-SceI (red cell). Analysis of the CD4 reporter protein (green cell) reveals which cells have 
undergone misrepair by loss of the intervening fragment and analysis of H2AX foci (green dots) provides data about 
the overall repair. Sequence analysis was performed with the displayed primers (green arrows) to allow direct 
analysis of the misrejoined site. The diagram is based on Rass et al. (2009) and not drawn to scale. (B, C) Misrepair 
events as per CD4 expression (B) and overall repair analysis by the H2AX foci assay (C) in GC92 cells. GC92 cells 
were transfected with the I-SceI plasmid and treated with EdU and nocodazole 30 min prior to harvest. Harvest took 
place 48 h after I-SceI plasmid transfection. All cells were stained with anti-I-SceI and either anti-CD4 or anti-H2AX 
(white circles) antibody (AB) plus DAPI. Representative images were captured with a 63x objective using Metafer 
Isis software. The scale bar represents 10 µm.  
3.1.1. Analysis of misrepair events in GC92 cells 
To analyze misrepair events by the frequency of CD4-positive GC92 cells, damage was induced 
by the transfection of a plasmid encoding I-SceI protein. As a first step, the fluctuation of I-SceI 
protein levels over time was analyzed (Figure 3.2 A). Therefore, GC92 cells were harvested at 
multiple timepoints post-I-SceI plasmid transfection and the frequency of I-SceI-positive cells 
was investigated by immunofluorescence microscopy. The first signs of I-SceI were observed 
12 h after transfection of the I-SceI plasmid and I-SceI levels were highest after 48 h (also 
confirmed by immunoblotting Figure S8.1 a) with 34.2% of I-SceI-positive cells (Figure 3.2 A). 
At 72 h post-I-SceI plasmid transfection, I-SceI protein levels declined strongly and the 
remaining I-SceI-positive cells only showed weak I-SceI protein levels (Figures 3.2 A, S8.1 a). 
Therefore, harvesting of the GC92 cells for reporter assay experiments in this study was not 
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conducted earlier than 72 h post-I-SceI transfection, to avoid analyzing cells while damage 
induction was still fully active. 
Next, how misrepair events arise over time was investigated as per the frequency of CD4-
positive GC92 cells following I-SceI plasmid transfection. However, classical reporter assay 
analysis via flow cytometry showed huge fluctuations in the measured frequency of CD4-
positive cells. Therefore, the origins of these fluctuations were first investigated. Two factors 
were uncovered as reasons for these fluctuations and the analysis was optimized accordingly. 
First, the preferred method for reporter assay analysis in this study was the detection of CD4-
positive cells by immunofluorescence microscopy instead of the typically-used flow cytometry. 
The usage of flow cytometry for reporter assay experiments showed high background 
fluctuations (further described in chapter 5.5.1), which would require sample sizes at least 3 to 
10-fold greater than the sample sizes used in other studies to obtain somewhat meaningful 
results 35,155,322. Additionally, microscopic analysis of reporter assay experiments lacked false 
positive events, which means in all experiments conducted during this study, CD4-positive cells 
were exclusively observed in cells positive for I-SceI. Consequently, the standard deviation (SD) 
was reduced in samples analyzed by microscopy, which increased the effect size, and thus 
decreased the required sample size to gain meaningful results. The second factor greatly 
influencing the frequency of CD4-positive GC92 cells is the transfection efficiency of the I-SceI 
plasmid, as it affects the frequency of I-SceI-positive cells, and thus the frequency of cells in 
which DSBs are induced. Indeed, plasmid transfection efficiencies in GC92 cells vary greatly 
from less than 1% to nearly 80% positive cells (M = 28.1%, SD = 17.4%) after transfection with 
a plasmid encoding the reporter protein RFP (Figure S8.1 b). The transfection efficiencies of 
the similar-sized I-SceI plasmid also varied greatly. Thus, when analyzed in all cells, the high 
fluctuations of CD4-positive cells could be attributed to fluctuating transfection efficiencies 
(M = 2.7%, SD = 1.7%, Figure S8.1 c). This problem was tackled in other studies by 
normalizing the treated sample to an untreated control, which fails to solve the problem, as 
differences in plasmid transfection efficiencies were still observed, even in simultaneously 
transfected samples. Therefore, the logical solution would be to limit the measurement of 
misrepair events to cells with damage induction by only analyzing CD4-positive cells in all I-
SceI-positive cells. However, as described earlier, cells could not be harvested before I-SceI 
activity declined to avoid analysis during fully active damage induction. This problem was 
solved by co-transfection of the I-SceI plasmid with an RFP plasmid. In contrast to I-SceI protein 
levels, RFP protein was detectable in 25.0% of the cells 24 h after transfection (Figure 3.2 A). 
RFP expression peaked at 72 h with 32.4% positive cells. To further examine the expression of 
RFP co-transfected with the I-SceI plasmid, the frequency of cells positive for both proteins was 
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analyzed (Figure 3.2 B). The frequency of RFP-positive cells was slightly lower (M = 27.3%) 
compared to I-SceI-positive cells (M = 33.8%) 48 h after transfection with both plasmids. 
Strikingly, the frequency of cells positive for both proteins was similar to the frequency of RFP-
positive cells at 26.4%, indicating that RFP-transfected cells typically also contained the I-SceI 
plasmid. Therefore, RFP could be used as a marker for cells transfected with the I-SceI plasmid 
and was thus representative of cells where damage induction occurred. After solving the high 
fluctuation problem during analysis, the kinetics with which misrepair events arose post-I-SceI 
plasmid transfection were analyzed by microscopy-based detection of CD4-positive cells among 
all RFP-positive GC92 cells (Figure 3.2 A, S9.2 a). The quantity of CD4-positive cells among 
RFP-positive cells grew exponentially from 24 h to 72 h post-I-SceI transfection to 9.8% and 
declined slightly thereafter. This observation was essential in establishing 72 h post-I-SceI 
transfection as the optimum timepoint to harvest the GC92 cells for analysis, as I-SceI was 
strongly reduced at this time and CD4-positive cells were maximal.  
For some experiments during this study, it was necessary to transfect cells with plasmids 
encoding tagged proteins. In these experiments, the exogenous protein levels needed to be 
present prior to damage induction. Hence, the experimental conditions needed to be adjusted. 
As described earlier, simultaneous transfection of the RFP and I-SceI plasmids resulted in nearly 
every RFP-positive cell also being I-SceI-positive (Figure 3.2 B). Interestingly, this behavior was 
not only observed after simultaneous transfection but also if transfection of the RFP plasmid 
occurred 36 h before the I-SceI plasmid. To further investigate this curious behavior, other 
plasmids were co-transfected with either the RFP or the I-SceI plasmid. A plasmid encoding an 
RFP-tagged 102 kDa protein was co-transfected with or transfected 36 h prior to I-SceI plasmid 
transfection (Figures S8.2 b). While 17.2% or 18.2% of the cells were positive for the tagged 
protein, the frequency of cells positive for both proteins was nearly identical under both 
transfection procedures. This behavior was not observed when transfection of two plasmids 
took place at least 48 h apart (Figure S8.2 c). In conclusion, transfection of cells with an RFP or 
a tagged protein plasmid 36 h prior to I-SceI plasmid transfection ensured that over 95% of 
cells positive for RFP or the tagged protein were also positive for I-SceI (Figures 3.2 B, S8.2 b). 
This knowledge was used to adjust the experimental conditions and develop a standardized 
protocol (Figure 5.1) and standardized analysis for all misrepair measurements in GC92 cells, 
which could also be applied in experiments where exogenous protein was investigated. 
Ultimately, if the frequency of CD4-positive cells among all damage-induced cells (analyzed by 
RFP-positive cells) 72 h post-I-SceI and RFP co-transfection from all experiments during this 
study was combined, the mean value of misrepair events was at 9.6% (95% confidence interval 
(95% CI) [9.2%, 9.9%]) and the population was normally distributed (Figures S8.3 a, b).  
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In the GC92 reporter assay, DSBs are induced when I-SceI is present in the cells, which is a 
duration of roughly 60 h. Therefore, it is not possible to state in which cell cycle phase the DSBs 
were induced or in which cell cycle phase misrepair took place. To analyze in which cell cycle 
phase misrepair events arise, GC92 cells were synchronized with a double thymidine block. 
Subsequently, the cells were held in G1 16 h after thymidine release by serum starvation or in 
G2 8 h after thymidine release by treatment with the CDK1 inhibitor RO-3306 over the entire 
duration of the DSB induction and repair time (Figure S8.3 c). EdU treatment was used to mark 
cells progressing in the cell cycle, and thus exclude them from analysis. The frequency of 
misrepair events in G1 phase cells was 8.7%, which was similar to asynchronously grown cells. 
In contrast, the frequency of misrepair events in G2 phase cells was 2.7%, which was 
significantly lower (p < 0.001) than asynchronously grown cells. The effect size (d = 6.14) 
exceeded Cohen’s convention for a large effect (d = 0.80) 82. Hence, the majority of misrepair 
events are generated during G1 phase. Importantly, the application of the cell cycle-specific 
analysis of misrepair events was very harmful to the cells, and thus the results have to be 
carefully considered. However, the G1 specificity of the misrejoining of the two distant I-SceI-
induced DSBs in GC92 cells was confirmed during this work by additional experiments (chapter 
3.3.3). 
 
Figure 3.2 Misrejoining of distant DSB ends and overall repair in GC92 cells in relation to I-SceI levels 
(A) Rise of DSBs and misrepair events over time post-I-SceI transfection in GC92 cells. (B) Effect of co-transfection 
or transfection of the I-SceI and RFP plasmids 36 h apart. (A) GC92 cells were co-transfected with the RFP and I-
SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest took place at multiple 
timepoints post-I-SceI transfection. Cells were stained with anti-I-SceI, anti-CD4, or anti-H2AX plus anti-RFP AB 
and DAPI. (B) GC92 cells were either co-transfected with the RFP and I-SceI plasmids or RFP was transfected 36 h 
prior to I-SceI and harvesting occurred 48 h post-I-SceI transfection. Cells were stained with anti-I-SceI or anti-CD4 
plus anti-RFP AB and DAPI. (A, B) Samples were scanned using Metafer software and plasmid-transfected cells were 
analyzed. RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Data represent the mean 
of 4 independent experiments performed in duplicate (n = 4). Error bars show the SD  
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3.1.2. Overall repair of distant endonuclease-induced DSBs in GC92 cells 
To assess overall repair of the I-SceI-induced DSBs, the H2AX foci assay was applied in GC92 
cells co-transfected with the I-SceI and RFP plasmids. When a DSB is induced, the histone 
variant H2AX is phosphorylated several Mbp from the DSB end 329, which can be detected by 
immunostaining as a H2AX focus. As the two DSBs induced by I-SceI are only 3.2 kb apart in 
the GC92 reporter system, the expected increase of H2AX foci in an unrepaired situation would 
be 1 focus (Figures 3.1 A, C). However, H2AX foci could also increase by 2 if the two distant 
DSB ends are not held in proximity after damage induction or if the reporter construct is 
integrated more than once.  
In the H2AX foci assay, it is possible to analyze DSB repair in a cell cycle-dependent manner. 
Therefore, GC92 cells were co-transfected with the RFP and I-SceI plasmids and treated with 
EdU and nocodazole 30 min before harvest. The EdU and DAPI intensities were scanned under 
the microscope to identify the cell cycle phase of each RFP-positive cell (figures S8.4 a, b). 
However, this only enables the allocation of a cell cycle phase to a cell at the moment of harvest, 
but fails to provide information about when DSBs were induced or repaired over the 72 h post-
I-SceI transfection. In addition, the cell cycle distribution in CD4-positive and CD4-negative 
cells was similar at the time of harvest, which clearly shows that misrepaired cells still 
progressed in the cell cycle. Despite this, it was necessary to analyze H2AX foci in a cell cycle-
dependent manner since S and G2 phase cells had at least 10x higher background levels of 
H2AX foci than the expected theoretical effect of an unrepaired situation. Therefore, only cells 
in G1 phase at the time of harvest were analyzed. First, H2AX foci were analyzed in GC92 cells 
co-transfected with the I-SceI and RFP plasmids at multiple timepoints post-plasmid 
transfection. The background mean H2AX foci in G1 RFP-positive cells fluctuated between 
1.0 and 1.2 foci before I-SceI protein levels increased (24 h post-I-SceI transfection) and 
returned to background levels with the decrease of the I-SceI signal at 72 h post-I-SceI 
transfection (Figure 3.2 A). At 36 h post-I-SceI transfection, a maximum mean value of 
2.0 H2AX foci was observed in G1. This observation was important for the validation of the 
established experimental procedure (Figure 5.1) with the cell harvest at 72 h post-I-SceI 
transfection. At this timepoint H2AX foci had returned to background levels, showing that 
repair was mostly complete. This was not surprising, as the I-SceI levels were strongly reduced 
and the maximum number of CD4-positive cells also occurred at 72 h post-I-SceI plasmid 
transfection. However, since damage induction and repair is fluent over the entire time I-SceI 
is present in the cells, the maximum mean H2AX foci value is not expected to occur at a specific 
timepoint. Thus, the observed maximum mean value of 2.0 H2AX foci (meaning an increase 
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of approximately 1 focus) might not represent an unrepaired situation but could be attributed 
to a mixture of cells with repaired and unrepaired DSBs.  
In conclusion, the overall repair was analyzed using the mean value of H2AX foci in G1 phase 
cells with damage induction by I-SceI (analyzed in RFP-positive cells). This resulted in a mean 
value of 1.1 foci (95% CI [1.1, 1.2]) per cell when all experiments from this study were 
combined (Figure S8.5 a). The mean value for H2AX foci in cells without I-SceI DSB induction 
(RFP-negative cells) was 1.2 foci, which was very similar compared to the mean value for H2AX 
foci in cells with I-SceI-induced DSBs (RFP-positive cells, Figure S8.5 b). Therefore, the mean 
H2AX foci in RFP-negative cells qualified as a control to compare conditions with and without 
DSB induction to ensure that effects observed during this study truly originated from two 
unrepaired distant I-SceI-induced DSBs. Such controls were performed for every H2AX foci 
experiment in this study and the mean values ranged from 0.8 to 1.3 foci. Surprisingly, the 
mean value for H2AX foci in misrepaired CD4-positive cells was 0.4 foci, which was 
significantly lower (p = 0.001, d = 3.49) compared to the mean value of H2AX foci in RFP-
positive cells, and thus also lower than the background level. A more detailed analysis revealed 
that the median number of H2AX foci in RFP-positive cells within one experiment was either 
0 or 1 (Figure S8.5 c).  
3.1.3. Sequence analysis of the misrejoined break sites in GC92 cells 
In addition to the reporter assay and the H2AX foci assay, the DNA sequences adjacent to the 
misrejoined break sites were analyzed in GC92 cells to monitor repair-associated alterations. 
GC92 cells were transfected with the I-SceI plasmid and the CD4-positive cells were enriched 
by magnetic-activated cell sorting (MACS) 72 h post-transfection. The DNA was amplified and 
in contrast to other studies 154,155,322, the primers used for the DNA amplification were placed 
further apart to maximize the information about the sequences. The sequences were analyzed 
with regard to alterations such as deletions or insertions of nucleotides at the misrejoined break 
sites. The I-SceI recognition site consists of 18 bp and nucleolytic cleavage by I-SceI produces a 
4 nt 3′ overhang (see Table 8.2). Misrejoining of the distant DSB ends with loss of the 
intervening fragment and no additional base deletions was called high-fidelity misrepair event 
and produced a new I-SceI recognition site. Analysis of all sequences (Table 8.1, 8.2) showed 
that 90% of all misrejoined sites ranged from no additional deletions to deletions of less than 
50 nt, with the majority of deletions being fewer than 10 nt (Figures 3.3 A). The mean value of 
additional deletions at the misrejoined sites was 34 nt (Figure 3.3 B). Closer inspection of the 
misrejoined break sites revealed that misrejoining of distant DSB ends occasionally included 
insertions, which ranged from 2 to 31 nt in size (Figure 3.3 C). Furthermore, the insertions were 
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found in combination with all sizes of deletions, and the inserted sequences were often 
templated (Figure 3.3 C, Table 8.2). In addition, most DSB ends were misrejoined with the use 
of MHs. MHs were observed in combination with all deletion sizes (Figure 3.3 C) and maximally 
4 nt long, which was concurrently the most common MH size (Figure 3.3 D). 
In conclusion, upon I-SceI damage induction, misrepair events arose primarily in G1 phase in 
approximately 10% of I-SceI-positive GC92 cells by loss of the intervening fragment. All of the 
induced DSBs were repaired, as the number of H2AX foci after damage induction was 
approximately equal to 1 H2AX focus in cells without damage induction. The majority of the 
misrepaired events were connected with the additional loss of nucleotides at the misrejoined 
sites. These deletions suggest that the process involved in the generation of these misrepair 
events includes the digestion of bases from the DSB end. Hence, resection could be involved in 
the misrepair of distant DSBs, which is a frequently-observed feature in error-prone repair 
mechanisms 207,257,401. 
 
Figure 3.3 Sequence analysis of misrejoined break sites 
GC92 cells were harvested 72 h post-I-SceI transfection and incubated with anti-CD4 AB and magnetic MicroBeads 
for MACS enrichment. After cell lysis, DNA purification, and amplification, the DNA was sequenced. (A, B) 
Distribution of deletion sizes of all 40 analyzed sequences from the 4 independent experiments (A) or of the mean 
values from the 4 independent experiments (B) (n = 4). (A) Events with no additional deletions were given a value 
< 1 nt to include them in the logarithmic scale. (B) Error bar shows the (95% CI). (C) Insertion size (blue) of each 
sequence in relation to its deletion size of the 9 observed insertions and MH size (black) of each sequence in relation 
to its deletion size for all 32 sequences with additional deletions from the 4 independent experiments (n = 4). (D) 
Frequency of MH length used for rejoining in all 32 sequences with additional deletions from the 4 independent 
experiments (n = 4). (A, B, C, D) For further details see Tables 8.1, 8.2. Most sequences were part of the analysis in 
Biehs et al. (2017). 
3.1.4. Comparing the misrepair of distant and close endonuclease-induced DSBs 
Additional reporter systems were used and compared to the end-joining reporter construct in 
GC92 cells throughout this study to establish how the choice of proteins for misrepair in the 
GC92 end-joining reporter system is influenced by its structure. These additional reporter 
systems were end-joining reporter constructs in GCS5 and GCSH14 fibroblast cell lines 154 
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(Figures 3.4 A). Both cell lines showed similar I-SceI protein level kinetics as GC92 cells. In 
addition, HeLa pGC cells were used as controls to validate the efficiency of inhibitors for 
proteins that are known to be involved in error-free gene conversion. The end-joining construct 
in GCSH14 cells is similar to the GC92 reporter construct but with GFP as a reporter protein 
instead of CD4 and with an approximately 200 bp shorter distance between the reporter gene 
and the second I-SceI recognition site (Figure 3.4 A). GCSH14 cells were harvested 72 h post-I-
SceI and RFP co-transfection for analysis of the frequency of GFP-positive cells. Surprisingly, 
the mean value of misrepair events in GCSH14 cells was 7.7%, which was significantly lower 
(p = 0.005, d = 1.66) in comparison to the mean value of 10.1% misrepair events in the GC92 
cells (Figure 3.4 B). Taking the sequence analysis of the misrejoined break sites in GC92 cells 
into account (Figures 3.3 A, Tables 8.1, 8.2), an explanation could be that larger deletions might 
harm the GFP gene because it is closer to the second I-SceI recognition site than the CD4 gene 
in GC92 cells (Figure 3.4 A). 
In contrast to the end-joining reporter systems in GC92 and GCSH14 cells with two distant I-
SceI recognition sites, the GCS5 cell line contains an end-joining reporter construct with two I-
SceI recognition sites in close proximity (Figures 3.4 A). The end-joining reporter construct in 
GCS5 cells contains GFP as a reporter just like the end-joining construct in GCSH14 cells does. 
However, the intervening fragment between the two I-SceI recognition sites is only 34 bp long, 
much shorter than the 3.2 kb of the end-joining constructs in GC92 or GCSH14 cells. The 
expression of the GFP gene in GCS5 cells is prevented by a Koz-ATG insert in the intervening 
fragment. At 72 h post-I-SceI and RFP co-transfection misrepair events in GCS5 cells occurred 
in 29.7% GFP-positive cells, which was more frequent compared to CD4-positive GC92 cells 
(Figures 3.4 B, C). The increased frequency of misrepair events in GCS5 compared to GC92 cells 
might be due to the proximity of the two DSBs. Thus, GCS5 cells were used to compare 
misrepair of distant DSB ends in GC92 cells to the misrepair of close DSBs. 
 
Figure 3.4 Misrepair of two relatively-close and two relatively-distant I-SceI-induced DSBs 
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(A) End-joining reporter constructs in GC92, GCS5, and GCSH14 cells. GCS5 and GCSH14 human fibroblast cells 
containing end-joining reporter constructs can be selected using G418. Both constructs have GFP as a reporter gene. 
While the two I-SceI recognition sites in GCSH14 cells are 3.2 kb apart from each other, the intervening fragment in 
GCS5 cells is only 34 bp long with GFP expression being prevented by a Koz-ATG insert. The diagrams are based on 
Rass et al. (2009) Guirouilh-Barbat et al. (2016) and not drawn to scale. (B, C) Misrepair events in GC92, GCSH14, 
GCS5, and HeLa pEJ cells. GC92, GCSH14, GCS5, and HeLa pEJ cells were harvested 72 h post-co-transfection with 
the RFP and I-SceI plasmids. Cells were stained with anti-CD4 or anti-GFP plus anti-RFP AB and DAPI. Samples were 
scanned using Metafer software and only plasmid-transfected cells were analyzed. RFP was used as a marker for 
cells with damage induction (see chapter 3.1.1). Data represent the mean of 8 independent experiments performed 
in duplicate (n = 8). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained 
by two-sample Student’s t-test.  
3.2. End-joining-associated proteins and their role in the repair of distant DSBs 
The second part of this study focused on proteins associated with end-joining and what 
influence the impairment of these proteins has on the misrepair and overall repair of distant 
and close endonuclease-induced DSBs. Therefore, the main experimental procedure involved 
the depletion, inhibition, or knock-out (KO) of proteins in the end-joining reporter cell systems 
and utilization of the assays described in part one. 
3.2.1. Misrepair is dependent on c-NHEJ factors 
First, which end-joining factors are involved in the misrejoining of DSB ends was investigated. 
In human cells, the majority of DSBs are repaired by c-NHEJ in all cell cycle phases (Figure 
2.4). During c-NHEJ, the DSB ends are protected by the KU70/80 heterodimer and held 
together by DNA-PKcs 188,362. Together, this complex is called DNA-PK. LIG4 is necessary for the 
ligation of the DSB ends 191. Inhibition of the c-NHEJ core component DNA-PK by Nu7441 
prevents DNA-PKcs autophosphorylation. Thus, the DNA-PK complex gets stuck on the break 
ends, which prevents the completion of repair 99,117. Accordingly, inhibition of DNA-PK in GC92 
cells resulted in a decrease of misrepair events by 90% (Figure 3.5 A). Close inspection of the 
single DNA-PK components revealed that the depletion of KU70/80 increased misrepair events 
to 17.3%, while depletion of DNA-PKcs decreased misrepair events to 1.5% (Figure 3.5 B). A 
decrease of misrepair events to 5.0% was also observed after depletion of LIG4. In GCS5 cells, 
where the two DSBs are close to each other, DNA-PK inhibition, LIG4, or KU70/80 depletion 
resulted in a decrease of misrepair events from nearly 30% to levels between 1.2% and 1.5% 
(Figures 3.5 A, S8.6 a). DNA-PKcs depletion alone led to a two-thirds decrease in misrepair 
events (Figures S8.6 a).  
To examine the cause of the decreased misrepair in GC92 cells after impairment of c-NHEJ 
factors, the H2AX foci assay was used. Both, DNA-PK inhibition and DNA-PKcs depletion 
resulted in H2AX foci increasing to 3.1 or 2.6, respectively (Figures S8.6 b, c). Both increases 
were significant (p ≤ 0.001) compared to the control. Therefore, it can be concluded that the 
decrease of misrepair events in GC92 cells after DNA-PK inhibition or DNA-PKcs depletion is 
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caused by unrepaired DSBs. In contrast, KU70/80 depletion did not have an effect on the H2AX 
foci assay compared to the control (Figure S8.6 c), which corresponds to the increased quantity 
of misrepair events in the reporter assay. Finally, LIG4 depletion caused an increase to 
1.7 H2AX foci. Although this increase was not significant (p = 0.182), the effect size (d = 2.12) 
exceeded Cohen’s convention for a large effect 82. Combined with the finding that misrepair 
events dropped by half compared to the control after LIG4 depletion (Figure 3.5 B), the missing 
50% of misrepair events might be caused by unrepaired DSBs in a fraction of the cells. In 
conclusion, misrepair events of distant DSBs in GC92 cells is dependent on c-NHEJ factors. 
However, this dependency dwindles if the DSB ends are not protected by KU70/80. 
 
Figure 3.5 c-NHEJ factors are required in end-joining reporter systems 
(A, B) Impact of DNA-PK inhibition (A) or depletion of core c-NHEJ factors (B) on misrepair in GC92 (A, B) and/or 
GCS5 (A) cells. GCS5 and/or GC92 cells were treated with inhibitors and/or siRNAs against DNA-PK (Nu7441), 
DNA-PKcs, KU70/80, or LIG4. As a control, cells were treated with DMSO or control siRNA. Harvesting occurred 
72 h post-co-transfection with I-SceI and RFP plasmids. Downregulation by siRNA was confirmed by immunoblotting. 
Cells were stained with anti-CD4 or anti-GFP plus anti-RFP AB and DAPI. Samples were scanned using Metafer 
software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 or 16 independent 
experiments performed in duplicate (n = 8 for A, B right; n = 16 for B left). RFP was used as a marker for cells with 
damage induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-
value was obtained by one-way ANOVA with Bonferroni correction (A, B left) or by two-sample Student’s t-test (B 
right). (D) Several data points were part of the analysis in Biehs et al. (2017). 
At this point of the study, a predicament arose: on one hand, the generation of misrepair events 
is dependent on c-NHEJ factors, which includes the protection of the DSB ends by the KU70/80 
heterodimer; on the other hand, the generation of misrepair events might involve resection 
(chapter 3.1.3). Simultaneously, it has been established in the literature 239,273,362 that KU 
generally prevents resection. However, the additional deletions observed in the sequence 
analysis of the misrejoined sites (Figure 3.3 A, Table 8.1), indicate a resection size far smaller 
than observed in publications addressing this subject. The GC92 reporter assay is limited in 
providing information regarding the possibility of limited resection taking place while KU 
protects the DSB ends. Hence, the system was switched to address this question after X-ray 
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irradiation (X-IR). Experiments from members of the working group led to the speculation that 
slowly repairing DSBs during G1 phase after X-IR might depend on the same repair pathway as 
misrejoining of distant DSBs. Therefore, experimental procedures, which are usually used to 
investigate resection in G2 were modified and applied to examine the roles of core c-NHEJ 
factors and resection in the slow DSB repair in G1 phase. Late DSB repair in G2 phase is 
conducted by HR. In this process, resection takes place to generate large regions of ssDNA, 
which are protected by pRPA 37. Therefore, pRPA is considered an indirect marker for the 
presence of ssDNA. During HR, pRPA is exchanged with RAD51 to allow invasion of the sister 
chromatid and use it as a template for high-fidelity repair 77,280. This exchange is only possible 
if KU is no longer binding to the DSB ends 74. 
First, the H2AX foci assay was performed in 82-6 hTERT cells after 7 Gy X-IR in samples treated 
with the DNA-PK inhibitor at various timepoints (Figures S8.7 a, b). NU7441 is a selective small 
molecule inhibitor for DNA-PK (IC50 of 14 nM) 99,172 that competes with ATP for the ATP-
binding domain of DNA-PK 305. It causes IR-induced DNA DSBs to persist due to trapping of 
DNA-PK at the DSB ends, preventing further repair 377. As DNA-PK is required for the fast repair 
process, the inhibitor was added 6 h, 8 h, 10 h, or 12 h post-irradiation to ensure that the fast 
repair component was concluded. Analysis of H2AX foci 14 h post-irradiation revealed that the 
cells were unable to repair DSBs from the moment the DNA-PK inhibitor was added. Thus, the 
repair of DSBs is dependent on DNA-PK throughout the slow repair process in G1 phase. After 
establishing that the slow repair requires the core c-NHEJ component DNA-PK, the question of 
whether resection can occur in the presence of KU was directly addressed by KU foci analysis. 
Due to their size and the fact that only two KU molecules bind to a DSB, KU foci analysis 
required confocal laser scanning microscopy (CLSM). In HeLa cells, KU80 foci largely co-
localized with H2AX foci in G1 as well as in G2 (Figure 3.6 A). At 8 h post-4 Gy X-IR, co-
localization of KU80 with H2AX foci was often observed along with a drop in the DAPI intensity 
(Figures 3.6 A, C). However, co-localization studies with KU80 and H2AX foci were 
problematic since H2AX forms large blotches, especially at late timepoints. To ensure that the 
KU80 foci were specific and did not result from non-specific background signals (as observed 
in unirradiated samples, Figure 3.6 B), co-localization of KU80 with RAD51 foci was 
investigated in G2. KU80 foci did not co-localize with RAD51 foci (Figures 3.6 D, E). Finally, it 
was investigated if KU80 foci co-localize with pRPA foci. This experiment required high doses 
of irradiation since pRPA foci are only observed in G1 phase after high doses of X-IR or after 
high-LET irradiation 36. KU80 was observed to co-localize almost completely with pRPA 4 h 
post-10 or 20 Gy X-IR (Figures 3.6 F, G). Thus, resection occurs at the break site despite the 
presence of KU. In conclusion, the involvement of c-NHEJ factors was shown in the slow repair 
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process in G1 and KU could be linked to resected DSB ends. However, this combination was 
surprising because although resection is frequently associated with error-prone end-joining 
mechanisms 102,116, it is generally accepted that c-NHEJ factors prevent resection 239,273,362. 
 
Figure 3.6 KU80 foci co-localize with pRPA foci after high doses of X-IR in G1 phase 
HeLa cells were treated with EdU and nocodazole 30 min prior to X-IR and harvested at the indicated timepoints. 
(A, D, F) KU80 foci co-localize with H2AX (A) and pRPA (F) but not with RAD51 (D) foci. (B) KU80 foci in 
unirradiated samples. (A, B, D, F) Cells were stained with anti-H2AX, anti-RAD51, or anti-pRPA plus anti-KU80 AB 
and DAPI. Images were obtained with a 100x objective using CLSM. Scale bar is 5 µm. Images were analyzed with 
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LAS AF Lite software. No co-localization (red circles), co-localization (white circles), and co-localization in concert 
with a DAPI signal drop (local DAPI minimum, black circle) was analyzed. All pRPA or RAD51 foci were analyzed 
for co-localization with KU80. H2AX foci co-localization with KU80 foci are merely examples. Of note, the 
experimental procedure was conducted together with M. Steinlage and CLSM images were taken together with J. 
Mirsch. (C, E, G) Exemplary line blots of co-localization analysis. Each co-localization was confirmed by line blot 
with maximum intensity Imax > 100 (arb. units) and distance (max. intensity) dx < 20 nm (with the majority being 
smaller than 5 nm). (B, D, E, F, G) Some co-localization analyses were included in Biehs et al. (2017). 
3.2.2. Varying roles for PARP1 in different end-joining mechanisms 
In addition to the c-NHEJ repair pathway, a backup end-joining pathway called alt-EJ has been 
described. This type of DSB repair is known to include deletions due to resection. Alt-EJ usually 
takes over in the absence of KU and the described deletions are often several hundred 
nucleotides long 207,257,401. The mechanism involves factors such as PARP1 and ligation is 
conducted by LIG1/3 359. Although the misrejoinig of distant DSB ends in GC92 cells has been 
established as occurring in a manner dependent on c-NHEJ factors, whether the impairment of 
alt-EJ factors also impacts misrepair events was investigated. First, PARP1 was examined. PARP 
inhibitors often have an effect on the cell cycle 20,195,252, which makes them tricky to work with 
in experiments such as the reporter system because inhibitor treatment was required over the 
duration of several days. The PARP inhibitor PJ34 proved to be unsuitable because the impact 
on the cells was severe, resulting in 20x fewer cells than the minimum required for analysis. 
However, treatment with the PARP inhibitor Olaparib over several days did allow analysis 
although Olaparib also has a strong effect on the cell cycle, which impacts the measurements 
of DNA repair activity 195. Nevertheless, Olaparib (IC50 of PARP1 = 5 nM and PARP2 = 1 nM) 
is known to have fewer side effects  269. Recently, the van Houten working group at the 
University of Pittsburgh used atomic force microscopy 29 to find that Olaparib does not trap 
PARP1 on DNA as so many other PARP inhibitors do, but affects the PARylation dynamics by 
enhanced PARP1 mobility (conference contribution 243).  
In GC92 cells, Olaparib treatment resulted in a significant decrease (p = 0.003) in misrepair 
events from 10.3% in the untreated sample to 4.4% with an effect size of 3.56 (Figure 3.7 A). 
Since PARP inhibitors are not specific, the experiment was also confirmed by PARP1 depletion 
(Figure 3.7 B). In contrast, in GCS5 cells, where the two DSBs are induced only 34 bp apart 
from each other, no effect was observed after PARP inhibition by Olaparib (Figure 3.7 A) or 
after PARP1 depletion (Figure S8.8 a). As established in chapter 3.2.1, misrepair in GC92 cells 
increases after KU70/80 depletion (Figure 3.5 B) even though c-NHEJ factors are otherwise 
required for the misrejoining of distant DSB ends. As PARP1 is involved in alt-EJ, a pathway 
that takes over, especially in KU70/80-deficient cells 257,401, the combined effect of KU70/80 
depletion and Olaparib inhibitor treatment was analyzed. The increased misrepair levels after 
KU70/80 depletion were reduced by treatment with Olaparib to 1.2%, which is significantly 
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lower (p < 0.001, d = 9.22) than inhibition or depletion of PARP1 alone (Figure 3.7 B). To 
further analyze the misrepair events in GC92 cells, the H2AX foci assay was used. Olaparib 
treatment or PARP1 depletion did not impair overall repair in GC92 cells after I-SceI damage 
induction (Figures 3.7 C, S8.8 b). However, Olaparib treatment in combination with KU70/80 
depletion resulted in a significant increase (p < 0.001) of H2AX foci from 0.9 to 3.0 with an 
effect size of 7.40 (Figures 3.7 C). In conclusion, PARP1 is required for 50% of the misrejoining 
of distant DSBs in GC92 cells but is not necessary for repair of the DSBs. Conversely, KU70/80 
depletion makes DSB repair entirely dependent on PARP1.  
 
Figure 3.7 PARP1 has multiple roles in different end-joining mechanisms 
(A, B, C) Impact of PARP inhibition (A, C), PARP1 depletion (B), or PARP inhibition in combination with KU70/80 
depletion (B, C) on misrepair (A, B) and overall repair (C) in GC92 (A, B, C) and/or GCS5 (A) cells. GCS5 and/or 
GC92 cells were treated with inhibitors and/or siRNAs against PARP (Olaparib), PARP1, and/or KU70/80. As a 
control, cells were treated with DMSO or control siRNA. (A, B) Harvest occurred 72 h post-co-transfection with I-
SceI and RFP plasmids. Downregulation by siRNA was confirmed by immunoblotting. Cells were stained with anti-
CD4 or anti-GFP plus anti-RFP AB and DAPI. Samples were scanned using Metafer software and only plasmid-
transfected cells were analyzed. Data represent the mean of 8 independent experiments performed in duplicates 
(n = 8). (C) Cells were co-transfected with RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min 
prior to harvest. Harvest took place 72 h post-plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, 
and DAPI. Samples were scanned using Metafer software and only plasmid-transfected G1 cells were analyzed. Data 
represent the mean of 5 independent experiments (n = 5). (A, B, C) RFP was used as a marker for cells with damage 
induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was 
obtained by one-way ANOVA with Bonferroni correction. 
Next, the influence of alt-EJ ligases LIG1/3 on the misrejoining of distant DSBs in GC92 cells 
was investigated. Depletion of LIG1/3 did not alter the percentage of misrejoining events in 
GC92 cells (Figure 3.8 A). However, a comparison was difficult, as the data significantly 
deviated from a normal distribution at the 0.05 level. With a reduction to only 9.8% misrepair 
events from 10.4% in control cells, the effect size was 0.32, which is a small effect under Cohen 
82 and negligible in comparison to other effects observed in this study. Although confirmation 
of LIG1/3 downregulation by immunoblotting gave consistent results when no additional 
proteins were depleted, the data looked like a bimodal distribution, which could result from 
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variations in siRNA efficiency. As observed in chapter 3.2.1, depletion of the c-NHEJ ligase LIG4 
reduced misrepair in GC92 cells by half. Additional depletion of the alt-EJ ligases LIG1/3 caused 
a reduction in misrepair events to 1.1% with an effect size of 4.18 (Figure 3.8 A). As before, the 
data significantly deviated from a normal distribution at the 0.05 level. Additional PARP 
inhibition in combination with LIG4 depletion resulted in a significant reduction (p < 0.001) in 
misrepair events to 1.0% (Figure 3.8 B). In contrast, PARP inhibition in combination with 
LIG1/3 depletion did not show any additional effect compared to PARP inhibition alone. 
According to the highly-reduced misrepair in GC92 cells, depletion of all three ligases or LIG4 
in combination with the PARP inhibitor caused a repair defect with 2.8 or 3.0 H2AX foci, 
respectively (Figure S8.8 c). 
 
Figure 3.8 The role of LIG1/3 is limited to alt-EJ 
(A, B) Impact of depletion of several ligases with (B) or without (A) PARP inhibitor treatment on misrepair in GC92 
cells. GC92 cells were treated with inhibitors and/or siRNAs against PARP (Olaparib), LIG4, and/or LIG1/3. As a 
control, cells were treated with DMSO or control siRNA. Harvest took place 72 h post-co-transfection with the I-SceI 
and RFP plasmids. Downregulation by siRNA was confirmed by immunoblotting. Cells were stained with anti-CD4, 
anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were 
analyzed. Data represent the mean of 8 or 16 independent experiments performed in duplicate (n = 8 for B; n = 16 
for A). RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Error bars show the 95% CI. 
Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni correction. 
(A) Several data points were part of the analysis in Biehs et al. (2017). 
As the depletion of LIG1/3 did not show an effect on the measurement of misrepair events in 
GC92 cells and the data distribution had a bimodal behavior, the misrejoined sites were 
investigated by sequence analysis. The distribution of additional deletions after depletion of 
LIG1/3 was almost identical compared to the control (Figure 3.9 A Tables 8.1, 8.3), as was the 
mean deletion size of the 4 independent experiments (Figure 3.9 B). The insertion size at sites 
with additional deletions was also similar, though LIG1/3-depleted samples featured far fewer 
misrejoined sites with insertions (Figures 3.9 C). Upon closer inspection, no insertions were 
observed at misrejoined sites where additional deletions were bigger than the mean value of 
36.92 nt. After LIG1/3 depletion, the use of MHs at misrejoined break sites with additional 
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deletions showed similar behavior compared to the control (Figure 3.9 D). Nevertheless, the 
largest class of MHs in control cells (4 nt) was reduced in favor of 2 nt MHs and, for the first 
time, even the use of 6 nt MHs was observed. Finally, LIG1/3 does not seem to play a role in 
the misrejoining of distant DSB ends, but if present, may influence the insertions at the 
misrejoined sites with long deletions and even the size of the MHs used for rejoining. However, 
if the c-NHEJ ligase LIG4 is depleted, LIG1/3 can take over to generate half of the misrepair 
events in a PARP1-dependent manner. 
 
Figure 3.9 LIG1/3 depletion barely influences misrejoined sites in GC92 cells 
GC92 cells were treated with siRNA against LIG1/3 (and control siRNA) and harvested 72 h post-I-SceI transfection. 
Cells were incubated with anti-CD4 AB and magnetic MicroBeads to be enriched by MACS. After cell lysis, DNA 
purification, and amplification, the DNA was sequenced. (A, B) Distribution of deletion sizes for all 40 (siCtrl) or 
39 (siLIG1/3) analyzed sequences from the 4 independent experiments (A) or of the mean values from the 
4 independent experiments (B) (n = 4). (A) Events with no additional deletions were given a value < 1 nt to include 
them in the logarithmic scale. (B) Error bars show the 95% CI. (C) Insertion size of each sequence in relation to its 
deletion size of the 9 (siCtrl) or 4 (siLIG1/3) observed insertions (n = 4). (D) Frequency of MH length used for 
rejoining in all 32 (siCtrl) or 30 (siLIG1/3) sequences with additional deletions from the 4 experiments (n = 4). (A, 
B, C, D) For further details see Tables 8.1, 8.3. Most sequences were part of the analysis in Biehs et al. (2017). 
3.2.3. The misrejoining of distant DSB ends relies on various polymerases 
Polymerases play an important role in DNA repair. Two polymerases are connected to c-NHEJ, 
namely POL and POLµ 420. In contrast, POL is involved in MMEJ, a pathway associated with 
the use of MHs 38. POL is observed to create templated insertions and preferentially use 4 nt 
MHs for rejoining 171,410. Co-depletion of both c-NHEJ-associated polymerases POL and POLµ 
significantly reduced the mean misrepair events from 8.4% to 5.1% with an effect size of 3.80 
(p < 0.001, Figure 3.10 A). In contrast, single depletion failed to generate this impact, 
indicating that when only POL or POLµ is impaired, the other polymerase can mostly take 
over. Depletion of POL resulted in a reduction to 5.6% misrepair events. Combined depletion 
of all three polymerases reduced misrejoining of distant DSBs even further to only 1.2%. Indeed, 
H2AX foci analysis showed an increase from 1.1 to 2.6 foci after depletion of all three 
polymerases, validating the hypothesis that the reduction in misrepair was due to a lack of 
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repair (Figure 3.10 B). Depletion of either POL/µ or POL increased H2AX foci to 1.6. 
Although the difference of the means compared to the control was not significant at the 0.05 
level, the effect sizes (dsiPOL/µ = 1.66; dsiPOL = 1.55) exceeded Cohen’s convention for a large 
effect 82. These data suggest that depletion of either POL/µ or POL results in a partial repair 
defect. Furthermore, POL/µ and POL all play a role in the misrejoining of distant DSBs after 
I-SceI damage induction in the GC92 reporter system, but independently of one another.  
 
Figure 3.10 Misrepair in GC92 cells requires POL/ and POL 
(A, B) Impact of depletion of several polymerases on misrepair (A) or overall repair (B) in GC92 cells. GC92 cells 
were treated with siRNAs against POL/µ and/or POL. As a control, cells were treated with control siRNA. (A) 
GC92 cells were harvested 72 h post-co-transfection with the I-SceI and RFP plasmids. Downregulation by siRNA 
was confirmed by immunoblotting. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned 
using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent 
experiments performed in duplicate (n = 8). (B) Cells were co-transfected with RFP and I-SceI plasmids and treated 
with EdU and nocodazole 30 min prior to harvest. Harvest took place 72 h post-plasmid transfection. Cells were 
stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-
transfected G1 cells were analyzed. Data represent the mean of 5 independent experiments (n = 5). (A, B) RFP was 
used as a marker for cells with damage induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was 
calculated by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni correction. 
3.2.4. ARTEMIS is essential for the misrepair of DSBs 
At this point of the study, it has been established that misrepair events in GC92 cells arise in a 
c-NHEJ-dependent manner. However, certain factors associated with alt-EJ contribute to the 
generation of misrepair events. The nuclease ARTEMIS is closely associated with DNA-PKcs in 
c-NHEJ 144,251. There, ARTEMIS processes DSB ends before ligation, when necessary. 
Additionally, ARTEMIS plays a role in alt-EJ 278 and is essential in V(D)J recombination 104, 
which makes it an interesting candidate to investigate in this study. 
First, ARTEMIS was depleted by siRNA in GC92 cells and misrepair was measured (Figure 
3.11 A). The mean percentage of misrejoining events dropped significantly from 10.4% to 1.8% 
with an effect size of 6.85 (p < 0.001). Surprisingly, the results in ARTEMIS-depleted GC92 
cells differed from those in the master’s thesis 35 where misrepair events were only reduced by 
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half (Figure S8.9 a). During the master’s thesis, the frequency of CD4-positive cells among all 
cells was analyzed with 24 h less time for the downregulation by siRNA. This difference in the 
results underscores the importance of the analysis development in this study (e.g. to only 
analyze cells in which damage induction took place as described in chapter 3.1.1). Compared 
to GC92 cells, a smaller effect was observed in GCS5 cells, where misrepair dropped from 28.0% 
to 12.5% following ARTEMIS depletion (Figure 3.11 A). The generation of misrepair events in 
GCSH14 cells was also dependent on ARTEMIS (Figure S8.9 b).  
 
Figure 3.11 ARTEMIS is required for misrejoining of DSB ends 
(A, B, C) Impact of the absence (A, B, C) and complementation (B) of ARTEMIS on misrepair (A, B) or overall repair 
(C) by depletion in GC92 (A, C) or GCS5 (A) cells or in GC92 ARTEMIS KO cells (B). GC92, GCS5, or GC92 ARTEMIS 
KO cells were treated with siRNA against ARTEMIS. As a control, cells were treated with DMSO or control siRNA. 
(A) Cells were harvested 72 h post-co-transfection with the I-SceI and RFP plasmids. (B) GC92 WT or ARTEMIS KO 
cells were transfected with the RFP, cMyc-ART-WT, or cMyc-ART-D37N plasmid. After 36 h, cells were transfected 
with I-SceI and harvested after an additional 72 h. Representative images were captured with a 63x objective using 
Metafer Isis software. Scale bar represents 10 µm. Diagram of the WT exogenous ARTEMIS and the endonuclease 
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mutant D37N are not drawn to scale. (A, B) Downregulation, KO, and expression of exogenous plasmids were 
confirmed by immunoblotting. Cells were stained with anti-CD4 or anti-GFP plus anti-RFP or anti-cMyc AB plus 
DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were analyzed. Data 
represent the mean of 8 or 16 independent experiments performed in duplicates (n = 16 for A; n = 8 for B). (C) Cells 
were co-transfected with the RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. 
Harvest took place 72 h post-plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. 
Samples were scanned using Metafer software and only plasmid-transfected G1 cells were analyzed. Data represent 
the mean of 5 independent experiments (n = 5). (A, B, C) RFP and cMyc were used as markers for cells with damage 
induction and exogenous protein (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by 
Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni correction. (B, C) Several data points were 
part of the analysis in Biehs et al. (2017). 
Next, two GC92 KO cell lines were generated using CRISPR/Cas9 with different gRNAs (Figure 
S8.9 d). In both GC92 ARTEMIS KO cell lines, misrepair events were never observed (Figures 
3.11 B, S8.9 c). All further experiments were conducted with the ARTEMIS KO cell line 
generated with gRNA #3. To exclude a loss of the end-joining substrate during the generation 
of the KO cell line causing the absence of misrepair events in GC92 ARTEMIS KO cells, 
exogenous epitope-tagged ARTEMIS protein was introduced into the cells by transfection with 
the WT ARTEMIS plasmid (Figure 3.11 B). The quantity of misrepair events in GC92 ARTEMIS 
KO cells positive for the cMyc-ARTEMIS protein rose to 7.6%. GC92 cells transfected with an 
ARTEMIS mutant plasmid encoding an ARTEMIS protein with Asp37 mutated to Asn (which 
results in the disruption of the endonuclease function) failed to generate any misrepair events. 
To elaborate on the findings in GC92 cells after ARTEMIS depletion or in GC92 ARTEMIS KO 
cells, the H2AX foci assay was conducted. The mean number of H2AX foci rose to 3.0 and 2.9, 
respectively. This was a significant difference (p < .001) compared to the control with effect 
sizes of 2.85 and 6.79 (Figure 3.11 C). These results demonstrate the absolute necessity of the 
endonuclease function of ARTEMIS in the misrejoining of distant DSBs after I-SceI damage 
induction.  
Next, SFB-tagged ARTEMIS WT protein was precipitated and purified from stably-transfected 
HEK293 cells after no irradiation, 30 min, or 2 h post-X-IR with 5 Gy. Proteins that were co-
precipitated with ARTEMIS were analyzed by mass spectrometry (MS) to further establish 
factors that might be of interest in this kind of end-joining repair. Of note, the protein name 
used in MS analysis is indicated in parenthesis whenever it differs from the protein name used 
in this thesis. Generally, interacting proteins either showed an increase (ratios > 2), decrease 
(ratios < 0.5), or maintained a more-or-less steady interaction (ratios between 0.5 and 2) with 
ARTEMIS (DCLRE1C) after damage induction and the indicated repair time (Table 8.4). Several 
established direct or indirect ARTEMIS interaction partners and novel potential interacting 
proteins were observed. The strongest interaction (indicated by the most interacting peptides) 
was with DNA-PKcs (PRKDC) 144,251. Several factors of the c-NHEJ machinery were co-
precipitated with ARTEMIS (KU80 (XRCC5), KU70 (XRCC6), XRCC4, and LIG4). LIG4 showed 
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an interaction increase 2 h post-irradiation. Another established ARTEMIS interaction partner 
is the DNA damage checkpoint control protein TOPBP1, which showed a damage-inducible 
increase in interacting peptides with ARTEMIS 30 min and 2 h post-irradiation. TOPBP1 
provides the binding platform for resection and anti-resection factors 355, including anti-
resection factor 53BP1. One of 53BP1s downstream factors is PTIP (PAXIP1), which was 
observed in this experiment and is an established ARTEMIS-interacting factor in a damage-
inducible manner 400. Furthermore, POH1 (PSMD14) was also observed to increasingly interact 
with ARTEMIS 2 h post-irradiation. POH1 has two roles in DSB repair: as a regulator of c-NHEJ 
it restricts 53BP1 accumulation and in G2 it promotes HR by functioning in the process of 
relieving the anti-resection barrier posed by 53BP1 59,203. Another steady interaction was 
observed with all members of the MRN complex: MRE11, RAD50, and NBS1 (NBN) 228,303,383. 
Interestingly, a novel damage-inducible interaction increase was observed with NONO and 
SFPQ, which together form a complex, stabilize KU, and are involved in identifying and aligning 
the accurate DSB ends during c-NHEJ 187,213,387. Additionally, some chromatin remodeling 
factors were also observed to interact with ARTEMIS (e.g. MCRS1 86,98, KAP1 (TRIM28)). 
Interestingly, a damage-inducible increase in the interaction of DDX1 with ARTEMIS was 
observed. DDX1 plays a role in RNA clearance at DSBs and is thereby associated with facilitating 
template-guided repair of transcriptionally-active regions in the genome 236. 
In summary, ARTEMIS is an essential factor in the misrepair of DSBs and also in the resection 
process during repair in G1 phase after X-IR. Furthermore, ARTEMIS is associated with an array 
of proteins involved in the DNA damage response, and thus provides the foundation for the 
analysis of which additional factors might be involved in this repair pathway. 
3.2.5. Misrepair in 53BP1-depleted cells is conducted by alt-EJ  
A factor mentioned in the ARTEMIS interaction studies (chapter 3.2.4) is 53BP1. 53BP1 builds 
the binding platform for many downstream factors in the DNA damage response and is essential 
in counteracting resection 14,438. The finding that the repair pathway, which is responsible for 
the misrejoining of distant DSBs, might involve resection but at the same time limits it by 
protecting the DSB ends through KU-binding, makes the anti-resection factor 53BP1 a strong 
candidate to be involved in this pathway. Depletion of 53BP1 by transfection with siRNA 
(Figures 3.12 A, B) or by CRISPR/Cas9 viral transduction with a gRNA (Figure S8.10 a), led to 
elevated frequencies of misrepair events in GC92 cells between 16.2% and 20.4% with the 
means differing significantly (p < 0.001) from the controls. These elevated levels were reduced 
to 10.1% in 53BP1-depleted cells upon transfection with a WT HA-53BP1 plasmid (Figure 
3.12 B). Consistent with the elevated levels of misrepair events in GC92 cells after 53BP1 
depletion, the mean H2AX foci level was not altered (Figure 3.13 B). 
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Figure 3.12 53BP1 depletion increases misrepair in GC92 cells 
(A) Impact of 53BP1 depletion (A, B) and 53BP1 complementation (B) on misrepair in GC92 cells. GC92 cells were 
treated with siRNA against 53BP1. As a control, cells were treated with control siRNA. (A) Cells were harvested 72 h 
post-co-transfection with I-SceI and RFP plasmids. (B) Cells were transfected with the RFP or siRNA-resistant HA-
53BP1-WT plasmid. 36 h after plasmid transfection, cells were transfected with I-SceI and harvested after an 
additional 72 h. Representative images were captured with a 63x objective using Metafer Isis software. Scale bar 
represents 10 µm. Diagram of the exogenous WT 53BP1 is not drawn to scale. (A, B) Downregulation by siRNA and 
expression of exogenous plasmids were confirmed by immunoblotting. Cells were stained with anti-RFP or anti-HA 
plus anti-CD4 AB and DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were 
analyzed. Data represent the mean of 8 independent experiments performed in duplicate (n = 8). RFP and HA were 
used as markers for cells with damage induction and exogenous protein (see chapter 3.1.1). Error bars show the 
95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni 
correction (for B) or by two-sample Student’s t-test (for A). Several data points were part of the analysis in Biehs et 
al. (2017). 
To investigate how this increase in misrepair of distant DSBs emerges in 53BP1-depleted GC92 
cells, additional factors were depleted and misrepair events and overall repair observed. 
Additional depletion of DNA-PKcs or LIG4, as well as additional inhibition of DNA-PK did not 
alter the increased frequency of misrepair events in 53BP1-depleted cells (Figure 3.13 A) and 
also did not impact the overall repair (Figure 3.13 B). Therefore, the block at the DNA ends by 
the DNA-PK inhibitor can be overcome in 53BP1-depleted GC92 cells, which was not possible 
in the WT situation (compare to Figure 3.5 A). This suggests the usage of another end-joining 
mechanism to generate misrepair events in 53BP1-depleted cells. As KU70/80 and 53BP1-
depleted cells both showed an increase in misrepair events, the dependence of 53BP1-depleted 
cells on alt-EJ factors (similar to KU70/80-depleted GC92 cells) was tested (compare to Figure 
3.7 B). PARP inhibition by Olaparib or depletion of PARP1 or LIG1/3 in 53BP1-depleted GC92 
cells resulted in significant reduction (p < 0.001) in misrepair events to levels between 1.3% 
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and 2.3% with effect sizes between 10.30 and 9.01 (Figure 3.13 C). Moreover, for all conditions 
including depletion or inhibition of alt-EJ factors in addition to 53BP1 depletion, a significant 
rise of H2AX foci from 1.1 to levels between 2.5 and 2.8 (p-values between 0.011 and 0.023) 
was observed (Figure 3.13 D). Next, the previously-investigated polymerases (chapter 3.2.3) 
were depleted in GC92 cells in addition to 53BP1. Polymerases POL/µ neither impacted the 
increased frequency of misrepair events (Figure S8.10 b) nor the overall repair compared to the 
single 53BP1 depletion (Figure S8.10 c). However, co-depletion of POL with 53BP1 strongly 
reduced misrepair events in GC92 cells to 1.1% (Figure S8.10 b) and increased the mean H2AX 
foci to 3.0 (Figure S8.10 c).  
 
Figure 3.13 Misrepair in 53BP1-depleted GC92 cells requires alt-EJ factors  
(A, B, C, D) Impact of inhibition or depletion of c-NHEJ factors (A, B) or alt-EJ factors (C, D) on misrepair (A, C) or 
repair (B, D) in 53BP1-depleted GC92 cells. GC92 cells were treated with inhibitors and/or siRNAs against DNA-PK 
(Nu7441), DNA-PKcs, LIG4, PARP (Olaparib), PARP1, LIG1/3, and/or 53BP1. As a control, cells were treated with 
DMSO or control siRNA. (A, C) Harvest took place 72 h post-co-transfection with I-SceI and RFP plasmids. 
Downregulation by siRNA was confirmed by immunoblotting. Cells were stained with anti-CD4, anti-RFP AB, and 
DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were analyzed. Data 
represent the mean of 8 independent experiments performed in duplicate (n = 8). (B, D) GC92 cells were co-
transfected with RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest took 
place 72 h post-plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were 
scanned using Metafer software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 
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5 independent experiments (n = 5). (A, B, C, D) RFP was used as a marker for cells with damage induction (see 
chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by 
one-way ANOVA with Bonferroni correction. (B, C, D) Several data points were part of the analysis in Biehs et al. 
(2017). 
53BP1 is associated with several other factors. This includes PTIP and ARTEMIS 400 in one 
downstream cascade and RIF1 and REV7 127 in another downstream cascade. Additionally, 
RAP80 is also described to pose a resection barrier in S/G2 phase 203. Therefore, the impact of 
impairment of these factors in the GC92 reporter assay was investigated next. 53BP1 depletion 
in GC92 ARTEMIS KO cells neither affected the abolished misrepair events in the ARTEMIS KO 
cell line (Figure 3.14 A) nor the repair defect in the H2AX foci assay (Figure S8.10 d). 
Impairment of RIF1 or REV7 by CRISPR/Cas9 viral transduction of gRNAs led to elevated 
frequencies of misrepair events in GC92 cells, comparable to 53BP1-depleted cells (Figure 
3.14 B). In contrast, PTIP impairment by CRISPR/Cas9 viral transduction of a gRNA 
significantly reduced the misrepair events compared to the control to 4.2% (p < 0.001). 
Depletion of RAP80 increased misrepair events to 21.2%, which differed significantly 
(p = 0.018) from the control with an effect size of 1.34 (Figure 3.14 C). 
 
Figure 3.14 The absence of the known resection barrier proteins RIF1, REV7, and RAP80 increased, 
while the absence of the 53BP1-associated factor PTIP reduced the misrepair of distant DSB ends 
(A) Impact of 53BP1 depletion (A), 53BP1-associated factors impaired by CRISPR/Cas9 viral transduction (B), or 
RAP80 depletion (C) on misrepair in GC92 WT (A, B, C) or ARTEMIS KO (A) cells. (A, C) GC92 WT or ARTEMIS KO 
cells were treated with siRNAs against 53BP1 or RAP80. As a control, cells were treated with control siRNA. (B) 
GC92 cells were transduced with CRISPR/Cas9 and RIF1 #1, REV7 #4, or PTIP #1 gRNA plasmids and selected. (B, 
C) Downregulation by CRISPR/Cas9 or siRNA was confirmed by immunoblotting. (A, B, C) Cells were harvested 
72 h post-co-transfection with the I-SceI and RFP plasmids and stained with anti-CD4, anti-RFP AB, and DAPI. 
Samples were scanned using Metafer software and only plasmid-transfected cells were analyzed. Data represent the 
mean of 8 independent experiments performed in duplicates (n = 8). RFP was used as a marker for cells with damage 
induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was 
obtained by one-way ANOVA with Bonferroni correction (for B) or by two-sample Student’s t-test (for C). 
In summary, 53BP1 depletion proved to be an effective way to clarify that misrepair of distant 
DSBs in GC92 cells only occurs in an alt-EJ-dependent manner if resection barriers such as 
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53BP1 are absent. This is similar to the situation when DSB ends are not protected by KU70/80 
(chapter 3.2.1) and is different to the WT situation where resection takes place using a repair 
mechanism dependent on c-NHEJ factors. Therefore, 53BP1 depletion can be used as a tool to 
investigate how the WT resection-dependent pathway differs from the backup pathway alt-EJ. 
3.3. Resection in end-joining: how resection barriers can be overcome 
As established in the first and second part of this results section, misrejoining of distant DSB 
ends might involve short resection and relies on various factors that are known resection 
barriers. The leading question of part three is how resection can occur in a pathway dependent 
on c-NHEJ factors and which mechanisms overcome the previously-described resection barriers. 
3.3.1. Misrepair relies on the pro-resection factor BRCA1  
BRCA1 plays a central role in counteracting the anti-resection factor 53BP1 in S/G2 phase by 
promoting its dephosphorylation 186. BRCA1 is the pivotal component in a number of protein 
complexes involved in DNA repair. One complex, for instance, is the BRCA1-C complex, which 
initiates resection in S/G2 and includes proteins such as MRE11 and CtIP 78,412. However, BRCA1 
also forms the BRCA1-A complex, which is essential in regulating the extent of resection during 
HR by stabilizing 53BP1 in S/G2 phase 162. It involves factors such as ABRAXAS and RAP80. In 
G1 phase, BRCA1 is rapidly recruited to the DSBs by KU80 197,336. To investigate BRCA1’s role 
in the misrepair of distant DSBs, BRCA1 was depleted in GC92 cells. The mean frequency of 
misrepair in BRCA1-depleted cells was significantly reduced by half compared to the control 
(p < 0.001, Figure 3.15 A). Next, CRISPR/Cas9 technology was used to generate a GC92 BRCA1 
KO cell line (Figure S8.11 a). The frequency of misrepair events was also reduced by half in this 
BRCA1 KO cell line compared to the WT, as were the misrepair events in GC92 cells in which 
BRCA1 was impaired by CRISPR/Cas9 viral transduction of another gRNA (Figure S8.11 b). 
BRCA1 depletion in GCS5 cells, which contain the reporter construct with two close DSBs, 
showed a decrease in misrepair events to one-third compared to the control (Figure S8.11 c). 
Since BRCA1s role in S/G2 is to antagonize 53BP1, BRCA1 was next co-depleted with 53BP1 in 
GC92 cells. In BRCA1-53BP1 co-depleted cells, misrepair events increased to 15.5%, which 
resembled the situation with single 53BP1 depletion (Figure 3.15 B, compare to 3.12 A). Thus, 
BRCA1 is specifically required to counteract 53BP1 in the misrejoining of distant DSB ends. 
However, BRCA1 is dispensable in the absence of 53BP1 and misrepair events are generated by 
alt-EJ (as established in chapter 3.2.5). Depletion of BRCA1 did not affect the abolished 
misrepair events in GC92 ARTEMIS KO cells (Figure 3.15 B). The H2AX foci assay was used to 
investigate overall repair. Although BRCA1 depletion reduced misrepair events by 50%, no 
impact was observed in the H2AX foci assay (Figure S8.11 d). While GC92 ARTEMIS KO cells 
 52 
showed a full repair defect with an increase to 3 H2AX foci, BRCA1 depletion in GC92 
ARTEMIS KO cells reduced this repair defect to 1.8 H2AX foci with an effect size of 1.83 
compared to the control.  
 
Figure 3.15 BRCA1 depletion decreases misrepair in GC92 cells 
(A, B) Impact of BRCA1 depletion (A, B) or BRCA1-53BP1 co-depletion (B) on misrepair (A, B) in GC92 WT (A, B) 
or ARTEMIS KO (B) cells. GC92 WT or ARTEMIS KO cells were treated with siRNAs against BRCA1 and/or 53BP1. 
As a control, cells were treated with control siRNA. Cells were harvested 72 h post-co-transfection with I-SceI and 
RFP plasmids. Downregulation by siRNA was confirmed by immunoblotting. Cells were stained with anti-CD4, anti-
RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were analyzed. 
Data represent the mean of 8 independent experiments performed in duplicate (n = 8). RFP was used as a marker 
for cells with damage induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s 
d and p-value was obtained by one-way ANOVA with Bonferroni correction. Several data points were part of the 
analysis in Biehs et al. (2017). 
Due to the location of the gRNA, the generated GC92 BRCA1 KO cell line contains a BRCA1 
protein with a deleted BRCT domain while the RING domain is still present (Figure S8.11 a). 
The BRCT domain is important for BRCA1s interaction with other proteins and the RING 
domain is the location of its E3 ubiquitin ligase activity 127. Therefore, which BRCA1 domains 
are required for the misrepair of distant DSBs was investigated next. Exogenous FLAG-BRCA1 
protein was introduced into the cells by transfection (Figures 3.16 A). The frequency of 
misrepair events in BRCA1-depleted GC92 cells positive for the exogenous WT BRCA1 protein 
rose significantly to 10.1% compared to the BRCA1-depleted condition (p < 0.001, d = 4.10). 
Transfection with a BRCA1 mutant plasmid encoding a BRCA1 protein with Ile26 mutated to 
Ala, which partially impairs the BRCA1 RING domain, also resulted in frequencies of misrepair 
events similar to the control. However, Feng et al. (2015) proposed that this mutant has residual 
activity. Therefore, exogenous BRCA1 with a Cys61 mutated to Gly RING domain mutation was 
used. Here, the frequency of misrepair events remained at 50% compared to the control, which 
resembled the situation after BRCA1 depletion. Finally, GC92 cells were transfected with a 
BRCA1 plasmid with a BRCT domain mutant encoding a BRCA1 protein with Ser1655 mutated 
to Ala. The complementation with the BRCA1 BRCT mutant also failed to restore the full 
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frequency of misrepair events. The exogenous BRCA1 protein levels of the complementation 
experiments presented in Figure 3.16 A were low. In contrast, all other plasmids used in this 
study resulted in overexpression and high protein levels. Therefore, the effect of BRCA1 
overexpression was examined next. The SFB-BRCA1 plasmid was used, which resulted in high 
quantities of exogenous BRCA1 in GC92 cells (Figure S8.11 e). The frequency of misrepair was 
not altered by BRCA1 overexpression.  
 
Figure 3.16 The RING and BRCT domains of BRCA1 are required for the misrepair of distant DSBs 
(A) BRCA1 complementation in BRCA1-depleted GC92 cells. GC92 cells were treated with siRNA against BRCA1. As 
a control, cells were treated with control siRNA. GC92 cells were transfected with the RFP or siRNA-resistant FLAG-
BRCA1-WT, FLAG-BRCA1-I26A, FLAG-BRCA1-C61G, or FLAG-BRCA1-S1655A plasmid. 36 h after plasmid 
transfection, cells were transfected with I-SceI and harvest took place after an additional 72 h. Downregulation by 
siRNA and expression of exogenous plasmids were confirmed by immunoblotting. Cells were stained with anti-RFP 
or anti-FLAG plus anti-CD4 AB and DAPI. Samples were scanned using Metafer software and only plasmid-
transfected cells were analyzed. Data represent the mean of 8 independent experiments performed in duplicate 
(n = 8). RFP and FLAG were used as a marker for cells with damage induction and exogenous protein (see chapter 
3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way 
ANOVA with Bonferroni correction. Representative images were obtained with a 63x objective using Metafer Isis 
software. Scale bar represents 10 µm. Diagrams of the exogenous BRCA1 WT, the I26A partial RING domain mutant, 
the C61G RING domain mutant, and the S1655A BRCT domain mutant are not drawn to scale. Several data points 
were part of the analysis in Biehs et al. (2017). 
To summarize, BRCA1 is an important factor in the misrejoining of distant and close DSB ends 
after I-SceI damage induction. For the misrejoining of distant DSBs, both the RING and the 
BRCT domain are required. In a 53BP1 impaired background, BRCA1 is dispensable for the 
misrepair of distant DSB ends. 
3.3.2. The resection initiating factor CtIP is required for the misrejoining of distant 
DSB ends 
As mentioned in the previous chapter (3.3.1), BRCA1 interacts with the endonuclease CtIP to 
initiate resection during HR 78,412. In unirradiated samples, this interaction is exclusively 
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observed in S/G2 phase and dependent on a CDK complex-mediated phosphorylation of CtIP at 
Ser327 428. Hence, it was first tested if a BRCA1-CtIP interaction is possible in G1. Exogenous 
GFP-CtIP was immunoprecipitated from G1-synchronized HEK293 cells. The cells showed a 
synchronization in G1 phase 24 h post-plasmid transfection (Figure S8.12 a). Thus, only 
transfected cells were immunoprecipitated using a GFP antibody. Upon damage induction, 
phosphorylation of CtIP at Ser327 was observed 30 min post-5 Gy X-IR (Figure S8.12 b). 
Simultaneously, CtIP was observed interacting with BRCA1 in irradiated cells, but not in the 
unirradiated sample. The damage-inducible BRCA1-CtIP interaction was confirmed by 
immunoprecipitation of endogenous BRCA1 from HEK293 cells, which pulled down exogenous 
GFP-CtIP 30 min post-irradiation. Additionally, exogenous GFP-CtIP phospho-mutant with 
Ser327 mutated to Ala was immunoprecipitated from G1-synchronized HEK293 cells. As 
expected, no phosphorylation was observed at site 327. Moreover, BRCA1 did not interact with 
the exogenous CtIP phospho-mutant. The lack of interaction was confirmed by 
immunoprecipitation of endogenous BRCA1, which failed to co-immunoprecipitate the 
exogenous CtIP phospho-mutant. Therefore, in contrast to S/G2 phase, the BRCA1-CtIP 
interaction exists in G1 only in a damage-inducible manner. Similar to S/G2 phase, it is also 
dependent on the phosphorylation of CtIP at Ser327. 
The damage-inducible interaction of CtIP with BRCA1 in G1 phase makes CtIP a promising 
candidate that might be involved in the misrepair of distant DSBs after I-SceI-induced damage. 
Indeed, CtIP depletion in GC92 cells resulted in a significant reduction of the mean misrepair 
events from 9.8% to 5.0% (p < 0.001, d = 2.39, Figure 3.17 A). This observation was confirmed 
after CtIP impairment by viral transduction of CRISPR/Cas9 in GC92 cells (Figure S8.13 a). 
However, the reduction in misrepair events did not impact overall repair in CtIP-depleted GC92 
cells as per the mean value of H2AX foci (Figure 3.17 B). An even bigger effect (d = 5.37) was 
observed in the reduction of misrepair events in the GCSH14 reporter system, which also 
monitors distant DSBs (Figure 3.17 A). In contrast, CtIP depletion in the GCS5 reporter system 
with two relatively-close DSBs had no impact on its misrepair events. Next, CtIP was 
overexpressed in GC92 cells by transient transfection of a WT CtIP plasmid encoding exogenous 
RFP-CtIP (Figure 3.17 C). Surprisingly, misrepair events increased significantly to a mean value 
of 18.5% (p < 0.001) with an effect size of 3.82. To test if this effect was caused by the 
overexpression of the exogenous CtIP, a stable SFB-CtIP GC92 cell line was generated, which 
did not overexpress CtIP. Misrepair events in this cell line were not altered compared to the 
control. Thus, CtIP and BRCA1 interact in G1 phase after damage-induction and depletion of 
each protein resulted in a 50% decrease in misrepair events in GC92 cells, but did not alter the 
overall repair efficiency. However, their roles in misrepair seem to differ since only 
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overexpression of CtIP resulted in increased misrepair of distant DSB ends and only BRCA1 
depletion showed a decrease in misrepair of close DSB ends. 
 
Figure 3.17 CtIP is required for misrejoining of distant DSB ends 
(A, B, C) Impact of CtIP depletion (A, B) or exogenous CtIP (C) on misrepair (A, C) or overall repair (B) in GC92 (A, 
B, C), GCSH14, or GCS5 (A) cells. GC92, GCSH14, or GCS5 cells were treated with siRNA against CtIP. As a control, 
cells were treated with control siRNA. (A) Cells were harvested 72 h post-co-transfection with I-SceI and RFP 
plasmids. Downregulation by siRNA was confirmed by immunoblotting. (B) Cells were co-transfected with RFP and 
I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest took place 72 h post-plasmid 
transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using Metafer 
software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 5 independent 
experiments (n = 5). (C) GC92 cells were transfected with the RFP or RFP-CtIP-WT plasmid or a stable GC92 cell 
line was used, which does not overexpress SFB-CtIP-WT. 36 h after plasmid transfection, cells were transfected with 
I-SceI and harvest took place after an additional 72 h. Representative images were obtained with a 63x objective 
using Metafer Isis software. Scale bar represents 10 µm. (A, C) Cells were stained with anti-RFP or anti-FLAG plus 
anti-CD4 or anti-GFP AB plus DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells 
were analyzed. Data represent the mean of 8 independent experiments performed in duplicate (n = 8). (A, B, C) RFP 
and FLAG were used as a marker for cells with damage induction and exogenous protein (see chapter 3.1.1). Error 
bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with 
Bonferroni correction. Several data points were part of the analysis in Barton et al. (2014). 
As CtIP seems to play an exclusive role in the misrejoining of distant DSBs, the misrejoined sites 
were investigated in CtIP-depleted GC92 cells by sequence analysis. The distribution of 
deletions after depletion of CtIP differed in many aspects from the distribution in control 
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sequences (Figure 3.18 A, Tables 8.1, 8.5). First, while the frequency of sequences with no 
additional deletions remained similar, the frequency of deletions below 10 nt was greatly 
reduced after CtIP depletion. Second, the categories with deletions between 10 nt and 50 nt 
were also reduced with the exception of additional deletions between 20 nt and 30 nt, which 
increased. Finally, all categories of additional deletions above 50 nt also increased after CtIP 
depletion with accumulations between 50 nt and 200 nt, as well as above 300 nt. Accordingly, 
the mean deletion size increased significantly from 34 nt to 120 nt after CtIP depletion 
(p = 0.003) with an effect size of 2.97 (Figure 3.18 B). The distribution of insertions in relation 
to the deletion size expectedly showed more insertions at bigger deletions due to the greater 
percentage of bigger deletions in total (Tables 8.1). Moreover, more insertions were observed 
after CtIP depletion compared to control cells and the mean insertion size increased (Figure 
3.18 C). Surprisingly, the misrejoining of distant DSBs without the use of MHs at sites with 
deletions more than tripled in CtIP-depleted cells compared to the control (Figure 3.18 D). 
Furthermore, the most frequent category in control cells of 4 nt MH length was completely 
abolished after CtIP depletion. These findings suggest that CtIP is involved in a pathway, which 
preferentially generates small deletions of fewer than 50 nt at the DSB and then misrejoins 
distant DSBs using MHs, preferentially 4 nt long. In the absence of CtIP, the size of the deletions 
in the remaining 50% of misrepair events increases, bigger insertions are used, and distant DSBs 
are preferentially rejoined without the use of MHs. Due to the growth in deletion size some 
sequence alterations might harm the reporter gene and go unnoticed in the reporter assay. 
Therefore, the analyzed sequences were limited in their maximum size by selection of CD4-
positive cells and the primers used for amplification. 
 
Figure 3.18 CtIP depletion results in an increase in the deletion size at the misrejoined sites of the 
remaining misrepair events and rejoining is primarily conducted without MHs 
GC92 cells were treated with siRNA against CtIP (and control siRNA) and harvested 72 h post-I-SceI transfection. 
Cells were incubated with anti-CD4 AB and magnetic MicroBeads to be enriched by MACS. After cell lysis, DNA 
purification, and amplification, the DNA was sequenced. (A, B) Distribution of deletion sizes of all analyzed 
40 (siCtrl) or 41 (siCtIP) sequences from 4 or 5 independent experiments (A) or of the mean value from the 4 or 
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5 independent experiments (B) (n = 4 for siCtrl; n = 5 for siCtIP). (A) Events with no additional deletions were given 
a value < 1 nt to include them in the logarithmic scale. (B) Error bars show the 95% CI. (C) Mean insertion size of 
the 9 (siCtrl) or 13 (siCtIP) observed insertions (n = 4 for siCtrl; n = 5 for siCtIP). Error bars show the SD. (D) 
Frequency of MH length used for rejoining in all 32 (siCtrl) or 35 (siCtIP) sequences with additional deletions from 
the 4 or 5 experiments (n = 4 for siCtrl; n = 5 for siCtIP). (A, B, C, D) For further details see Tables 8.1, 8.5. 
To investigate how this decrease in misrejoining of distant DSBs arises in CtIP-depleted GC92 
cells, additional proteins were impaired by depletion or inhibition. First, the impact of impaired 
c-NHEJ and alt-EJ factors in addition to CtIP depletion was examined. Inhibition of DNA-PK or 
depletion of DNA-PKcs further decreased the frequency of misrepair in CtIP-depleted GC92 cells 
(Figure 3.19 A). In contrast, PARP inhibition by Olaparib or additional depletion of LIG1/3 
resulted in similar frequencies of misrepair events compared to CtIP depletion alone (Figures 
3.19 A, S8.13 b). Next, CtIP was co-depleted in combination with polymerases investigated in 
previous chapters (3.2.3, 3.2.5). Additional depletion of POL did not impact the frequency of 
misrepair events in CtIP-depleted GC92 cells (Figure 3.19 B). Conversely, additional depletion 
of POL/µ further reduced the misrepair events to a mean value of 0.9%, which was a 
significant difference (p < 0.001) compared to the 4.6% in cells with only CtIP depletion. 
Accordingly, co-depletion of POL/µ with CtIP increased the mean value of H2AX foci to 2.7, 
while additional depletion of POL did not show a repair defect (Figure S8.13 c). Therefore, 
POL acts in one pathway together with CtIP to generate misrepair events in GC92 cells. This 
fits with POLs described preferential use of 4 nt MHs for rejoining 414, which were abolished 
in the sequence analysis of the misrejoined sites after CtIP depletion (Figure 3.18 D). 
Additionally, misrepair events that arise in the absence of CtIP rely on c-NHEJ-associated 
polymerases.  
 
Figure 3.19 In the absence of CtIP, DNA-PK is required to misrejoin the remaining distant DSB ends, 
while POL and PARP are not 
(A, B) Impact of inhibition or depletion of c-NHEJ factors, alt-EJ factors (A), or polymerases (B) on misrepair in CtIP-
depleted GC92 cells. GC92 cells were treated with inhibitors and/or siRNAs against CtIP and DNA-PK (Nu7441), 
DNA-PKcs, PARP (Olaparib), POL, or POL/µ. As a control, cells were treated with DMSO. Harvest took place 72 h 
post-co-transfection with I-SceI and RFP plasmids. Downregulation by siRNA was confirmed by immunoblotting. 
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Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only 
plasmid-transfected cells were analyzed. Data represent the mean of 8 independent experiments performed in 
duplicate (n = 8). RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Error bars show 
the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni 
correction. 
As established in chapter 3.2.4, the nuclease ARTEMIS is crucial for misrepair of distant DSB 
ends. Therefore, CtIP was next depleted in GC92 ARTEMIS KO cells, which maintained the 
abolishment of misrepair events as was observed in GC92 ARTEMIS KO cells (Figure 3.20 A). 
The H2AX foci assay was conducted to investigate if the lack of misrepair events was due to 
the lack of repair, as GC92 ARTEMIS KO cells had a full repair defect of 3 H2AX foci (Figure 
3.11 C). The mean H2AX foci were significantly reduced from 2.9 foci in GC92 ARTEMIS KO 
cells to 1.7 foci in CtIP-depleted GC92 ARTEMIS KO cells (p < 0.001) with an effect size of 5.69 
(Figure 3.20 B). In comparison to the 0.9 H2AX foci in control cells, the mean 1.7 foci in CtIP-
depleted GC92 ARTEMIS KO cells was significantly higher (p = 0.013) with an effect size of 
3.52, which is consistent with a partial repair defect. In conclusion, the combination of proteins 
by which the remaining misrepair events in CtIP-depleted GC92 cells arise, indicates the 
requirement for c-NHEJ and not alt-EJ factors. However, the observed increase in additional 
deletions at the misrejoined break sites suggest a more detrimental mutagenic mechanism.  
 
Figure 3.20 CtIP depletion in GC92 ARTEMIS KO cells partially rescues the ARTEMIS repair defect 
(A, B) Impact of CtIP depletion on misrepair (A) or overall repair (B) in GC92 ARTEMIS KO cells. GC92 WT or 
ARTEMIS KO cells were treated with siRNA against CtIP. As a control, cells were treated with control siRNA. (A) 
Cells were harvested 72 h post-co-transfection with I-SceI and RFP plasmids. Downregulation by siRNA was 
confirmed by immunoblotting. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned 
using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent 
experiments performed in duplicates (n = 8). (B) Cells were co-transfected with the RFP and I-SceI plasmids and 
treated with EdU and nocodazole 30 min prior to harvest. Harvest took place 72 h post-plasmid transfection. Cells 
were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only 
plasmid-transfected G1 cells were analyzed. Data represent the mean of 5 independent experiments (n = 5). (A, B) 
RFP was used as a marker for cells with damage induction and exogenous protein (see chapter 3.1.1). Error bars 
show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with 
Bonferroni correction. Several data points were part of the analysis in Biehs et al. (2017). 
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Due to this interesting influence of CtIP in addition to ARTEMIS impairment and CtIPs major 
role in specifically impacting the misrejoining of distant DSB ends, other proteins associated 
with CtIP might be of interest. Strikingly, the damage-inducible ARTEMIS interaction partner 
PTIP (PAXIP1) 400 was observed to be co-precipitated after damage induction with SFB-CtIP WT 
protein precipitated and purified from stably-transfected HEK293 cells (30 min post-5 Gy X-IR, 
analyzed by MS; Table 8.6). This result raises the question of how CtIP depletion would affect 
the misrejoining of distant DSBs in GC92 cells in the absence of the upstream PTIP factor 53BP1. 
The mean value of misrepair events in CtIP-53BP1 co-depleted GC92 cells was significantly 
reduced to 2.2% (p < 0.001) compared to CtIP depletion alone with an effect size of 2.16 
(Figure 3.21 A). In contrast, co-depletion of CtIP and the pro-resection factor BRCA1 did not 
have any additional impact on misrepair events. The reduction in misrepair events upon CtIP-
53BP1 co-depletion resulted from a repair defect, as evidenced by the H2AX foci assay (Figure 
3.21 B). Next, CtIP and 53BP1 co-depleted GC92 cells were transfected with the WT CtIP 
plasmid, which resulted in overexpressed RFP-CtIP. It needs to be emphasized that in 
comparison to all other conditions this combination misrejoined distant DSBs most frequently, 
with nearly every-second RFP-positive cell resulting in a misrepair event (Figure 3.22 A).  
 
Figure 3.21 The increase of misrepair events in 53BP1-depleted GC92 cells is dependent on CtIP 
(A, B) Impact of co-depletion of 53BP1 or BRCA1 with CtIP on misrepair (A) or overall repair (B) in GC92 cells. 
GC92 cells were treated with siRNAs against BRCA1, 53BP1, and/or CtIP. (A) Harvest took place 72 h post-co-
transfection with I-SceI and RFP plasmids. Downregulation by siRNA was confirmed by immunoblotting. Cells were 
stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-
transfected cells were analyzed. Data represent the mean of 16 independent experiments performed in duplicate 
(n = 16). (B) Cells were co-transfected with RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min 
prior to harvest. Harvest took place 72 h post-plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, 
and DAPI. Samples were scanned using Metafer software and only plasmid-transfected G1 cells were analyzed. Data 
represent the mean of 5 independent experiments (n = 5). (A, B) RFP was used as a marker for cells with damage 
induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was 
obtained by one-way ANOVA with Bonferroni correction (for A) or by two-sample Student’s t-test (for B). 
In the last part of this chapter, the influence of several CtIP domains on the misrejoining of 
distant DSBs was investigated. For this reason, CtIP-depleted GC92 cells were transfected with 
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CtIP plasmids encoding a variety of CtIP proteins, including the WT and mutants impaired in 
certain domains. Inhibition of ATM, an important Ser/Thr-protein kinase, resulted in the 
reduction of misrepair events in GC92 cells by 50% (Figure S8.14 a). ATM is known to 
phosphorylate CtIP at Ser664 and Ser745 subsequent to the aforementioned CDK 
phosphorylation in S/G2 phase. This ATM-mediated CtIP phosphorylation is required to control 
resection during HR 238,397. Therefore, an exogenous CtIP phospho-mutant with Ser664 and 
Ser745 both mutated to Ala was transfected into CtIP-depleted GC92 cells, which resulted in 
the same frequency of elevated misrepair events as exogenous WT CtIP (Figure 3.22 B). Next, 
exogenous CtIP impaired in its endonuclease function by Asn289 and His290 both mutated to 
Ala was used in CtIP-depleted GC92 cells and misrepair events were still not impacted compared 
to the exogenous WT CtIP. Thus, both the ATM-dependent phosphorylation sites of CtIP and its 
endonuclease function are dispensable for misrejoining of distant DSBs. Surprisingly, 
exogenous endonuclease-impaired CtIP in combination with CtIP-53BP1 co-depletion caused a 
huge decrease in the frequency of misrepair events to 2.2% (Figure 3.22 A). 
 
Figure 3.22 The endonuclease function of CtIP is dispensable for the misrejoining of distant DSB ends in 
WT cells but crucial in 53BP1-depleted cells  
(A, B) Impact of WT and mutant CtIP complementation on misrepair in CtIP-depleted (B) or CtIP-53BP1 co-depleted 
(B) GC92 cells. GC92 cells were treated with siRNAs against 53BP1 and/or CtIP. Cells were transfected with the RFP 
or siRNA-resistant RFP-CtIP-WT, RFP-CtIP-S664A/S745A, RFP-CtIP-S664E/S745E, or RFP-CtIP-N289A/H290A 
plasmid. 36 h after plasmid transfection, cells were transfected with I-SceI and harvest occurred after an additional 
72 h. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and 
only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent experiments performed in 
duplicate (n = 8). (B) Diagrams of the exogenous CtIP WT, the S664/S745 phospho-mimic- or phospho-mutant of 
the ATM-dependent phosphorylation sites, and the N289A/H290A endonuclease mutant are not drawn to scale. Of 
note, preliminary experiments with RFP-CtIP-S664A/S745A and RFP-CtIP-S664E/S745E were performed by C. 
Ruder and similar results were observed 332. (A, B) RFP was used as a marker for cells with damage induction and 
exogenous protein (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-
value was obtained by one-way ANOVA with Bonferroni correction. 
As established earlier in this chapter, BRCA1 interacts with CtIP in G1 phase in a damage-
inducible manner dependent on CtIP phosphorylation at Ser327 (Figure S8.12 b). Thus far, the 
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possible involvement of CtIP phosphorylation at this site during misrejoining of distant DSBs 
has not been clarified. Therefore, CtIP-depleted GC92 cells were transfected with a CtIP plasmid 
encoding a CtIP phospho-mutant with Ser327 mutated to Ala. GC92 cells with this exogenous 
CtIP phospho-mutant retained the misrepair events at 4.6%, a similar level as CtIP-depleted 
cells (Figure 3.23 A). The difference in the mean values was significant (p < 0.001) compared 
to the exogenous CtIP WT, with an effect size of 8.16. The involvement of CtIP as a pro-resection 
factor in S/G2 phase is mainly dependent on its phosphorylation at Thr847 315. Consequently, 
CtIP-depleted GC92 cells were next complemented with an exogenous CtIP phospho-mutant 
where Thr847 was mutated to Ala. The exogenous CtIP 847 phospho-mutant showed a similar 
phenotype as the 327 phospho-mutant and the CtIP-depleted situation (Figure 3.23 A).This 
result again links this novel repair pathway to resection.  
 
Figure 3.23 CtIP S327 and T847 phosphorylation sites are required for misrejoining of distant DSB ends 
(A) Impact of CtIP complementation with phospho-mutants S327A and T847A on misrepair in CtIP-depleted GC92 
cells. GC92 cells were treated with siRNA against CtIP. Cells were transfected with the RFP or siRNA-resistant RFP-
CtIP-WT, RFP-CtIP-S327A, or RFP-CtIP-T847A plasmid. 36 h after plasmid transfection, cells were transfected with 
I-SceI and harvest took place after an additional 72 h. Downregulation by siRNA and expression of exogenous 
plasmids were confirmed by immunoblotting. Representative images were obtained with a 63x objective using 
AxioVision software. Scale bar represents 10 µm. Diagram of the exogenous CtIP WT and the S327A or T847A 
phospho-mutants are not drawn to scale. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were 
scanned using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 
8 independent experiments performed in duplicate (n = 8). RFP was used as a marker for cells with damage 
induction and exogenous protein (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by 
Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni correction. Several data points were part 
of the analysis in Barton et al. (2014). 
Next, overall repair was analyzed using the H2AX foci assay after CtIP depletion in GC92 
ARTEMIS KO cells plus transfection with WT CtIP and the phospho-mutant plasmids (Ser327 
or Thr847 mutated to Ala). As described in Figure 3.20 B, the depletion of CtIP in GC92 
ARTEMIS KO cells resulted in a partial rescue of the ARTEMIS repair defect. Upon 
complementation with exogenous WT CtIP, the ARTEMIS repair defect was restored with a 
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mean value of 2.7 H2AX foci (Figure S8.14 b). This was a significant difference compared to 
the partial rescue in CtIP-depleted GC92 ARTEMIS KO cells (p = 0.013, d = 2.23). Usage of any 
of the two exogenous CtIP phospho-mutants in CtIP-depleted GC92 ARTEMIS KO cells again 
resulted in the partial rescue of the ARTEMIS repair defect. Finally, the effect of CtIP phospho-
mimic mutants on the misrejoining of distant DSBs was tested. Exogenous CtIP with Ser327 
and/or Thr847 mutated to Glu all resulted in elevated misrepair events comparable to the 
exogenous WT CtIP (Figure S8.15 a). However, when one of the two CtIP phosphorylation sites 
was mutated to Ala, misrepair events remained as low as in CtIP-depleted GC92 cells, 
independent of a phospho-mimic mutation at the other phosphorylation site. 
In conclusion, CtIP is necessary for the misrejoining of distant DSB ends after I-SceI damage 
induction but is not required for repair. Both CtIP Ser327 and Thr847 phosphorylation sites are 
required to generate misrepair events in GC92 cells. Beyond its role in this particular pathway, 
CtIP is essential for the repair and misrejoining of distant DSBs by alt-EJ, as it occurs after 
53BP1 depletion. 
3.3.3. The kinase PLK3 activates CtIP for the misrejoining of distant DSBs 
CtIP is constitutively active in S/G2 phase through CDK complex-mediated phosphorylation at 
Ser327 and Thr847, which is required to initiate resection during HR 176,177,339,428. Accordingly, 
the impact of impaired CDK activity on the misrejoining of distant DSB ends in GC92 cells was 
examined next. Roscovitine is a selective CDK inhibitor (IC50 for CDK1 = 0.65 µM, for 
CDK2 = 0.7 µM) with little effect on G1-specific CDK complexes 266. Neither CDK1/2 inhibition 
by roscovitine nor CDK2 depletion altered the frequency of misrepair events in GC92 cells 
(Figure 3.24 A). As expected, the same treatment did reduce frequencies of gene conversion 
events in HeLa pGC cells (Figure S8.16 a), which raised the question of which other kinase 
might influence misrejoining of distant DSB ends. Polo-like kinases can phosphorylate the same 
motifs as CDKs (an idea first introduced and pursued by O. Barton in her studies of slow DSB 
repair in G1 phase). As PLK1 was observed to interact with CtIP in the MS analysis (Table 8.6), 
a PLK inhibitor that inhibits PLK1 and PLK3 was used in GC92 cells. GW843682X is a selective 
PLK inhibitor (IC50 of PLK1 = 2.2 nM and PLK3 = 9.1 nM) with 100-fold selectivity over other 
kinases, including CDK1 and CDK2 266. Indeed, this inhibitor significantly reduced the frequency 
of misrepair events to 4.6% (p < 0.001, d = 2.58; Figure 3.24 B). In contrast to the impairment 
of CDK2, PLK inhibition had no impact on gene conversion events in HeLa pGC cells (Figure 
S8.16 b). Astonishingly, PLK1 depletion had no impact on misrepair events in GC92 cells 
(Figure S8.16 c). Instead, depletion of PLK3 decreased misrepair events to the same frequency 
as the PLK inhibitor treatment, which was confirmed by several siRNAs (Figures 3.24 B). Similar 
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to the CtIP depletion in GCS5 cells, PLK inhibition did not have an impact on the misrepair of 
close DSBs (Figure 3.24 C). 
The behavior of PLK3 differs greatly depending on the cell line. In thymidine-synchronized HeLa 
cells, PLK3 is specifically observed in G1 phase and required for transition into S phase, while 
in several other cell lines, PLK3 is expressed throughout the cell cycle and even shows the 
strongest kinase activity in S/G2 phase 32,76,166,415,437. Interestingly, PLK3 is phosphorylated and 
activated by ATM in a damage-inducible manner 18, which could explain why ATM is required 
for the misrepair of distant DSBs (Figure S8.14 a). To further understand the role of PLK3 in 
the misrejoining of distant DSB ends, the influence of PLK and CDK inhibition on misrepair 
events was examined in synchronized GC92 cells. Similar to the situation in asynchronously 
grown cells, PLK inhibition reduced the misrepair events in G1-synchronized cells by half while 
CDK inhibition (roscovitine) did not show any impact (Figure S8.16 d). A reduction of misrepair 
events to 1.5% from the already much lower frequency of 2.7% misrepair events in WT G2-
synchronized cells was also observed after PLK inhibition. Astonishingly, CDK inhibition by 
roscovitine in G2-synchronized GC92 cells resulted in a significant increase to 8.2% misrepair 
events (p < 0.001) with an effect size of 4.58. This raises the question of why such an increase 
was not observed in asynchronous cells after CDK inhibition. Speculatively, this may be because 
these events preferentially arise in G1 and that this type of repair is only observed in G2-
synchronized cells because of the synchronization procedure in which the specific CDK1 
inhibitor RO-3306 is used to keep G2 cells from progressing to mitosis. RO-3306 is an ATP 
competitive selective inhibitor of CDK1 (Ki for CDK1/cyclinB = 35 nM, 
CDK2/cyclinE = 340 nM), which binds the ATP pocket of CDK1 389 more selectively than the 
ATP pocket of other CDKS such as CDK2. Even though the inhibitor has a 10-fold higher affinity 
for CDK1, a small impact on CDK2 is to be expected. This hypothesis is supported by the fact 
that the inhibition of HR by roscovitine, which completely inhibits CDK2, resulted in increased 
frequencies of misrepair events. Of note, double inhibition by roscovitine and PLK nearly 
abolished misrepair events, which confirms that the increase of misrepair events observed after 
CDK inhibition was dependent on PLK3. Furthermore, these results indicate that this kind of 
PLK3-dependent repair is usually prevented in S/G2 phase in favor of HR. Indeed, Gelot et al. 
(2016) showed that the cohesin complex, which is required for chromosomal cohesion and 
therefore HR, suppresses the misrejoining of distant DSBs during S/G2 phase. 
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Figure 3.24 Misrejoining of distant DSB ends in GC92 cells is dependent on PLK3 
(A, B, C) Impact of CDK1/2 inhibition, CDK2 depletion (A), PLK1/3 inhibition (B, C), or PLK3 depletion (B) on 
misrepair in GC92 or GCS5 (C) cells. GC92 or GCS5 cells were treated with inhibitors and/or siRNAs against CDK1/2 
(roscovitine), CDK2, PLK1/3 (GW843682X), or PLK3. As a control, cells were treated with DMSO or control siRNA. 
Harvest took place 72 h post-co-transfection with I-SceI and RFP plasmids. (A) Of note, the frequently used 
roscovitine concentration of 25 M impairs cell cycle progression, and thus experiments were also performed at 
2 M. (A, B) Downregulation by siRNA was confirmed by immunoblotting. (B) Immunoblotting was performed by 
C. Ruder. (A, B, C) Cells were stained with anti-CD4 or anti-GFP plus anti-RFP AB and DAPI. Samples were scanned 
using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent 
experiments performed in duplicate (n = 8). RFP was used as a marker for cells with damage induction (see chapter 
3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way 
ANOVA with Bonferroni correction. Several data points were part of the analysis in Barton et al. (2014). 
Comparable to the depletion of CtIP, impairment of PLK3 decreased the misrejoining of distant 
DSBs in GC92 cells by half and did not influence the misrejoining of close DSB ends in GCS5 
cells. Therefore, it was interesting to determine whether additional similarities between these 
two factors could be found. PLK3 was overexpressed in PLK3-depleted GC92 cells by 
transfection with a plasmid encoding exogenous FLAG-PLK3 (Figure 3.25 A). Similarly to CtIP 
overexpression, a significant increase of misrepair events to 17.5% was observed in GC92 cells 
overexpressing exogenous PLK3 (p < 0.001, d = 3.19). A PLK3 mutant lacking the polo-box 
domain (PBD) retained the frequency of misrepair events at a level similar to PLK3-depleted 
cells, which implicates the polo-box domain in the misrejoining of distant DSB ends. Double 
depletion of PLK3 and CtIP in GC92 cells resulted in 4.5% misrepair events, a frequency that 
resembled the misrepair events after single PLK3 or CtIP depletion (Figure 3.25 B). This 
provides evidence, that CtIP and PLK3 are involved in the same mechanism. Additional 
depletion of PLK3 in 53BP1-depleted GC92 cells significantly reduced the misrepair events even 
further (compared to the single PLK3 depletion) to 2.2% (p < 0.001, d = 1.98, Figure S8.16 e). 
In addition, similar to CtIP depletion, PLK3 depletion in GC92 ARTEMIS KO cells did not affect 
the abolished misrepair events in GC92 ARTEMIS KO cells (Figure 3.25 B). Moreover, PLK3 
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depletion significantly decreased the repair defect, which was observed in GC92 ARTEMIS KO 
cells to 1.9 H2AX foci (p = 0.002, Figure 3.25 C). Compared to WT GC92 cells, this partial 
increase of H2AX foci in PLK3-depleted GC92 ARTEMIS KO cells was significant (p = 0.011) 
with an effect size of 2.11. PLK3 depletion in WT GC92 cells did not impact the mean number 
of H2AX foci. Together, these characteristics resemble the impact of CtIP depletion. Thus, both 
CtIP and PLK3 are necessary for the misrejoining of distant DSB ends after I-SceI damage 
induction, but are not required for repair. Similar to CtIP, PLK3 is essential for the repair and 
misrejoining of distant DSBs by alt-EJ, as it occurs after 53BP1 depletion. In addition, depletion 
of CtIP or PLK3 partly rescues the ARTEMIS repair defect, while misrepair events remain 
abolished. Of note, as PLK3 is involved in this novel end-joining mechanism and alt-EJ (both 
capable of producing misrepair events), it is not clear which mechanism is responsible for the 
increase of misrepair events in G2-synchronized GC92 cells after impairment of HR (Figure 
S8.16 d).  
 
Figure 3.25 The PLK3 depletion phenotype in GC92 cells resembles the CtIP depletion phenotype 
(A, B, C) Impact of PLK3 WT and mutant complementation (A) or CtIP (B) depletion on misrepair (A, B) or overall 
repair (C) in PLK3-depleted GC92 WT (A, B, C) or ARTEMIS KO (B, C) cells. GC92 WT or ARTEMIS KO cells were 
treated with siRNAs against PLK3 and/or CtIP. As a control, cells were treated with control siRNA. (A) GC92 cells 
were transfected with the RFP or siRNA-resistant FLAG-PLK3-WT or FLAG-PLK3-PBD plasmid. 36 h after plasmid 
transfection, cells were transfected with I-SceI and harvested after an additional 72 h. Representative images were 
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obtained with a 63x objective using Metafer Isis software. Scale bar represents 10 µm. Diagrams of the exogenous 
PLK3 WT and the PBD mutant are not drawn to scale. (B) Harvest took place 72 h post-co-transfection with I-SceI 
and RFP plasmids. (A, B) Downregulation by siRNA and expression of exogenous plasmids were confirmed by 
immunoblotting. Cells were stained with anti-RFP or anti-FLAG plus anti-CD4 AB and DAPI. Samples were scanned 
using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 or 
16 independent experiments performed in duplicate (n = 8 for A; n = 16 for B). (C) Cells were co-transfected with 
RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest took place 72 h post-
plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using 
Metafer software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 5 independent 
experiments (n = 5). (A, B, C) RFP and FLAG were used as a marker for cells with damage induction and exogenous 
protein (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was 
obtained by one-way ANOVA with Bonferroni correction. (B) Several data points were part of the analysis in Barton 
et al. (2014). 
PLK3 expression differs depending on the cell type 166. To investigate the PLK3 protein level 
relative to the cell cycle phase, GC92 cells were synchronized by double thymidine block (Figure 
3.26 A) and PLK3, CtIP, and BRCA1 protein levels were analyzed (figure 3.26 B). Both, CtIP 
and BRCA1 protein levels were higher in G2 and lower in G1-synchronized cells compared to 
asynchronously grown cells. In contrast, the protein level of PLK3 remained steady throughout 
the cell cycle. The aim of the experiments conducted in this chapter was not just to find the 
Ser/Thr-protein kinase involved in the misrejoining of distant DSB ends, but to also find the 
specific kinase that phosphorylates and activates CtIP. Since CtIP phosphorylation was observed 
in a damage-inducible manner post-X-IR in G1 phase (Figure S8.12 b), GC92 cells were 
synchronized in G1 by double thymidine block (Figure 3.26 A) and CtIP was 
immunoprecipitated (Figures 3.26 C). Upon damage induction, phosphorylation of CtIP at 
Ser327 was observed 1 h post-5 Gy X-IR. However, PLK inhibition abolished the damage-
inducible phosphorylation of CtIP at Ser327. As established in chapter 3.3.2, BRCA1 interacts 
with CtIP in a damage-inducible manner dependent on CtIP phosphorylation at Ser327 (Figure 
S8.12 b). Therefore, BRCA1 protein levels were also investigated in the immunoprecipitation 
experiment (Figures 3.26 C). Analogous to the abolished CtIP phosphorylation at Ser327 post-
damage induction and PLK inhibitor treatment, BRCA1 interaction with CtIP was greatly 
reduced. The reverse BRAC1 co-immunoprecipitation experiment confirmed these findings. 
Additionally, the results of this experiment were confirmed in further cell systems (HeLa, 82-
6 hTert, data not shown) and with additional ABs by other members of the working group 36. 
BRCA1 is rapidly recruited to the DSB by KU80 in G1 phase and the subsequent interaction is 
required for the stabilization of KU80 at the break end 197,336. To investigate the effect of PLK 
inhibition on that interaction, KU80 or BRCA1 was co-immunoprecipitated from GC92 cells 
synchronized in G1 phase by double thymidine block (Figure 3.26 D). Both, the experimental 
and published data in Jiang et al. (2013) revealed a BRCA1-KU80 interaction, even before 
damage induction. In Jiang et al. (2013), this interaction increased several hours after 
transfection with the I-SceI plasmid. In Figure 3.26 D, the BRCA1-KU80 interaction increased 
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30 min after damage induction by X-IR and decreased 1 h post-irradiation. Interestingly, the 
BRCA1-KU80 interaction remained visible 1 h post-irradiation when the GC92 cells were treated 
with the PLK inhibitor. In conclusion, PLK3 phosphorylates CtIP post-damage induction at 
Ser327 to promote its interaction with BRCA1. The BRCA1-KU80 interaction lessens in favor of 
the BRCA1-CtIP interaction, and thus BRCA1 can no longer stabilize KU.  
 
Figure 3.26 PLK3 is required for the damage-inducible BRCA1-CtIP-pS327 interaction and for the fading 
BRCA1-KU80 interaction after damage induction in G1 phase  
(A, B) Cell cycle distribution (A) and protein levels (B) in synchronized GC92 cells. GC92 cells were synchronized 
by double thymidine block and reached G2 phase 8 h post-second thymidine release and G1 phase 16 h post-second 
thymidine release. (A) Cells were harvested and stained with anti-pH3 AB and PI. (left) Samples were analyzed by 
flow cytometry. (right) Data represent the mean of 3 independent experiments (n = 3). Error bars show the SD. (B) 
Cells were harvested and protein levels were analyzed after immunoblotting of the samples. (C, D) BRCA1 and CtIP 
(C) or BRCA1 and KU80 (D) co-immunoprecipitation in G1-synchronized GC92 cells. BRCA1, CtIP, or KU80 was 
immunoprecipitated with anti-CtIP, anti-KU80, or anti-BRCA1 ABs from G1-synchronized GC92 cells 30 min and/or 
1 h post-5 Gy X-IR or from unirradiated controls treated with or without PLK inhibitor 1 h prior to X-IR. Protein 
levels were analyzed after immunoblotting of the samples.  
As established in chapter 3.3.2, phosphorylation of CtIP at both Ser327 and Thr847 is required 
for misrejoining of distant DSBs in GC92 cells. To verify that PLK3 is able to phosphorylate CtIP 
at these two sites, SFB-CtIP WT was immunoprecipitated and purified from stably-transfected 
HEK293 cells with or without in vitro incubation with recombinant PLK3. Likely CtIP 
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phosphorylation events at Ser, Thr, or Tyr sites were analyzed by MS and the probability-based 
approach Ascore 27. An Ascore value greater than 19 suggests likely phosphorylation at a given 
site, less than 19 indicates an unlikely phosphorylation site. CtIP WT incubated with 
recombinant PLK3 resulted in the likely phosphorylation of CtIP at Ser327 and Thr847 (Table 
8.7). Thus, PLK3 is able to phosphorylate CtIP at these two phosphorylation sites, which are 
required for misrepair events. CtIP showed high basal phosphorylation and incubation with 
recombinant PLK3 increased the phosphorylation levels. Therefore, an experiment was 
conducted to test if misrejoining of distant DSB ends only requires PLK3-dependent 
phosphorylation of CtIP at Ser327 and Thr847. CtIP-PLK3 double-depleted GC92 cells were 
transfected with a plasmid encoding RFP-CtIP WT (Figure 3.27 A). As PLK3 was depleted, and 
thus could not phosphorylate Ser327 and Thr847, unsurprisingly, the misrepair events 
remained at low levels, comparable to the PLK3-CtIP co-depleted GC92 cells. As a reminder, 
the expression of exogenous WT CtIP in CtIP-depleted GC92 cells elevated misrepair events, as 
did the usage of phospho-mimic mutants at sites 327 and/or 847 (Figure S8.15 a). Surprisingly, 
even the exogenous CtIP double phospho-mimic mutant did not increase the frequency of 
misrepair events (Figure 3.27 A). Thus, phosphorylation of CtIP at Ser327 and Thr847 by PLK3 
is not sufficient to fully activate CtIP for the misrejoining of distant DSB ends. Obviously, 
activation of CtIP by PLK3 is different than phosphorylation of CtIP by the CDK2 complex in 
S/G2 phase. Since PLK3 was involved in the increase of misrepair events in the absence of CDKs 
in G2 phase (as per figure S8.16 d), PLK3 and CDK2 may compete to phosphorylate CtIP and 
PLK3 loses in S/G2 phase because CDK complexes constitutively phosphorylate CtIP. In G1 
phase, PLK3 succeeds, as the CDK2 complex required to phosphorylate CtIP is not present. 
 
Figure 3.27 Phosphorylation at S327 and T847 by PLK3 is not sufficient for misrejoining of distant DSB 
ends 
(A) Impact of CtIP complementation with the double phospho-mimic-mutant on misrepair in CtIP-PLK3 double-
depleted GC92 cells. GC92 cells were treated with siRNAs against PLK3 and CtIP. Cells were transfected with RFP or 
siRNA-resistant RFP-CtIP-WT or RFP-CtIP-S327E/T847E plasmids. 36 h after plasmid transfection, cells were 
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transfected with I-SceI and harvested after an additional 72 h. Diagrams of the exogenous CtIP WT and the 
S327E/T847E phospho-mimic-mutant are not drawn to scale. Cells were stained with anti-CD4, anti-RFP AB, and 
DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were analyzed. Data 
represent the mean of 8 independent experiments performed in duplicate (n = 8). RFP was used as a marker for cells 
with damage induction and exogenous protein (see chapter 3.1.1). Error bars show the 95% CI.  
To investigate which additional CtIP sites might get phosphorylated by PLK3, further MS data 
were analyzed. Two approaches were used: (1) the aforementioned exogenous WT CtIP 
immunoprecipitation and purification from stably-transfected HEK293 cells with or without in 
vitro incubation with recombinant PLK3 (Table 8.7 a) and (2) exogenous WT CtIP 
immunoprecipitation and purification from stably-transfected HEK293 cells 30 min or 2 h after 
X-IR with or without PLK3 inhibitor treatment prior to irradiation (Table 8.7 b). Importantly, 
the experimental procedures of these experiments were conducted by J. Wang. To identify 
which other PLK3-mediated CtIP phosphorylations could be involved in this novel pathway, 
results were of interest that showed an increase in the Ascore (from less than 19 to greater than 
19) after in vitro incubation with recombinant PLK3 and when the Ascore was reduced in 
irradiated samples only after pretreatment with the PLK inhibitor (e.g. Ser326, Ser327). 
Interestingly, these two CtIP phosphorylation sites were only observed at 30 min but not 2 h 
post-X-IR, which is consistent with the observed phosphorylation of CtIP at Ser327 30 min or 
1 h post-irradiation in immunoprecipitation experiments (Figures 3.26, S8.12). Nevertheless, 
results where an Ascore increase was only observed post-damage induction and vanished upon 
PLK inhibitor treatment prior to irradiation (Ser608, Ser641) were also of interest. This 
situation was especially noteworthy because the observed phosphorylation only occurred upon 
damage induction. In conclusion, PLK3 phosphorylates CtIP at Ser327, Thr847, and at least one 
other site following DNA damage induction, and thus induces a mechanism that results in the 
misrejoining of distant DSB ends. Consequently, PLK3 impairment or overexpression showed a 
similar phenotype compared to CtIP impairment or overexpression. 
3.3.4. Nucleases conducting resection in this novel repair pathway 
From the beginning of this results section, resection was mentioned as the cause for 
misrejoining of distant DSB ends. In this final chapter, the nucleases executing the resection 
that results in the misrejoining of distant DSB ends were examined. Resection is also the initial 
step of HR (Figure 2.3). In a simplified HR model, the endonuclease function of MRE11 in 
concert with CtIP makes a single cut several bases away from the DSB end 10. From there, 
MRE11 exonuclease activity, together with EXD2, drives resection in a 3′ to 5′ direction towards 
the DSB end 53. Long-range 5′ to 3′ resection is performed by EXO1 in concert with BLM or by 
BLM/DNA2 287,382 to produce long strands of ssDNA, which are protected by RPA coating 37. In 
Rass et al. (2009), MRE11 was already found to be involved in the misrejoining of distant DSB 
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ends, which is consistent with the previously described data (as MRE11 also acts in concert with 
CtIP to conduct resection in S/G2 phase). This finding was confirmed by MRE11 depletion and 
MRE11 inhibition (Figures 3.28 A).  
Thanks to the recent development of specific inhibitors 354, the contribution of MRE11 to the 
misrejoining of distant DSBs could further be analyzed. Mirin is a small-molecule inhibitor of 
the MRN complex. It inhibits MRE11-associated exonuclease activity and prevents MRN-
dependent activation of ATM without affecting ATM protein kinase activity 120. In contrast, 
PFM39 is an altered derivate of mirin which blocks 3′ exonuclease activity specifically without 
interfering with the MRE11-dependent activation of ATM 354. PFM01, on the other hand, is a 
derivate of mirin that specifically blocks the endonuclease activity of MRE11 without affecting 
its exonuclease function or ability to activate ATM 354. All MRE11 inhibitors bind in proximity 
to the pocket of the active site (hydrophobic Leu59/Leu60 and Mn-ligand Asp58), which 
includes a His at site 61, a nearby loop starting at Asn93, and a groove for ssDNA-binding. For 
dsDNA exonuclease activity, rotation of the DNA phosphate backbone (controlled by His61) is 
necessary. For endonuclease activity, the Asn93 loop interacts with a base extending from the 
groove binding the ssDNA. While the endonuclease inhibitor is positioned to disrupt the ssDNA 
binding loop from Asn93 to Phe102, exonuclease inhibitors restrict dsDNA access and disrupt 
end opening by His61 354. Treatment of GC92 cells with an MRE11 endonuclease inhibitor did 
not alter the frequency of misrepair events (Figure 3.28 A). In contrast, inhibition of MRE11 
with an exonuclease-specific inhibitor significantly reduced the mean value of misrepair events 
to 4.9% compared to the control (p < 0.001, d = 2.56).  
 
Figure 3.28 MRE11 and EXD2 are required for misrejoining of distant DSBs but MRE11 endonuclease 
function is dispensable 
(A, B) Impact of MRE11 impairment and EXD2 depletion on misrepair (A) or overall repair (B) in GC92 cells. GC92 
cells were treated with inhibitors and/or siRNAs against MRE11 endonuclease activity (PFM01), MRE11 exonuclease 
activity (PFM39), MRE11, and/or EXD2. As a control, cells were treated with DMSO or control siRNA. (A) Harvest 
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took place 72 h post-co-transfection with I-SceI and RFP plasmids. Downregulation by siRNA was confirmed by 
immunoblotting. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer 
software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent experiments 
performed in duplicate (n = 8). (B) Cells were co-transfected with the RFP and I-SceI plasmids and treated with EdU 
and nocodazole 30 min prior to harvest. Harvest took place 72 h post-plasmid transfection. Cells were stained with 
anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected G1 
cells were analyzed. Data represent the mean of 5 independent experiments (n = 5). (A, B) RFP was used as a marker 
for cells with damage induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s 
d and p-value was obtained by one-way ANOVA with Bonferroni correction. (A) Several data points were part of the 
analysis in Biehs et al. (2017).  
Both inhibitors were confirmed to impair gene conversion events in HeLa pGC cells, and thus 
their functionality was validated (Figure S8.17 a). As MRE11 exonuclease functions together 
with EXD2 in HR, EXD2 was depleted in GC92 cells. EXD2 depletion resulted in a reduction of 
misrepair events to 4.2% (Figure 3.28 A). Moreover, treatment with the MRE11 exonuclease-
specific inhibitor in addition to EXD2 depletion resulted in a similar frequency of misrepair 
events. All of these aforementioned factors did not have an impact in the H2AX foci assay 
(Figure 3.28 B). 
The double depletion of MRE11 and CtIP did not further influence the frequency of misrepair 
events in comparison to single depletions (Figure S8.17 b). Next, misrepair events were 
investigated in 53BP1-depleted GC92 cells. Inhibition of the MRE11 endo- or exonuclease 
function reduced misrepair events to 1.5% and 2.4%, respectively (Figure 3.29 A). Accordingly, 
H2AX foci increased to 2.5 or 3.2 (Figure 3.29 B). MRE11 inhibition by the endo- or 
exonuclease-specific inhibitor did not alter the abolished misrepair events in GC92 ARTEMIS 
KO cells (Figure 3.29 A). Similar to CtIP depletion, depletion of EXD2 and/or MRE11 
exonuclease inhibitor treatment in GC92 ARTEMIS KO cells resulted in 1.6 to 1.7 H2AX foci 
(Figure 3.29 C). Compared to the repair defect in GC92 ARTEMIS KO cells, the mean value was 
significantly lower (p ≤ 0.001) with effect sizes between 3.43 and 3.71. The mean value 
compared to the control was not significantly different at the 0.05 level, though the effect size 
ranged between 1.24 and 1.95. To summarize, MRE11 exonuclease function and EXD2 are both 
required for the misrejoining of distant DSB ends but not essential for repair. Impairment of 
either one or both factors partly rescued the ARTEMIS repair defect. In contrast, MRE11 
endonuclease function is dispensable for misrepair in GC92 cells. However, both MRE11 endo- 
and exonuclease activities are required for misrepair and overall repair in alt-EJ, as it occurs in 
53BP1-depleted cells.  
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Figure 3.29 MRE11 endo- and exonuclease activities are required for misrepair in 53BP1-depleted GC92 
cells 
(A, B, C) Impact of MRE11 inhibitors on misrepair (A) or overall repair (B, C) in 53BP1-depleted GC92 cells (A, B) 
or in GC92 ARTEMIS KO cells (A, C). GC92 WT or ARTEMIS KO cells were treated with inhibitors and/or siRNAs 
against MRE11 endonuclease activity (PFM01), MRE11 exonuclease activity (PFM39), EXD2, and/or 53BP1. As a 
control, cells were treated with control siRNA. (A) Harvest took place 72 h post-co-transfection with the I-SceI and 
RFP plasmids. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer 
software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent experiments 
performed in duplicate (n = 8). (B, C) Cells were co-transfected with the RFP and I-SceI plasmids and treated with 
EdU and nocodazole 30 min prior to harvest. Harvest took place 72 h post-plasmid transfection. Cells were stained 
with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-
transfected G1 cells were analyzed. Data represent the mean of 5 independent experiments (n = 5). (A, B, C) RFP 
was used as a marker for cells with damage induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size 
was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni correction. 
Next, EXO1 was depleted in GC92 cells, which significantly reduced misrepair events compared 
to the mean value of control cells to 4.4 (p < 0.001) with an effect size of 4.34 (Figure 3.30 A, 
3.30 B). The impact of EXO1 impairment on misrepair events in GC92 cells was confirmed by 
CRISPR/Cas9 viral transduction (Figure S8.18 a). Furthermore, transfection of EXO1-depleted 
GC92 cells with an EXO1 plasmid encoding WT EXO1, restored the frequency of misrepair 
events to a level comparable to the control (Figure 3.30 B). In contrast, BLM and/or DNA2 
depletion did not alter the misrepair events in GC92 cells although they are involved in 5′ to 3′ 
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resection during HR (Figure 3.30 A). Notably, previous studies have shown that BLM influences 
sequence alterations at misrejoined distant DSB sites, where BLM is involved in the protection 
against long-range deletions 148. EXO1 depletion in combination with CtIP depletion (Figure 
S8.18 b) or inhibition of MRE11 by the exonuclease-specific inhibitor (Figure 3.30 C) did not 
further influence the frequency of misrepair events compared to single EXO1 depletion. Thus, 
all three proteins are involved in the same mechanism to misrejoin distant DSB ends. In 
contrast, concurrent depletion of EXO1 and 53BP1 in GC92 cells resulted in numbers of 
misrepair events being elevated to 15.3%, which is a similar frequency to the single 53BP1 
depletion (Figure 3.30 C). EXO1 depletion did not affect the abolished misrepair events in GC92 
ARTEMIS KO cells. Despite EXO1s role in the misrejoining of distant DSB ends, EXO1 depletion 
did not show an impact in the H2AX foci assay (Figure S8.18 c). However, EXO1 depletion in 
GC92 ARTEMIS KO cells reduced the repair defect observed in GC92 ARTEMIS KO cells to 
1.7 H2AX foci. Depletion of EXO1 in combination with MRE11 exonuclease inhibition in GC92 
ARTEMIS KO cells also resulted in a reduced mean value of H2AX foci (M = 1.7). The 
difference between the mean values of both conditions was not significant at the 0.05 level 
compared to the control, but effect sizes were 1.5 and 2.79, respectively.  
In conclusion, EXO1 is required for the misrejoining of distant DSB ends but is not necessary 
for overall repair. Depletion of EXO1 alone or in combination with MRE11 exonuclease 
inhibition resulted in the same frequency of misrepair events, and thus both factors act in a 
single mechanism. This suggests that CtIP-dependent misrejoining requires both, MRE11 and 
EXO1. Depletion of EXO1 alone or in combination with MRE11 exonuclease inhibition in GC92 
ARTEMIS KO cells partly rescued the ARTEMIS repair defect. This further proves that both are 
required for the same mechanism to misrejoin distant DSB ends. In contrast to MRE11 
inhibition, EXO1 depletion did not influence the misrepair in 53BP1-depleted cells. Therefore, 
EXO1 does not seem to be required for alt-EJ, as it occurs in 53BP1-depleted cells. In the 
literature, EXO1 is described as being prevented from accumulating at DSBs by KU80 218,373,382. 
To further link EXO1 to the misrejoining of distant DSBs, which is dependent on KU, SFB-EXO1 
WT protein was precipitated and purified from stably-transfected HEK293 cells after no 
irradiation or 30 min post-5 Gy X-IR. Proteins that co-precipitated with EXO1 were analyzed by 
MS (Table 8.8). Interestingly, the CtIP-interacting protein EXD2 53 was observed to increasingly 
interact with EXO1 post-irradiation. Despite reports of EXO1 being segregated from DSBs by 
KU 218,373,382, KU80 (XRCC5) was co-precipitated with EXO1 in both unirradiated and irradiated 
samples. Moreover, KU70 (XRCC6) also co-precipitated with EXO1 and this interaction 
increased 30 min after irradiation. An even stronger post-irradiation EXO1 interaction was 
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observed with DNA-PKcs (PRKDC), thus linking all proteins of the DNA-PK complex to EXO1, 
mostly in a damage-inducible manner.  
 
Figure 3.30 EXO1 is required for misrejoining of distant DSB ends 
(A, B, C) Impact of EXO1 complementation (B), MRE11 inhibition (C), BLM/DNA2 (A), 53BP1 (C), and/or EXO1 
depletion on misrepair in GC92 WT (A, B, C) or ARTEMIS KO (C) cells. GC92 WT or ARTEMIS KO cells were treated 
with inhibitors and/or siRNAs against MRE11 exonuclease activity (PFM39), 53BP1, and/or EXO1. As a control, cells 
were treated with control siRNA. (A, C) Cells were harvested 72 h post-co-transfection with I-SceI and RFP plasmids. 
(B) Cells were transfected with the RFP or siRNA-resistant FLAG-EXO1-WT plasmid. 36 h after plasmid transfection, 
cells were transfected with I-SceI and harvested after an additional 72 h. Representative images were obtained with 
a 63x objective using Metafer Isis software. Scale bar represents 10 µm. Diagram of the exogenous EXO1 WT is not 
drawn to scale. (A, B, C) Downregulation by siRNA and expression of exogenous plasmids were confirmed by 
immunoblotting. Cells were stained with anti-RFP or anti-FLAG plus anti-CD4 AB and DAPI. Samples were scanned 
using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent 
experiments performed in duplicate (n = 8). RFP and FLAG were used as markers for cells with damage induction 
and exogenous protein (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and 
p-value was obtained by one-way ANOVA with Bonferroni correction. (A, B) Several data points were part of the 
analysis in Biehs et al. (2017). 
In conclusion, several nucleases involved in HR during resection are also observed in the 
misrejoining of distant DSBs. However, for the limited resection observed in the misrejoining 
of distant DSBs, these factors are orchestrated in a different way. 
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4. Discussion 
Mutagenic error-prone end-joining of DNA DSBs in WT human cells is poorly understood but 
important to comprehend, as it endangers genomic stability and hence, initiates carcinogenesis 
51,161,413. Previous studies on this subject have provided contradicting results. Some studies 
suggest that alt-EJ plays a role in the error-prone end-joining repair pathway in WT human cells 
148,302,322. In contrast, other studies have reported that c-NHEJ factors prevent alt-EJ and are 
associated with generating genomic rearrangements 142,357. To study the mechanism of error-
prone repair in human cells, mutagenic end-joining events were investigated in this work with 
a primary focus on the misrejoining of two 3.2 kb distant I-SceI-induced DSBs. In this study, 
evidence was provided that: 
 All I-SceI-induced DSBs are repaired and in approximately 10% repair results in the 
misrejoining of the distant DSBs (chapter 3.1); 
 This misrejoining is associated with additional deletions at the misrejoined break site 
and caused by limited resection (chapter 3.1, 3.3); 
 The underlying error-prone repair mechanism is specific for G1 phase of the cell cycle 
and is responsible for the misrepair of distant, but not close, DSBs (chapters 3.1, 3.3); 
 This error-prone repair mechanism relies on c-NHEJ factors, involves PARP1, but does 
not require alt-EJ factors such as LIG1/3 (chapter 3.2); 
 This error-prone resection-dependent c-NHEJ pathway is initiated by PLK3-dependent 
CtIP activation and subsequent CtIP interaction with BRCA1 to antagonize the anti-
resection factor 53BP1 (chapter 3.3); 
 The resection mechanism in this error-prone c-NHEJ pathway differs from that in alt-EJ 
and HR (chapter 3.3) and is characterized by (1) limited resection (chapters 3.1, 3.2); 
(2) resection being executed by EXO1; (3) resection involving EXD2 and MRE11; and 
(4) resection not requiring MRE11s endonuclease function (chapter 3.3); 
 The impairment of factors initiating or executing resection in this error-prone c-NHEJ 
pathway enables a repair pathway switch, but once resection took place both DNA-PKcs 
and ARTEMIS are indispensable for repair completion (chapters 3.2, 3.3); 
 The break sites are mostly misrejoined using microhomologies, and thus resection-
dependent c-NHEJ depends on a variety of polymerases, including POL, POL, and 
POL (chapter 3.2); 
 The absence of resection-dependent c-NHEJ results in less intrachromosomal genomic 
rearrangements, but more detrimental mutagenic sequence alterations at the remaining 
misrejoined break sites (chapter 3.3). 
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Therefore, this work describes a novel error-prone resection-dependent c-NHEJ repair pathway 
in WT human cells. This repair pathway was characterized in its initiation and execution. What 
makes resection-dependent c-NHEJ so unique is the involvement of resection in combination 
with c-NHEJ factors, which were hitherto thought to be mutually exclusive. This is why the 
name resection-dependent c-NHEJ 36 describes it so well (henceforth abbreviated as res-
cNHEJ). Although the reporter assay, which was the main focus in this study, does not represent 
a physiological situation, it was essential for the characterization of the newly discovered repair 
pathway and could answer questions classical assays could not. The following chapters deal 
with (1) the strengths and weaknesses of the reporter assay employed; (2) the detailed 
mechanism of res-cNHEJ; (3) how the initiation of res-cNHEJ impacts DSB repair pathway 
choice; and (4) the physiological relevance of res-cNHEJ with the focus on open questions and 
future directions. 
4.1. The repair of endonuclease-induced DSBs 
The end-joining reporter assay in GC92 cells allows the investigation of mutagenic DSB repair 
(see Figure 3.1 A for the structure of the reporter assay). The endonuclease I-SceI introduces 
two DSBs 3.2 kb apart and the misrejoining of the distant DSBs can be measured with the help 
of a reporter protein. A disadvantage of most reporter assays is that only events that result in 
the expression of a reporter can be measured. This means that there is no information about 
how often DSBs are induced before misrepair occurs because accurate repair is not monitored. 
Thus, the statement that 10% of cells with damage induction undergo misrepair (chapter 3.1) 
needs to be considered as the frequency of misrepair over the entire repair time. However, this 
disadvantage was not a problem for this study, as the aim of this work was to characterize the 
underlying novel mutagenic repair pathway. 
4.1.1. Enhancing the accuracy of reporter assay analysis  
In this study, detailed consideration was given to clarify when and how DSBs are induced, 
repaired, and misrepaired in the reporter system (Figure 3.2 A). Furthermore, the protocol was 
adjusted to ensure sufficient downregulation of endogenous protein levels at the time I-SceI 
expression began (Figure 5.2). Another important adjustment to the protocol was the reduction 
of background fluctuations by changing the measurement method from the typical flow 
cytometry to immunofluorescence microscopy (chapter 3.1.1). In addition, analysis quality was 
enhanced by only analyzing cells transfected with the I-SceI plasmid, and thus cells in which 
damage was induced (chapter 3.1.1). This was achieved by using RFP as a marker. With the 
established protocol, more than 95% of RFP-positive cells were also positive for the 
endonuclease I-SceI (Figures 3.2 B). Of course, this means that some I-SceI-positive cells escape 
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the analysis. However, on average, 10% of distant DSBs are misrejoined and express the 
reporter in approximately 30% of RFP-positive cells. Therefore, misrepair events in all cells 
were approximately 3%, which is consistent with results in other studies 35,154,155,322. The 
frequency of undetected I-SceI-positive cells was much higher in cells where a tagged exogenous 
protein was used instead of RFP due to the transfection efficiency of larger proteins being lower 
(Figure S8.2 b). Nevertheless, the benefit of this analysis is a normalization of the reporter-
positive cells to RFP or the exogenous protein-positive cells. Thus, the frequency of misrepair 
events remained stable at approximately 10%. In Biehs et al. (2017), the common reporter 
assay analysis method was used wherein misrepair events of treated samples are normalized 
relative to control samples (example in Figure S8.9 a). As described in chapter 3.1.1, this 
normalization is not sufficient. However, even for experiments where RFP was not mentioned 
in Biehs et al. (2017), all experiments were conducted by co-transfection of I-SceI and RFP 
plasmids to exclude all data in which transfection efficiencies differed by more than 5% between 
samples. Importantly, some treatments generally seemed to influence transfection efficiencies, 
which resulted in lower frequencies of RFP-positive cells compared to controls. Consequently, 
these treatments appeared to have higher frequencies of misrepair events than was actually the 
case when normalizing treated samples to controls. This problem was solved with the new 
analysis method used in this dissertation. In conclusion, the first benefit and strength of this 
study is the adjustment of the experimental procedure and analysis of the reporter assay, which 
enhances the accuracy of the results. 
4.1.2. Beyond the reporter assay: the H2AX foci assay in GC92 cells 
A major disadvantage of reporter assays is that only events resulting in the expression of the 
reporter after the misrejoining of DSBs can be measured. They, therefore, fail to provide 
information about overall DSB repair. This shortcoming was solved in this study by combining 
the GC92 reporter assay with the H2AX foci assay (Figures 3.1 A, C, 3.2 A). With this method, 
the repair of I-SceI-induced DSBs could be investigated by using H2AX as a DSB marker 247. 
Therefore, this study provides information about the quality and the quantity of endonuclease-
induced DSB repair. An interesting aspect of H2AX foci in this assay was how they increased 
in relation to the I-SceI protein levels. Although I-SceI was already overexpressed in many cells 
24 h post-I-SceI plasmid transfection, a rise of DSBs, as indicated by the H2AX foci, was only 
observed at 36 h and remained high until 48 h post-I-SceI transfection (Figure 3.2 A). To 
interpret this finding, it is important to remember that DSB induction occurs over the entire 
duration that I-SceI is present in the cells (approximately 60 h) and that DSBs can be induced 
repeatedly as long as they are repaired accurately and the I-SceI recognition site is not 
disrupted. Therefore, this indicates that DSBs are repaired quickly in the beginning and only 
 78 
start persisting long enough to be detectable at later timepoints. Interestingly, the frequency of 
misrepair events only rises after DSBs begin to persist. Thus, in the beginning, fast repair results 
in accurate rejoining, which is not detectable in the assay and misrepair occurs when repair is 
slow. Therefore, studies that do not include such kinetics and adjust their experimental 
procedure accordingly, might miss out on a certain type of repair and obtain different results.  
As two DSBs are induced, the H2AX foci would theoretically increase by 2 foci in an unrepaired 
situation. Indeed, the impairment of major DSB repair factors resulted in an increase of 2 H2AX 
foci (e.g. Figure S8.6 b). However, as discussed in chapter 3.1.2, the H2AX signal extends 
beyond the distance of the two I-SceI recognition sites, suggesting that an increase of 2 foci 
would only be observed if the unrepaired breaks are not held in proximity. An increase of 2 foci 
could also mean that the reporter construct has integrated more than once. Understanding the 
meaning of an increase of 2 H2AX foci is crucial for the interpretation of results showing a 
partial repair defect with an increase by 1 H2AX focus (e.g. Figure S8.6 c). If 2 H2AX foci were 
visible because the DSB ends were not held in proximity, a partial repair defect (increase by 
1 focus) could occur when the break ends are held together to only allow the formation of 
1 H2AX focus. A second model for a partial repair defect involves repair taking place in some 
cells but not in others. Although this question should be possible to answer by analyzing the 
median of H2AX foci in each experiment (as displayed for cells that repaired the DSBs in Figure 
S8.5 c), the number of experiments was too small for a conclusive statement. Thus, the 
interpretation of a partial repair defect remains speculative and in this study, may indeed have 
different interpretations depending on the factor investigated. In conclusion, the expansion of 
the reporter assay with the H2AX foci assay enhances the quality of the analysis by filling the 
gap in the overall repair analyses, which are usually associated with reporter assays. 
4.1.3. Radiation-induced DSBs in comparison to endonuclease-induced DSBs 
Although the main focus of this study was the misrepair of distant endonuclease-induced DSBs, 
additional experimental procedures were included to analyze other areas where res-cNHEJ 
might play a role. In addition, these methods were used to further analyze how the factors 
involved in res-cNHEJ contribute to DSB repair pathway choice. Damage in these experiments 
was generally induced by X-IR. DSBs are repaired with biphasic kinetics after X-IR 272. The fast 
repair component is executed by c-NHEJ throughout the cell cycle, while slow repair during G2 
phase is performed by HR 34. Although several factors have been associated with the slow repair 
process during G1 phase 34,327, until recently 36, the underlying repair pathway for slowly 
repairing G1 phase DSBs was unclear. Based on data from the working group, the slow DSB 
repair pathway in G1 phase likely is the same as the repair of distant endonuclease-induced 
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DSBs. Furthermore, studies investigating the repair of complex DNA damage following high-
LET irradiation 15,343, also showed a dependency on resection and error-prone repair. Therefore, 
the radiation-based assays used during this study are typically used to investigate HR during 
S/G2 phase but modified to specifically investigate slow DSB repair and resection in G1 phase. 
High doses of X-IR were used to generate clustered DNA damage by increasing the number of 
DSBs. To investigate the impact of res-cNHEJ factors on DSB repair pathway choice, protein 
interactions were studied in immunoprecipitation experiments with G1-synchronized cells. To 
expand this approach, the interactome of key res-cNHEJ factors was investigated by tandem 
affinity purification mass spectrometry (TAP-MS) 129,418 to identify possible new interaction 
partners and analyze how the entire interactome is affected after DNA damage. The obtained 
results will direct future analyses of this repair pathway.  
4.2. Resection-dependent c-NHEJ (res-cNHEJ) 
This chapter is dedicated to the mechanics of the novel error-prone res-cNHEJ. The first 
distinction between a c-NHEJ pathway involving resection and alt-EJ was introduced by 
Goodarzi and Jeggo (2013) to describe how DSBs persisting in G1 phase might be repaired. The 
persisting DSB ends were described as originating from non-ligatable ends or from chromatin 
complexity. Due to previous studies, it is known that the repair of persisting DSBs in G1 phase 
involves ARTEMIS and ATM 34. Other studies have shown that CtIP is required for error-prone 
end-joining during G1 429, that the repair of complex DSB ends during G1 phase is dependent on 
CtIP and MRE11 15,319,322, and that complex DSBs from high-LET irradiation additionally require 
EXO1 15. Importantly, DSB complexity can either mean chemically complex at the DSB ends or 
complex due to clustered damage. The misrejoining of distant endonuclease-induced DSBs 
might involve chemically complex breaks if I-SceI needs to be actively removed before the 
breaks can be repaired, as has been observed for other complex break ends 12. However, this 
theory can be refuted because I-SceI-induced DSBs can cause different repair pathway responses 
from simple rejoining to resection-dependent repair. These DSB pathway responses are 
dependent on the distance of the DSB ends (chapter 4.3.1), and thus similar to clustered DSB 
ends, as both fail to rejoin the accurate break ends. 
4.2.1. Barriers to resection during res-cNHEJ 
A key protein in preventing any kind of DNA degradation is the KU heterodimer 188. The 
misrejoining of distant (3.2 kb) DSBs was enhanced in KU-depleted GC92 cells (Figures 3.5 B), 
and this increase was dependent on alt-EJ factors (Figures 3.7 B). Therefore, KU-binding 
protects the DSB ends and prevents a pathway switch to alt-EJ. In other studies, reporter 
constructs were incorporated in KU-deficient Chinese hamster ovary (CHO) cell lines 155,156,258. 
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Although no increase in misrepair events was observed in these studies, sequence analyses 
revealed an increase in the size of the additional deletions at the misrejoined break site. This 
supports the model wherein misrepair switches to alt-EJ in the absence of KU. The larger 
deletions observed in these studies might also explain why the misrejoining of close (34 bp) 
DSBs decreased in this study after KU depletion (Figures S8.6 a); the proximity of the DSB site 
probably harms the reporter gene. This has also been observed in other studies 197,293. Therefore, 
KU-binding of the DSB ends is essential to ensure DSB repair by res-cNHEJ can take place 
(Figure 4.1). Prevention of uncontrolled resection or a switch to alt-EJ is also provided by 
53BP1. In the absence of 53BP1, the misrejoining of distant DSB ends increased (Figures 3.12 A, 
B), which was entirely dependent on alt-EJ factors (Figures 3.13 C, D). Thus, 53BP1 is an 
additional factor required to allow DSB repair by res-cNHEJ (Figure 4.1). 
 
Figure 4.1 Model for the failure of accurate DSB repair  
I-SceI induces two 3.2 kb separated DSBs in GC92 cells with 4 nt 3′ overhangs. KU binds and protects the DSB ends 
while BRCA1 stabilizes KU. 53BP1 binds to histone octamers to prevent resection. KU translocates one helical turn 
inwards to allow DNA-PKcs-binding. The accurate repair of the DSB ends by c-NHEJ fails, which could occur for 
many reasons. Of note, Sibanda et al. (2017) speculate that because of the vicinity of the BRCA1 and DNA-PKcs-
binding sites on KU80, BRCA1 and DNA-PKcs compete with each other for KU80-binding. Based on Jiang et al. 
(2013); Grundy et al. (2014); Saha and Davis (2016); Chang et al. (2017); Sibanda et al. (2017), and data herein 
(chapters 3.2, 3.3). 
BRCA1 stabilizes KU during G1 phase of the cell cycle, through its interaction with KU80, to 
promote high-fidelity rejoining of break ends 197,336. Jiang et al. (2013) found that the BRCA1-
KU80 interaction was present in undamaged G1 cells and increased after I-SceI damage 
induction. Herein, this observation was broadened by validating that KU80 interacts with 
BRCA1 in G1 phase following DNA damage induction by X-IR (Figure 3.26 D). This interaction 
was present with no damage induction, increased 30 min post-irradiation, and was lower than 
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in undamaged cells 1 h post-irradiation. The absence of BRCA1 reduced the frequency of the 
misrejoining of distant and close DSBs (Figures 3.15 A, S8.11 c). Jiang et al. (2013) observed 
longer deletions in BRCA1-depleted cells. Thus, the reduction of close misrepair events likely 
has a similar origin as KU depletion, through longer deletions, which harm the reporter gene. 
In contrast, the reduction of misrejoining of distant DSBs is caused by the requirement of BRCA1 
for the initiation of the res-cNHEJ pathway (further details in chapter 4.2.2). Importantly, 
BRCA1-bound KU might prevent proper DNA-PKcs-binding as Sibanda et al. (2017) suggest 
that the close proximity of the BRCA1 and DNA-PKcs-binding sites on KU80 sterically exclude 
simultaneous binding.  
Translocation of KU during res-cNHEJ 
In the literature, it is generally accepted that KU prevents resection 239,273,362. Indeed, 
biochemical studies showed that KU needs to be actively removed from the break ends before 
resection can take place 373. Nevertheless, studies of single-ended DSBs have shown that 
resection is executed during HR while KU is bound to the DSB end and needs to be removed 
before the strand invasion takes place 74. Importantly, these studies all investigated extensive 
resection, which produces the long 3′ overhangs necessary for repair by HR. The results of the 
sequence analysis in this study indicated a much more limited resection (Figures 3.3 A, B) 
associated with the misrejoining of distant DSBs. In addition, KU80 co-localized with pRPA 
during G1 phase after 10 and 20 Gy X-IR (Figures 3.6 F, G). RPA requires approximately 30 nt 
ssDNA to coat and protect ssDNA stably 42. As only high doses of X-IR resulted in pRPA foci 
during G1 phase and the frequency of pRPA foci increased with increasing radiation doses, it 
can be assumed that only these high doses produce ssDNA regions long enough for pRPA to 
bind. This is supported by the sequence analysis, where 90% of the additional deletions at the 
misrejoined break sites ranged between no deletion and 50 nt deletions, with the majority of 
deletions less than 10 nt (Figures 3.3 A, B). Nevertheless, if KU remains bound to the break 
ends during the resection process in res-cNHEJ, it needs to be moved. This movement likely is 
very limited due to the very stable binding of KU to the DNA (Figure 4.2). Indeed, this is a 
favored model because it would explain why resection remains so limited during res-cNHEJ. 
The inwards translocation of KU by one helical turn (10 nt) to allow DNA-PKcs-binding is well-
described 271,321,424. Furthermore, in biochemical studies, KU was able to translocate inwards 
stepwise to allow the binding of up to 5 KU molecules on duplex DNA 385. The question then is: 
if (1) the translocation of KU inwards is something that happens when DSBs persist; (2) the 
inwards translocation of KU beyond 1 helical turn is inhibited right after damage induction to 
first prioritize accurate repair by c-NHEJ; and/or (3) the translocation of KU is promoted by an 
enzymatic activity to actively promote resection.  
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The most likely scenario is a combination of these mechanisms. For example, the inward 
translocation of KU might be actively promoted. Lee et al. (2016) showed that the 
phosphorylation of KU in the pillar and bridge region of KU70 leads to a conformational change, 
which leads to less stringent binding of KU to the DNA. This promotes the release of KU from 
the DSB ends through a combination of the low binding affinity of KU and possibly the 
assistance of the MRN complex with CtIP. The authors state that this phosphorylation is limited 
to S/G2 phase, but only because in their study this phosphorylation allows the removal of KU 
and long-range 5′ to 3′ resection to produce large 3′ overhangs. Perhaps KU is also 
phosphorylated in G1 to lower its binding affinity to the DNA, and thus promote the 
translocation of KU inwards (for further details on how the same KU phosphorylation could 
have a different outcome in G1 compared to S/G2, see chapter 4.2.3). Even the removal of KU 
and subsequent rebinding of KU upon completion of resection in G1 phase cannot be excluded, 
but such a model is unfavorable because it would raise the question of how resection remains 
so limited. In addition, the translocation of KU might be inhibited right after DSB induction by 
a stabilizing interaction with BRCA1. This would raise the question as to how the initiation of 
res-cNHEJ disrupts the BRCA1-KU interaction. In S/G2 phase of the cell cycle, CtIP is 
constitutively phosphorylated at Ser327 by S/G2-specific CDK complexes, which causes its 
interaction with BRCA1 428. During this study, it was established that in G1 phase, BRCA1 
interacts with CtIP following DNA damage induction, in a CtIP Ser327 phosphorylation-
dependent manner (Figures 3.26 C, S8.12 b). Indeed, the phosphorylation of CtIP at Ser327 
was required for the misrejoining of distant DSB ends (Figure 3.23 A). Interestingly, at the time 
the BRCA1-CtIP-pSer327 interaction was strongest, the BRCA1-KU80 interaction was weaker 
than in unirradiated samples (Figures 3.26 C, D). Moreover, the BRCA1-KU80 interaction 
remained strong when the damage-dependent CtIP phosphorylation was prevented, and thus 
the subsequent BRCA1-CtIP interaction could not occur. This indicates that the damage-
dependent formation of the BRCA1-CtIP interaction is involved in the disruption of the BRCA1-
KU80 interaction (Figure 4.2).  
Overcoming the resection barrier posed by 53BP1 during res-cNHEJ 
The BRCA1-CtIP interaction is important for the movement of 53BP1 away from the break end 
(Figure 4.2). The movement of 53BP1 is essential during S/G2 phase to enable HR and is 
achieved by several mechanisms. This includes the BRCA1-promoted dephosphorylation of 
53BP1, and thus disruption of the 53BP1 interaction with RIF1 and PTIP 96,127,178,186,353, as well 
as the BRCA1-dependent ubiquitination of H2A Lys217 to allow SMARCAD1 to reposition 
nucleosomes including the bound 53BP1 89,105. The extent of 53BP1 movement in G1 is unclear, 
as is the exact mechanism because resection remains so limited. However, Figure 3.15 B shows 
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that BRCA1 is no longer required in the absence of 53BP1, supporting the notion that BRCA1 
plays a role in relocating 53BP1 during res-cNHEJ as it does in HR. In conclusion, the data 
suggest that the damage-dependent phosphorylation of CtIP results in its interaction with 
BRCA1 and disrupts BRCA1s interaction with KU80 (Figure 4.2). In addition, both the BRCA1 
BRCT and RING domain are required for the misrejoining of distant DSB ends (Figure 3.16 A). 
This was not surprising for the BRCT domain, as it is necessary for BRCA1 to interact with 
phosphorylated CtIP. The requirement for the BRCA1 RING domain indicates that the E3 
ubiquitin ligase activity of BRCA1 is necessary for res-cNHEJ, as it is for the initiation of HR 127. 
Furthermore, the BRCA1-CtIP interaction is clearly required for the initiation of this novel repair 
pathway (Figures 3.23 A, 3.26 C). Importantly, the roles of BRCA1 and CtIP differed during res-
cNHEJ. The overexpression of CtIP, but not BRCA1, resulted in an increase of misrejoining of 
distant DSB ends (Figures 1.17 C, S8.11 e). This indicates that phosphorylated CtIP initiates 
resection by removing BRCA1 to destabilize KU, which could indeed be the primary reason for 
the BRCA1-CtIP interaction. 
4.2.2. Initiation of resection during res-cNHEJ 
As described, CtIP is phosphorylated at Ser327 upon damage induction in G1 phase (Figures 
3.26 C, S8.12 b). In Barton et al. (2014), PLK3 was identified as the kinase mediating this 
phosphorylation (Figure 4.2). Indeed, PLK3 is required for the misrejoining of distant, but not 
close, DSBs (just like CtIP; Figures 3.17 A, 3.24 B, C). In Barton et al. (2014), the possibility 
that PLK3 may be exclusive to G1 phase is mentioned because that was the case in thymidine-
synchronized HeLa cells 437. However, the protein levels of PLK3 in GC92 cells are similar in all 
cell cycle phases (Figure 3.26 B). In fact, this is also observed in multiple other cell lines, 
including several fibroblast cell lines 32,76,166,402,415. Nevertheless, the damage-inducible 
phosphorylation of CtIP by PLK3 is specific for G1 phase of the cell cycle 25. Furthermore, the 
CDK complexes responsible for constitutive CtIP phosphorylation during S/G2 phase 177 have no 
impact on the misrejoining of distant DSB ends (Figure 3.24 A). This indicates that the 
misrejoining of distant DSB ends, and thus res-cNHEJ is a G1-specific mechanism. However, 
PLK3-dependent misrejoining of distant DSBs was observed in G2 phase after the inhibition of 
HR by the impairment of S/G2-specific CDK complexes (Figure S8.16 d). Thus, PLK3 may be 
able to phosphorylate CtIP in G2 in the absence of these CDK complexes. Therefore, the damage-
inducible CtIP phosphorylation by PLK3 is probably suppressed by the constitutive CtIP 
phosphorylation by CDK complexes during S/G2 phase.  
In S/G2 phase, BRCA1 forms a complex with CtIP and the MRN complex 78. The requisite 
phosphorylation of CtIP at Thr847 10 is also present in G1 following DNA damage induction and 
necessary for the misrejoining of distant DSB ends (Figure 3.23 A). This phosphorylation is also 
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performed by PLK3 25. Therefore, BRCA1-CtIP likely interacts with the MRN complex in G1 
phase (further discussed in chapter 4.2.3). In Barton et al. (2014), CtIP Ser327 was 
phosphorylated 30 to 90 min following 5 Gy X-IR, whereas the phosphorylation of Thr847 
increased 120 min post-irradiation. In addition, the necessity of the PLK3 PBD to activate PLK3 
by interaction with Ser327-phosphorylated CtIP was observed to subsequently phosphorylate 
CtIP at Ser327 and Thr847 (Figure 4.2). Indeed, the PLK3 PBD was required for the 
misrejoining of distant DSB ends (Figure 3.25 A). Therefore, a model was proposed where PLK3 
binds via the PBD to Ser327-phosphorylated CtIP. It is unclear how this initial phosphorylation 
is accomplished. Based on models in the literature 122,325 the phosphorylation of CtIP at Ser327 
might be conducted by PLK3 in a self-priming mechanism, performed by an unknown kinase, 
or present in a fraction of the CtIP molecules from S/G2 phase residues 25. In any case, PLK3 
bound to CtIP-pSer327 then phosphorylates other CtIP molecules at Ser327 (Figure 4.2). 
Subsequently, PLK3 phosphorylates other sites such as Thr847 of the CtIP molecule to which 
PLK3 is bound and/or neighboring CtIP molecules.  
 
Figure 4.2 Model for overcoming resection barriers by the resection initiation mechanism during res-
cNHEJ  
After the failure of accurate repair, resection is initiated. PLK3 is phosphorylated by ATM and binds to CtIP-pS327 
via its PBD domain. The origin of this initial CtIP-pS327 remains speculative. Subsequently, the CtIP phosphorylation 
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at S327 is amplified by PLK3 through the phosphorylation of neighboring CtIP molecules. Furthermore, PLK3 
phosphorylates CtIP at T847 and additional sites. CtIP-pS327 interacts with BRCA1, which antagonizes the anti-
resection function of 53BP1. This potentially involves the movement of 53BP1 away from the DSB end. Importantly, 
the KU80-BRCA1 interaction is no longer observed during this time. This might be caused by the BRCA1-CtIP-pS327 
interaction to (1) destabilize KU and allow further KU translocation inwards or (2) to disrupt KU80-BRCA1 to allow 
DNA-PKcs-binding to KU (if steric competition exists as described in Sibanda et al. (2017)). Of note, it is plausible 
that the BRCA1-CtIP interaction forms a complex with MRN as is the case in S/G2 phase. Based on Barton et al. 
(2014); Panier and Boulton (2014); Saha and Davis (2016); Shibata (2017), and data herein (chapter 3.3). 
Hyper-phosphorylation of CtIP does not seem to play a role in G1-specific res-cNHEJ (Table 
8.7). However, the question arises as to whether phosphorylation of CtIP at Ser327 and Thr847 
by PLK3 is sufficient to initiate res-cNHEJ. Expressing a CtIP phospho-mimic mutant at these 
two sites in CtIP/PLK3-depleted cells was not sufficient for the misrejoining of distant DSB ends 
(Figure 3.27 A). Therefore, additional phosphorylation of CtIP by PLK3 is necessary for res-
cNHEJ. Importantly, in experiments with high-LET irradiation, resection was possible with this 
CtIP double phospho-mimic mutant 25. This indicates that phosphorylation of Ser327 and 
Thr847 is sufficient to initiate resection, but that res-cNHEJ is impaired at a subsequent step 
without complete phosphorylation of CtIP by PLK3. Based on the biochemical studies, strong 
candidate CtIP sites that might be phosphorylated by PLK3 are Ser326, Ser608, and Ser641 
(Table 8.7). In addition, several phosphorylation sites were identified that meet the criteria to 
be potentially phosphorylated by PLK3 but had a low probability for a phosphorylation in the 
one experiment performed during this study (e.g. Ser305, Ser555, Thr859).  
4.2.3. Nucleases conducting resection during res-cNHEJ 
An important characteristic of res-cNHEJ in G1 phase is that if resection is not initiated, a 
pathway switch can occur and still repair the DSBs. This may be one reason why res-cNHEJ has 
not been discovered thus far 25,36. After establishing how res-cNHEJ is initiated and how KU 
might translocate inwards to allow limited resection, the question remains as to which nucleases 
drive resection during res-cNHEJ. Resection is conducted in two steps during HR: short-range 
and long-range resection 354. During HR, resection is initiated by MRE11 endonuclease activity, 
which cleaves the ssDNA internally from the break end (Figure 2.3). This incision requires the 
presence of RAD50 and, for conformational reasons, NBS1 and Thr847-phosphorylated CtIP 10. 
Rass et al. (2009) showed that MRE11 is involved in the misrejoining of distant DSBs and, as 
described in chapter 4.2.2, so is CtIP-pThr847 (Figure 3.23 A). However, the use of an MRE11 
endonuclease-specific inhibitor 354 during this study showed that the endonuclease activity of 
MRE11 is dispensable for the misrejoining of distant DSB ends (Figure 3.28 A). Ultimately, it is 
unsurprising that resection in G1 is not initiated by an endonucleolytic MRE11-dependent cut, 
as that mechanism allows other resection processes to circumvent the protection of the DSB 
ends by KU. The lack of an endonucleolytic cut during res-cNHEJ indicates that resection is 
initiated from the DSB end, which again supports the notion that KU limits the extent of 
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resection in G1. Moreover, resection from the DSB ends could move phosphorylated KU, which 
would be bound less stringently to the DNA (as per the model introduced in chapter 4.2.1) 229. 
Thus, if KU is phosphorylated in G1 and S/G2 phase, the movement of KU would be determined 
by the direction of the resection process. This would explain different outcomes of KU 
phosphorylation in G1 (enabling limited resection that would not be visible with the 
experiments performed by Lee et al. (2016)) versus S/G2 phase (removal of KU and enabling 
extensive resection during HR). 
Another important aspect to consider regarding the lack of an endonucleolytic cleavage by 
MRE11 during res-cNHEJ, is an observation by Anand et al. (2016). In this study, this cut was 
possible in biochemical studies simply by the presence of the MRN complex in concert with 
CtIP-pThr847. This implies that there is a mechanism during G1 phase, which inhibits the 
endonucleolytic function of MRE11. This inhibition is likely connected to 53BP1, because in the 
absence of 53BP1, the endonuclease function of MRE11 plays a role (Figure 3.29 A). As 
described in chapter 4.2.2, it is to be expected that BRCA1-CtIP may form a complex with MRN 
during res-cNHEJ, as is observed during S/G2 phase 78. This might be another process by which 
MRE11 activity could be inhibited, as BRCA1 is known to suppress the nucleolytic activity of 
MRE11 during G1 phase 336,412. This is achieved through BRCA1s interaction with NBS1 336,412. 
Thus, this interaction might change the conformation of the complex to prevent the 
endonucleolytic cut by MRE11, as NBS1 is required during S/G2 phase during the incision by 
MRE11 for conformational reasons 10. However, the continued persistence of DSBs might 
change the way in which resection takes place during res-cNHEJ, as slow repair during G1 phase 
also repairs blocked ends, which likely require MRE11 endonucleolytic activity 12,241,319. Hence, 
the resection process during res-cNHEJ could be adjustable depending on the structure of the 
DSB end, just like the processing of the DSBs and the factors involved differ during resection-
independent c-NHEJ 71,72,145,302,326,370. 
The endonuclease I-SceI introduces DSBs under the formation of 4 nt 3′ ssDNA overhangs. Thus, 
5′ to 3′ resection factors, which are usually responsible for long-range resection during HR, 
came into focus during this study. 5′ to 3′ resection during HR produces extensive 3′ overhangs, 
which are necessary for strand invasion and requires the initiation of resection internally to the 
break end to overcome the block of the DSB ends 354. Resection in the 5′ to 3′ direction is either 
conducted by EXO1/BLM and/or BLM/DNA2 67,287,382. BLM is a helicase, which unwinds the 
dsDNA by translocating along ssDNA in a 3′ to 5′ direction 92. However, BLM also has a role in 
promoting DSB protection through the 53BP1/RIF1 pathway 148, which makes it difficult to 
investigate. Although BLM depletion had no impact on the frequency of misrepair events 
(Figure 3.30 A), Grabarz et al. (2013) showed that the lack of BLM results in large deletions at 
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the misrejoined break sites. More importantly, the combined impairment of BLM with DNA2 
also did not impact the misrejoining of distant DSB ends (Figure 3.30 A). This was not 
surprising, as 5′ to 3′ resection by BLM/DNA2 is stimulated during S/G2 phase by RPA 16, which 
binds to the generated ssDNA to protect it from digestion 37. RPA then directs the DNA2 
endonucleolytic activity towards a stepwise degradation of the 5′ DNA strand 16,240,282. As 
described previously, resection is generally too limited during G1 phase for RPA-binding, and 
thus would not allow the DNA2/BLM-dependent 5′ to 3′ resection.  
In the literature, EXO1 is described as a factor, which is prevented from accumulating at DSBs 
by KU80 218,373,382. Nevertheless, the misrejoining of distant DSBs was dependent on EXO1 to 
the same extent as CtIP (Figures 3.30 A, B, S8.18 b). This was unexpected but would be a 
favorable combination to ensure that resection during G1 remains limited by creating a hostile 
environment. However, KU is not the only factor that counteracts EXO1-dependent resection. 
In fact, RPA also restricts EXO1-mediated resection by removing and/or blocking it from binding 
to ssDNA 62,218,282. To overcome this restriction in S/G2 phase, EXO1 requires support. Several 
studies suggest that full EXO1 exonuclease activity, EXO1 recruitment, and/or the extent of 
EXO1 resection requires its stimulation by the MRN complex or factors such as MRE11, CtIP, 
BRCA1, BLM, and/or additional unknown proteins 16,62,121,169,170,209,282,373,381,382. In fact, EXO1 
only is able to conduct resection on its own in the absence of KU80, when EXO1 is 
overexpressed, and/or when the DSB ends in a long 3′ ssDNA tail 240,260,382. As EXO1 is required 
for resection in res-cNHEJ (Figure 4.3), further factors that might support EXO1 to allow DSB 
resection from the end despite KU80s presence were analyzed. As described, MRE11 has already 
been shown to be involved in the misrejoining of distant DSB ends 322. This was confirmed by 
this study and specified by the exonuclease-specific inhibition of MRE11 (Figure 3.28 A). This 
result suggested a dependency of misrejoining events on the 3′ to 5′ MRE11 exonuclease 
function. In Biehs et al. (2017), it is suggested that resection during G1 phase is either conducted 
by EXO1 or MRE11, depending on whether 3′ to 5′ or 5′ to 3′ resection is required. However, 
the DSBs generated by I-SceI always generate the same DSB end structures with 3′ overhangs. 
Another result, which speaks strongly against this model, is that the combined impairment of 
EXO1 and MRE11 exonuclease function did not further decrease the misrepair events (Figure 
3.30 C). In addition, Rass et al. (2009) observed that an MRE11 mutant, which displayed 
impaired nuclease activity (both endo- and exonuclease activity), had no impact on the 
misrejoining of distant DSB ends in GC92 cells. Furthermore, BRCA1 has been shown to 
suppress the MRE11 nucleolytic activity during G1 phase through its interaction with NBS1 
336,412. Closer inspection of the endo- and exonuclease-specific inhibitor functionalities provided 
a possible explanation (also see chapter 3.3.4 for more details on the effect of the inhibitors). 
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Mirin and PFM39 both inhibit the 3′ exonuclease activity of MRE11 354. However, mirin is known 
to prevent MRN-dependent ATM activation 120. In contrast, PFM39 does not prevent MRN-
dependent ATM activation 36,354 but speculatively, may instead impair MRE11s support of EXO1-
mediated resection. Importantly, EXO1/BLM-dependent resection during S/G2 phase works in 
cells treated with the PFM39 exonuclease-specific MRE11 inhibitor 354. This can be easily 
explained by BLM assuming the supporting role toward EXO1 in S/G2 phase, which would only 
be possible in the presence of RPA 16, and thus not an option during the limited resection in G1 
phase. Another factor, which might be required to support EXO1-dependent resection during 
res-cNHEJ, is the nuclease and RecQ helicase WRN. In biochemical experiments, the 5′ to 3′ 
dsDNA exonuclease activity of EXO1 is stimulated by WRN 351. In addition, WRN promotes c-
NHEJ with its helicase and exonuclease activity and prevents large deletions by protecting the 
DSBs from 5′ resection in error-prone end-joining 350. Thus, WRN is a strong candidate to be 
involved in res-cNHEJ. 
A major reason, why the model of both MRE11 exonuclease activity and EXO1-mediated 
resection during res-cNHEJ was included in Biehs et al. (2017), was the observation that EXD2 
was required for the misrejoining of distant DSBs (Figure 3.28 A). EXD2 conducts 3′ to 5′ 
resection in concert with MRE11 following the endonucleolytic cleavage by MRE11 during HR 
53. However, the biochemical studies in Broderick et al. (2016) strongly suggest that the role of 
EXD2 in res-cNHEJ is different than HR. Although EXD2 can resect ssDNA in a 3′ to 5′ direction, 
the resection of dsDNA in the 3′ to 5′ resection is only possible from nicks or gaps, and thus 
requires MRE11 endonuclease activity. As the MRE11 endonuclease activity is not involved in 
res-cNHEJ, EXD2 is not able to perform 3′ to 5′ dsDNA resection in concert with MRE11 from 
the break end. This raises the question of what is the role of EXD2 in res-cNHEJ? As I-SceI 
generates 3′ ssDNA overhangs, which are further expanded by EXO1 through its 5′ to 3′ 
exonuclease activity on dsDNA 227,230, EXD2 might process the ssDNA in the 3′ to 5′ direction. 
Thus, EXD2 could be responsible for the loss of nucleotides at the misrejoined break sites. 
Another possibility for an involvement of EXD2 might be found through its homolog CG6744 
in Drosophila melanogaster. The exonuclease domain in EXD2 was predicted due to this gene 
containing homology to the WRN exonuclease domain 91,358. In addition, the same gene also 
shares homology with the helicase ATP-binding domain of WRN 91. Therefore, the involvement 
of EXD2 in res-cNHEJ could be independent of its nuclease activity. Indeed, EXD2 might support 
EXO1, as was suggested for other proteins such as MRE11 and CtIP. This hypothesis is supported 
by the possible interaction of EXD2 with EXO1 (Table 8.8). Importantly, the interaction 
increased following DNA damage induction. In general, EXD2 might also be involved in the 3′ 
to 5′ dsDNA resection at DSBs with 5′ overhangs, as it has weak nuclease activity at such 
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structures 53. However, this possibility is irrelevant for the repair of DSBs with 3′ overhang in 
all assays with damage induction by I-SceI. 
4.2.4. Processing of resection intermediates during res-cNHEJ 
The ssDNA generated during resection in res-cNHEJ is too short for RPA to stably bind 42, and 
thus is not protected. The structure of DNA-PKcs forms a “head” region and a “palm” region 159. 
The “head” of DNA-PKcs has a small cavity, which allows ssDNA to enter and is believed to 
promote end-processing 408. Therefore, is was speculated in Biehs et al. (2017) that the 
generated ssDNA might be captured in the small cavity of DNA-PKcs to protect it from 
degradation (Figure 4.3).  
 
Figure 4.3 Model for resection and the processing of resection intermediates during res-cNHEJ  
As KU translocates inwards, resection can take place. Speculatively, the generated ssDNA is captured by DNA-PKcs 
to prevent the degradation of the overhang. Resection is conducted by EXO1 in a 5′ to 3′ direction. Although MRE11 
exonuclease activity may contribute by resecting in 3′ to 5′ direction, it is more likely that MRE11 only plays a 
supportive role in allowing EXO1 resection. Furthermore, EXD2 was observed to be involved. However, its role is 
unclear, as it can only resect dsDNA in S/G2 in the 3′ to 5′ direction following the endonuclease cut by MRE11, which 
does not play a role during res-cNHEJ. Nevertheless, EXD2 was observed to have 3′ to 5′ exonuclease activity on 3′ 
ssDNA, which could be one explanation for the involvement of EXD2. Of note, it is plausible that BRCA1-CtIP 
complexes with MRN, as is the case in S/G2 phase, especially considering that BRCA1 is known to interact with NBS1 
during G1 phase to inhibit the nuclease activity of MRE11. Importantly, DNA-PKcs likely hangs on the “arm” of KU80 
during the resection process (different compared to the model in Biehs et al. (2017)). Following resection, the 
endonuclease ARTEMIS cuts the hairpin-like structure of the DNA formed by DNA-PKcs. These cuts could be guided, 
and thus generate different sizes of deletions (as suggested in Biehs et al. (2017)). However, it is more likely that 
the size of generated ssDNA is controlled by the resection machinery, as ARTEMIS cuts hairpins and hairpin-like 
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structures (formed from ssDNA overhangs) an equivalent of 1 nt from the dsDNA-ssDNA transition in the 5′ direction 
to produce 3′ overhangs. This is why the capture of the ssDNA by DNA-PKcs is an attractive model: it would explain 
why ARTEMIS is crucial to process this hairpin-like structure. Based on Williams et al. (2008); Rass et al. (2009); 
Hammel et al. (2010); Panier and Boulton (2014); Williams et al. (2014); Chang et al. (2015); Broderick et al. 
(2016); Chang and Lieber (2016); Saha and Davis (2016), and data herein (chapters 3.2, 3.3). 
The putative DNA-binding domain is located between the “head” and the “palm” region of DNA-
PKcs. This is within an area where dsDNA enters (approximately one helical turn of dsDNA) 
and which includes a gap at the bottom of the “palm” region 291,408. The binding of DNA-PKcs 
to KU and the helical turn of dsDNA, therefore, stabilizes the position of the DNA-PK molecule. 
Thus, the model displayed in Biehs et al. (2017) where DNA-PKcs is bound to KU and the 
dsDNA, is unfavorable, as it would likely prevent further KU translocation inwards. 
Consequently, resection beyond 10 nt would be prevented in such a model 267,285,388,409. 
Therefore, it is likely that DNA-PKcs is not bound to KU and the DNA during resection in res-
cNHEJ. This is additionally supported by the fact that upon autophosphorylation of DNA-PKcs, 
a conformational change broadens the area between the “head” and the “palm” region, which 
allows the flexible gap to open, and thus release the dsDNA 159,291,409. Thus, the formation of a 
mature DNA-PK molecule, including the contact of DNA-PKcs with KU, the dsDNA, and the 
DNA-PK molecule on the other DSB end might be prevented to allow KU translocation and avoid 
DNA-PKcs autophosphorylation before resection is complete. Instead, DNA-PKcs might be 
linked to the “arm” of KU80 409 until a structure that allows DNA-PKcs-binding to the DNA is 
generated (Figure 4.4).  
The misrejoining of distant DSBs is entirely dependent on the endonuclease ARTEMIS (Figures 
3.11 A, B). The capture of the ssDNA in the small cavity of DNA-PKcs would form a loop or 
hairpin-like structure (Figure 4.3). In fact, the formation of such a structure is the main reason 
behind this model, as ARTEMIS is the only vertebrate nuclease in WT cells that is able to process 
hairpins 70. ARTEMIS processes hairpins or hairpin-like structures under the binding of the DNA 
at the ssDNA-dsDNA transition and performs an endonucleolytic cut an equivalent of 1 nt in 
the 5′ direction, which forms 3′ overhangs (except if the hairpin-like structure is formed from a 
5′ overhang) 70. Importantly, the endonuclease function of ARTEMIS is dependent on its 
interaction with DNA-PKcs 70,114,198,251,286. The necessity of ARTEMIS was also observed in other 
studies employing reporter assays 278,293. An important observation supporting the model is that 
in experiments with high-LET irradiation pRPA foci formation was reduced in cells lacking 
ARTEMIS 36. Another result supporting the necessity for ARTEMIS during res-cNHEJ is the 
observation that without ARTEMIS, DSBs remain unrepaired (Figures 3.11 C). However, 
whenever resection was not initiated or executed, the repair defect was partially rescued, 
indicating that ARTEMIS was not required if repair switched from res-cNHEJ to another 
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pathway (Figures 3.20 B, 3.25 C, 3.29 C, S8.11 d, S8.14 b, S8.18 c). Therefore, ARTEMIS 
resolves resection intermediates during res-cNHEJ.  
4.2.5. Completion of repair during res-cNHEJ 
The endonucleolytic cut by ARTEMIS produces ssDNA regions, which expose MHs and DSB 
ends for DNA-PKcs-binding (Figure 4.4). Sequence analysis of the misrejoined site confirmed 
that the majority of breaks are misrejoined using MHs (Figures 3.3 C, D). The annealing of the 
MHs requires the subsequent fill-in of the ssDNA gaps, and thus res-cNHEJ involves polymerases 
(Figure 4.4). Res-cNHEJ uses the polymerases POL, POL, and POL (Figures 3.10 A, B). Short 
MHs or high-fidelity misrepair events are likely associated with POL and POL. In contrast, 
the observation that the majority of misrejoined breaks used 3 or 4 nt MHs (Figures 3.3 C, D) 
fits well with the involvement of POL, which preferably uses these MH sizes 414. This aspect of 
res-cNHEJ seems to be closely related to MMEJ. In fact, the existence of res-cNHEJ answers the 
question of whether MMEJ is solely an alt-EJ mechanism or if the misrejoining under the usage 
of MHs exists as an error-prone mechanism in WT human cells (see also chapter 2.2.4). Yes, 
DSBs are rejoined using MHs in WT human cells in the form of res-cNHEJ, which involves c-
NHEJ and not alt-EJ-associated factors. POL uses the annealed short sequence on the 3′ ssDNA 
overhang as a primer while binding to the 5′ terminal phosphate of the opposing DNA end to 
extend the annealed 3′ overhang under the displacement of the 5′ strand (Figure 4.4) 207,414. 
Therefore, additional nucleases might be required to dispose of the generated flap. The 
described mechanism entails that POL requires 3′ overhangs. This supports the model that 
resection is conducted 5′ to 3′ and/or that the resection intermediates, which need to be 
resolved by ARTEMIS, are indeed hairpin-like and mainly result in 3′ overhangs. 
The autophosphorylation of DNA-PKcs can take place at any timepoint after DNA-PKcs contacts 
the DNA and DNA-PK is in contact with the DNA-PK molecule at the other DSB end 40,108,267,271. 
Thus, just like during c-NHEJ (see also chapter 2.2.3 for further details), the 
autophosphorylation and subsequent release of DNA-PKcs could be conducted before or after 
the fill-in of the gaps and/or further processing, but needs to be executed before ligation can 
take place 197.  
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Figure 4.4 Model for completion of res-cNHEJ  
The endonucleolytic cut by ARTEMIS produces 3′ ssDNA overhangs (see Figure 4.3). The majority of the misrejoined 
break sites revealed MHs (N), allowing the annealing of the DNA strands. All three polymerases POL, POL, and 
POL play a role in the misrejoining of distant DSBs. This model proposes how POL could conduct the fill-in of the 
gaps during res-cNHEJ. Of note, further end-joining-associated nucleases might be involved, as POL produces 5′ 
flaps, which would need to be removed. The limited resection and the short MHs allow ligation by LIG4, likely in a 
complex with XRCC4 and XLF, which are required for LIG4 to ligate sequences with MHs, gaps, and ssDNA 
overhangs. Speculatively, LIG4 is already present from the beginning of the process (Figure 4.1) and probably 
contributes to bringing the two DSB ends in proximity, as it does in c-NHEJ. Based on Gu, Lu, Tsai, et al. (2007); 
Gu, Lu, Tippin, et al. (2007); Lieber (2010); Kent et al. (2015); Reid et al. (2015); Brouwer et al. (2016); Wyatt et 
al. (2016); Jaafar et al. (2016), and data herein (chapter 3.2). 
In MMEJ as an alt-EJ mechanism, ligation is conducted by the alt-EJ ligase LIG3 and in its 
absence, by LIG1 116,346,347. However, the impairment of LIG1/3 had little to no influence on the 
misrejoining of distant DSBs or the sequence alterations at the misrejoined sites (Figures 3.8 A, 
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3.9 A, B, C, D). This has recently been confirmed by Gelot et al. (2016). This difference between 
MMEJ as an alt-EJ mechanism and res-cNHEJ might be due to the much larger resection during 
alt-EJ processes, which are caused by the lack of DSB end-protection and/or the lack of factors 
able to recruit the c-NHEJ ligation complex. The misrejoining of distant DSB ends by res-cNHEJ 
was dependent on the c-NHEJ ligase LIG4 (Figure 3.5 B), which is consistent with other studies 
136. Despite LIG4s involvement in the misrejoining of distant DSB ends and LIG4 acting 
downstream of ARTEMIS, the absence of LIG4 only resulted in a partial repair defect (Figure 
S8.6 c). Of course, as discussed in chapter 4.1.2, this could be due to a partial defect or because 
the break ends remain in proximity in contrast to ARTEMIS-deficient cells, where a full repair 
defect was observed (Figure 3.11 C). The observation of a full repair defect after the combined 
impairment of LIG4 with either LIG1/3 or the alt-EJ factor PARP1 (Figures 3.8 A, B, S8.8 c), 
implies that some breaks can be ligated in the absence of LIG4 by LIG1/3 in a PARP1-dependent 
manner. Importantly, this situation appears to be different than ligation after irradiation, where 
no switch to LIG1/3 was observed in hypomorph LIG4 mutant cells 36. However, this might be 
due to the partial loss of the LIG4 function in hypomorphic cells, which might result in 
differences compared to the depletion of LIG4 herein.  
Although the other components of the LIG4 complex, XRCC4 and XLF, were not investigated 
during this study, it can be expected that they are also involved in the ligation process (Figure 
4.4). This is due to the fact that LIG4 would not be able to ligate DSB ends, which have 
overhangs, MHs, and/or nucleotide gaps on its own 152,153,242. The involvement of these factors 
in res-cNHEJ was confirmed in radiation-based experiments in Biehs et al. (2017). However, 
the SFPQ/NONO complex could also play a role 213. SFPQ/NONO promotes the sequence-
independent pairing of DNA substrates via a side-by-side alignment and loop formation, which 
differs from the XLF-dependent pairing of the break ends 187. During this study, ARTEMIS was 
found to likely interact with SFPQ and NONO in a DNA damage-dependent manner (Table 8.4). 
This novel interaction might indicate a possible involvement of SFPQ and NONO in res-cNHEJ 
and further investigation into the regulation of this damage-inducible interaction would be an 
interesting future study. 
4.2.6. Additional factors involved in res-cNHEJ 
Additional barriers to resection during res-cNHEJ 
Res-cNHEJ is a DSB repair pathway that requires factors, which prevent excessive resection 
during G1 phase of the cell cycle. Thus, factors limiting resection are crucial to ensure efficient 
res-cNHEJ. Some of these factors, including KU, 53BP1, RIF1, REV7, and RAP80 were identified 
during this study (Figures 3.5 B, 3.12 A, 3.14 B, C). The impairment of RAP80, RIF1, or REV7 
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resulted in increased misrejoining of distant DSBs (Figures 3.14 B, C), indicating that they are 
all involved in limiting resection during res-cNHEJ. These proteins are also involved in 
preventing DSB resection during S/G2 phase. During S/G2 phase, RAP80 poses a resection 
barrier, which is removed by POH1 after the priming of 53BP1 by BRCA1 203. RIF1 directly 
interacts with ATM-phosphorylated 53BP1. Resection only can be initiated during HR after the 
dephosphorylation of 53BP1, and thus subsequent disruption of the 53BP1-RIF1 complex, 
which is promoted by BRCA1 186,353. REV7 is a downstream interaction partner of RIF1 417. Thus, 
much like 53BP1, all of these factors pose resection barriers. Hence, they might not have a direct 
impact on res-cNHEJ but their presence is crucial to prevent excessive and/or uncontrolled 
resection. Different behavior was observed for the 53BP1-interacting protein PTIP, the 
impairment of which reduced the frequency of misrepair events (Figure 3.14 B). ARTEMIS 
interacts with PTIP 400. Thus, ARTEMIS is the major downstream effector of the 53BP1 pathway, 
which means that this reduction in misrepair events might be indirectly caused by restriction of 
the ARTEMIS protein. However, the reduction of misrepair events in the absence of PTIP is only 
half compared to the complete abolishment of misrepair events in ARTEMIS-deficient cells 
(Figures 3.11 B, 3.14 B). Thus, a more likely explanation is a direct effect of PTIP on res-cNHEJ. 
PTIP is required for long-range chromatin interactions by loop formation, and thus 
guaranteeing the closeness of distant DSBs for joining during CSR, which is disturbed in the 
absence of PTIP 97,344. Therefore, PTIP might be required to ensure the proximity of the distant 
DSBs during res-cNHEJ to allow misrejoining to occur. Interestingly, during this study, it was 
observed that CtIP is a likely interaction partner of PTIP following damage induction (Table 
8.6). The investigation of this possible interaction might help to further characterize the res-
cNHEJ pathway in future studies. More factors are likely involved in limiting resection, 
including HELB, as it was shown that HELB limits long-range resection during S/G2 phase and 
is available in the nucleus in much higher concentration during G1 phase 380.  
Chromatin remodeling during res-cNHEJ 
The final protein investigated during this study was PARP1. PARP1 was initially linked to the 
repair of SSBs and the alt-EJ pathway in KU-deficient cells 102,116,404. Therefore, it was surprising 
that PARP inhibition by Olaparib or PARP1 depletion resulted in less misrejoining of distant 
DSBs (Figures 3.7 A, B). It was even more surprising, as the treatment of human fibroblasts 
with the PARP inhibitor PJ34 had no impact on res-cNHEJ in radiation-based assays 36. PJ34 
could not be used in this study, as it induces side effects such as mitotic arrest and induction of 
apoptosis 20,252, which makes it unsuitable for experiments such as the reporter assay that lasts 
several days. Instead, the PARP inhibitor Olaparib was used in this study, as it does not trap 
PARP on the DNA like the majority of PARP inhibitors. Olaparib affects the PARylation dynamics 
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by enhancing PARP1 mobility (conference contribution Liu et al. (2017)). This might explain 
the different observations. To validate the observed effect, the results were confirmed by PARP1 
depletion (Figure 3.7 B). This raised the question of what PARP1s role in res-cNHEJ is, as res-
cNHEJ is not an alt-EJ pathway but involves c-NHEJ factors. PARP1 regulates and promotes c-
NHEJ by a number of processes (for further details see chapter 2.2.3). One example is that 
PARP1 contributes to c-NHEJ by rapid chromatin expansion in concert with CHD2, which is 
required for efficient spreading of the LIG4 interaction partner XRCC4 250. Indeed, this would 
be a favorable explanation since during S/G2 phase, chromatin remodeling is also an important 
aspect of HR that allows resection 192. A strong argument for this is made by the fact that PARP1 
impairment behaved similarly to other factors involved in the initiation of resection. For 
example, PARP1 depletion or inhibition in combination with the impairment of other factors 
resulted in similar phenotypes as CtIP depletion, supporting the notion that PARP1 is required 
for the initiation of res-cNHEJ. Other possible roles for PARP1 during res-cNHEJ could be the 
stimulation of the kinase activity of DNA-PKcs 334 or the damage-inducible rapid recruitment of 
MRE11 158. In any case, the involvement of PARP1 explains why res-cNHEJ could go unnoticed 
so long and why confusion regarding the possibility of an alt-EJ pathway in WT human cells 
prevailed. Therefore, it was important to distinguish between PARP1s role in res-cNHEJ and 
alt-EJ. An important difference was that PARP1 is crucial for alt-EJ and without it, a repair 
defect is observed (Figures 3.7 B, C, 3.13 C, D). In contrast, in the absence of PARP1 during 
res-cNHEJ, the misrejoining of distant DSBs is reduced but the DSBs are still repaired (Figures 
3.7 A, B, C). For now, the role of PARP1 in res-cNHEJ remains unclear. However, since the role 
of PARP1 during res-cNHEJ might be linked to chromatin expansion as described for c-NHEJ 
by Luijsterburg et al. (2016) in concert with CHD2, chromatin remodeling might be required 
for res-cNHEJ (also discussed in chapter 4.4.1). For example, ARTEMIS was found to 
increasingly interact with the heterochromatin building factor KAP1 following DNA damage 
induction in this study (Table 8.4).  
Statement on future studies on res-cNHEJ 
In conclusion, this study reveals how res-cNHEJ is initiated, which nucleases conduct resection, 
and that the c-NHEJ pathway is related to res-cNHEJ. However, many questions remain open: 
(1) how does KU translocate inwards to allow resection?; (2) how does PARP1 contribute to 
res-cNHEJ?; (3) how is the endonuclease activity of MRE11 inhibited in G1 phase?; (4) what is 
the role of EXD2?; (5) is the MRE11 exonuclease activity of relevance for res-cNHEJ?; (6) how 
does EXO1 act in the presence of KU80?; (7) if the resection intermediates do not involve the 
capture of the ssDNA by DNA-PKcs, why is ARTEMIS indispensable for res-cNHEJ?; (8) why are 
different polymerases required for the misrejoining of distant DSBs?; and (9) what determines 
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the extent of resection during res-cNHEJ? Although many of these questions could be addressed 
with speculative models in this chapter (4.2), based on the data in this study and other studies, 
these questions will help to further characterize res-cNHEJ in the future. 
4.3. Repair pathway choice for the misrejoining of distant nuclease-induced DSBs 
A major force in DSB repair pathway choice is the initiation of resection, which is dependent 
on factors such as the location of the break, the structure of the break ends, the cell cycle phase, 
and the complexity of the break 13,15,17,71,72,74,75,140,145,147,202,288,302,312,326,370. This chapter discusses 
which other repair pathways contribute to the misrejoining of distant DSB ends and under 
which circumstances they are employed. 
4.3.1. Cell cycle-specific misrepair of distant DSB ends 
The first indication that the resection process involved in the misrepair of distant DSBs is not 
limited to S/G2 phase, was the observation that CtIP activation is dependent on PLK3 and not 
on S/G2-specific CDK complexes as is the case during HR (Figures 3.24 A, B, 3.26 C). Although 
PLK3 expression differs depending on the cell line, in GC92 cells, PLK3 was observed 
throughout the cell cycle (Figure 3.26 B). In Barton et al. (2014), the CtIP activation by PLK3 
was shown for G1 phase, and thus the misrepair in the end-joining reporter assay in GC92 cells 
likely is also G1-specific. This was confirmed by cell cycle-specific experiments in GC92 cells 
(Figure S8.3 c). Misrepair of distant DSBs was barely observed in G2-synchronized cells. 
However, misrepair events in G1-synchronized cells were nearly identical compared to 
asynchronously grown cells. Nevertheless, it remains unclear why the misrepair of distant DSB 
ends is a G1-specific event. As discussed in chapter 4.2.2, the impairment of HR by inhibition of 
S/G2-specific CDKs caused an increase in misrepair events in G2-synchronized GC92 cells to 
nearly the same frequency observed in asynchronously grown cells (Figure S8.16 d). Therefore, 
HR might suppress res-cNHEJ during S/G2 phase. Indeed, Gelot et al. (2016) recently found 
that the presence of the cohesin complex suppresses distant (3.2 kb), but not close (34 bp), 
misrepair of two endonuclease-induced DSBs during S/G2 phase in favor of HR. The cohesin 
complex is responsible for the coupling of the sister chromatids from the moment of replication 
until the segregation during mitosis, and thus imperative for the invasion of the sister chromatid 
during HR. Gelot et al. (2016) used mimosine for synchronization in G1 phase and observed a 
2-fold increase in misrepair events. Mimosine synchronizes cells in late G1 phase. This might 
explain why they observed an increase in misrepair events compared to Figure S8.3 c of this 
study (where misrepair events in early/mid G1-synchronized cells were nearly identical 
compared to asynchronously grown cells). Resection factors such as CtIP are upregulated in 
late G1 phase and with enhanced resection, misrepair increases (as observed in Figure 3.17 C) 
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428. In conclusion, the misrejoining of distant DSB ends is suppressed during S/G2 phase in favor 
of HR, and thus specific for G1 phase. 
The frequency of misrepair events from the misrejoining of close DSBs in GCS5 cells was higher 
in comparison to the misrepair events in GC92 and GCSH14 cells (Figures 3.4 B, C). This 
indicates that the misrepair of two close endonuclease-induced DSBs occurs more frequently, 
which was also observed in other publications 136,154. During this study, evidence was found that 
close DSBs do not require resection factors such as CtIP (Figure 3.17 A), and thus are not 
repaired by the G1-specific res-cNHEJ. That would explain the observation by Gelot et al. (2016) 
that close endonuclease-induced DSBs are not affected by the cell cycle phase. Interestingly, 
misrepair in another end-joining reporter assay in which two I-SceI recognition sites are 
separated by a puromycin resistance gene (approximately 600 bp), was not dependent on CtIP 
either 278. This indicates that the endonuclease-induced DSBs are still not far enough apart from 
one another to be misrepaired by G1-specific res-cNHEJ. In yet another reporter system, which 
only has one I-SceI restriction site but specifically investigates misrejoining using MHs, the 
frequency of misrepair events was also resection-dependent and involved factors such as CtIP. 
However, these events specifically arose in S/G2 phase and the CtIP activation was dependent 
on S/G2-specific CDK complexes 384. In Ahrabi et al. (2016), where they use a similar reporter 
assay, this type of repair was described as a backup for abrogated HR.  
Importantly, sequence alterations at misrejoined break sites behave similarly, even in reporter 
assays with different structures, as was first described in detail by comparing the misrepair of a 
single I-SceI recognition site reporter to a reporter with two I-SceI recognition sites spaced 
300 bp apart 173. However, the number of cells, showing no additional alterations at the 
misrejoined break site, so-called high-fidelity misrepair events, differed greatly, with close DSBs 
producing more high-fidelity events. This was also observed in Guirouilh-Barbat et al. (2016) 
where the end-joining reporter construct with close DSBs (GCS5 cells) was used. Therefore, G1-
specific res-cNHEJ may also contribute to the misrepair of close DSBs, but the frequencies are 
too low to be detected. Another possibility is that even breaks that are not misrepaired by the 
G1-specific res-cNHEJ pathway can produce similar kinds of sequence alterations by other 
processing mechanisms. This is supported by the observation that the misrepair of close DSBs 
is not associated with res-cNHEJ but mostly dependent on DNA-PKcs and ARTEMIS (Figures 
3.5 A, 3.11 A). Thus, the key element for misrepair of all distant and most close DSBs seems to 
be the presence of intermediate structures, which need to be processed by the endonuclease 
activity of ARTEMIS in concert with DNA-PKcs. Speculatively, these structures do not only arise 
by the controlled resection mechanism during res-cNHEJ but also by the minimal processing of 
the DSBs, as described for c-NHEJ (for further details see chapter 2.2.3) 71,72,145,302,326,370. As this 
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resection-independent process that requires ARTEMIS seems to be exclusive for close DSBs, it 
is not G1-specific as res-cNHEJ. However, an important indication that such a process might 
also contributes to the misrejoining of distant DSB ends is that the prevention of resection by 
the impairment of resection-initiating factors during res-cNHEJ only resulted in a partial rescue 
of the ARTEMIS repair defect (Figures 3.20 B, 3.25 C, 3.29 C, S8.11 d, S8.14 b, S8.18 c). This 
indicates that half of the ARTEMIS repair defect is independent of res-cNHEJ. However, in 
radiation-based assays, the rescue of the ARTEMIS repair defect was not always partial 36. In 
any case, res-cNHEJ is a G1-specific end-joining pathway that specifically misrejoins distant DSB 
ends. 
DSBs induced by the endonuclease I-SceI have a curious behavior; despite their location and 
structure being the same, they are not only repaired with different outcomes (as observed by 
sequence analysis in this study and others) but also by different factors. Although the distance 
of the DSBs influences the pathway choice, this neither explains why res-cNHEJ is initiated for 
the misrejoining of distant DSB ends nor why only half of the misrejoined distant DSB ends are 
repaired by res-cNHEJ. An important indication during this study was that H2AX foci only 
persist long enough to be monitored several hours after I-SceI is already present and able to 
induce DSBs (Figure 3.2 A). In addition, res-cNHEJ repairs DSBs with slow kinetics (Figure 
S8.7 a) 36 and accurate repair cannot be monitored in the reporter assay. Together, this 
indicates that the fast accurate repair of the I-SceI-induced DSBs impacts the decision for res-
cNHEJ as time progresses. One model that could explain such a behavior is that DSB response 
factors accumulate at the accurately repaired DSB. After a DSB is accurately repaired, I-SceI 
induces the next DSB before the repair machinery is dissolved, and thus gives the impression of 
a persistent DSB, which induces res-cNHEJ. An additional aspect strongly supporting such a 
process, is the model introduced in chapter 4.2.1, where BRCA1 is introduced as a possible 
factor that could influence the decision for res-cNHEJ based on its interaction with KU80 
(Figure 3.26 D). As a downstream factor in DSB recognition (for further details see chapter 
2.2.1), BRCA1 may be present in the proximity of the accurately repaired DSB when the next 
DSB is induced by I-SceI. This could promote the BRCA1-KU interaction at previously accurately 
repaired breaks and subsequently prevent the accurate repair of the newly induced DSB. In 
consideration with the differences between the repair of close and distant DSBs (see chapter 
4.3.1 for details), finding the wrong DSB end for misrepair takes longer for distant DSB ends, 
and thus explains the involvement of the time component in the initiation of res-cNHEJ in 
reporter assays.  
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4.3.2. Contribution of res-cNHEJ to the misrepair of distant endonuclease-induced 
DSBs 
In this study, experiments were conducted to investigate what happens if res-cNHEJ is not 
available. Partly, this was already described in chapter 4.2, as the absence of factors involved 
in res-cNHEJ resulted in less misrejoining of distant DSB ends. Therefore, the absence of res-
cNHEJ seemed to be beneficial to the cells, as less genomic rearrangements were observed. This 
was not only observed for intrachromosomal but also for interchromosomal genomic 
rearrangements (translocations) 25. Therefore, a repair pathway switch to resection-
independent c-NHEJ might occur if resection is not initiated and res-cNHEJ does not take place 
25,36,245. In the absence of CtIP, the misrejoining of distant DSBs was dependent on DNA-PK, the 
c-NHEJ-associated polymerases, and ARTEMIS (Figures 3.19 A, C, 3.20 A). Moreover, the alt-
EJ factors PARP1 and LIG1/3 were not involved, nor were PLK3, MRE11, or EXO1 required 
(Figures 3.19 A, 3.25 B, S8.13 b, S8.17 b, S8.18 b). This fits with the model of resection-
independent c-NHEJ occurring in the absence of CtIP 245.  
Loss of genetic information in CtIP-depleted cells 
However, the mean additional deletion size at misrejoined sites in CtIP-depleted GC92 cells 
increased nearly 4-fold after CtIP depletion (Figures 3.18 B). Indeed, deletions > 50 nt 
increased in frequency and length (Figures 3.18 A, Tables 8.1, 8.5). Moreover, it was revealed 
that the high-fidelity events remained consistent in CtIP-depleted cells compared to the control, 
while additional deletions between 1 and 10 nt decreased nearly 3-fold and 30 to 50 nt 
deletions decreased approximately 7-fold. In contrast, the additional deletions between 10 to 
30 nt, 50 to 200 nt, and 250 to 550 nt increased between 3 and 5-fold. The longest deletions 
were either near or actually affecting the reporter gene or the promoter. Importantly, due to 
the location of the primers in the gene and the promoter region, the presence of longer deletions 
would go unnoticed. Of note, an increase in long deletions after CtIP depletion was also 
observed by Rass et al. (2009) and Grabarz et al. (2013). Since these studies use primers located 
closer to each other, it is not surprising that the increase in the deletion size is observed to a 
lesser extent in comparison to this study. In contrast, Guirouilh-Barbat et al. (2016) did not 
observe an increase in the deletion size after CtIP depletion. A major problem in sequence 
analysis remains the categorization of the distribution of deletion sizes observed at the 
misrejoined break sites. Categories are usually implemented based on DNA repair models. In 
Biehs et al. (2017) a commonly used categorization for the distribution of additional deletions 
was implemented, as this is the norm when publishing sequence analysis data. Based on this 
categorization the increase in the deletion size after CtIP depletion would have gone unnotized. 
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Moreover, in comparison to this study, Guirouilh-Barbat et al. (2016) and Rass et al. (2009) 
used a different I-SceI plasmid.  
To summarize, certain sizes of additional deletions increased significantly and therefore a shift 
took place in the remaining misrepair events after CtIP depletion. This shift in sequence 
alterations proves that in the absence of CtIP most of the remaining misrepair events are 
affected, which challenges the model where in the absence of res-cNHEJ, DSBs switch to 
resection-independent c-NHEJ. Indeed, the increase in deletion sizes challenges the dogma that 
the reduced frequency of misrepair events is caused by repair of the accurate DSB ends (which 
cannot be monitored in the assay). Instead the reduced frequency of misrepair events might be 
caused by enhanced deletion sizes, which go unnoticed because they harm either the reporter 
gene and/or the promoter (and extend beyond the primer). Strikingly, the misrepair of distant 
DSB ends in a reporter system where the reporter gene is located closer to the DSB than the 
construct in GC92 cells (GCSH14 cells) had less frequent misrepair events (Figure 3.4 A, B). 
This was likely caused by some of the misrepair events in control cells not being monitored due 
to deletions above a certain size harming the reporter. In addition, the reduction of misrepair 
events in CtIP-depleted GCSH14 cells was larger than in GC92 cells (with double the effect size, 
Figure 3.17 A). This further indicates that indeed, very large deletions might be the cause for 
reduced misrepair events in CtIP-depleted cells and not a switch to accurate end break repair 
by c-NHEJ. This would make the comparison of intrachromosomal and interchromosomal 
genomic rearrangements more difficult since translocations are reduced following CtIP 
depletion 25. Importantly, the remaining translocations and the seemingly accurately rejoined 
breaks may have large alterations, which cannot be monitored when investigating translocation 
formation by any kind of staining procedure 25. In any case, an increase in longer deletions in 
CtIP-depleted cells contradicts the model in which cells switch to resection-independent c-NHEJ 
in the absence of res-cNHEJ. However, it has to be noted that the reporter assay selects for 
misrejoining events, and thus how the presence or absence of res-cNHEJ affects other 
experimental setups (for example, after X-IR) can only be speculated. In conclusion, in the 
absence of res-cNHEJ, a havoc form of end-joining takes over and creates worse mutagenic 
events. Havoc end-joining seems to be related to c-NHEJ or at least involves c-NHEJ factors.  
Misrejoining by microhomologies during res-cNHEJ 
Additional information about the sequence analysis regarded the way break sites were 
misrejoined. While control cells predominantly used MHs of 3 or 4 nt, the majority of DSBs 
were rejoined without the use of MHs after CtIP depletion (Figure 3.18 D). Importantly, the 
largest category (4 nt) was completely abolished in CtIP-depleted cells. This is consistent with 
POL not being required in CtIP-depleted cells (Figure 3.19 B) since POL preferentially uses 
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MHs of at least 3 nt 414. Notably, POL was associated with additional deletions of mostly 5 to 
50 nt in WT cells and with much larger deletion sizes in cells that underwent hyper-resection 
414. These POL-associated deletion sizes in WT cells are consistent with deletion sizes observed 
for res-cNHEJ (Figures 3.18 A, Tables 8.1, 8.5) and with the model wherein MHs and POL 
contribute to both res-cNHEJ and MMEJ (Figure 4.5). Furthermore, POL has been linked to 
the prevention of genomic havoc and the suppression of chromosomal instability 214,426. Indeed, 
POL was described as an important factor when canonical pathways fail in maintaining 
genome stability. POL protects the cells from translocation formation and helps to remain on 
the same chromosome for rejoining, which is the second indication that interchromosomal and 
intrachromosomal genomic rearrangements might have a different outcome for res-cNHEJ (also 
see chapter 4.4.3) 414. Together, these data confirm that res-cNHEJ reduces genomic 
information loss by employing short deletions and MHs to prevent worse mutagenic events, at 
least on an intrachromosomal scale. Furthermore, CtIP prevents long resection in G1 phase. The 
big question is which nucleases are involved in this process (which causes genomic havoc) and 
how they can operate in a situation where KU and 53BP1 prevent resection? Importantly, this 
process likely does not involve the endonucleolytic cut by MRE11 to overcome the resection 
barrier since Anand et al. (2016) showed that the MRE11-mediated endonucleolytic cut 
requires CtIP. Here, it again needs to be stressed that the data from this study specifically refer 
to a situation where screening for misrepair takes place. Nevertheless, other studies also speak 
of a mechanism preventing chromosomal instability or genomic havoc by allowing limited 
mutagenesis 156,214,426. In conclusion, these observations provide evidence that although res-
cNHEJ is an error-prone end-joining mechanism, the absence of res-cNHEJ is not beneficial for 
the cells and results in worse mutagenic events. The prevention of such havoc end-joining might 
be the physiological relevance of res-cNHEJ. 
4.3.3. Alternative end-joining of nuclease-induced DSBs 
In chapter 4.2, wherein the res-cNHEJ pathway was introduced, many comparisons were drawn 
to the resection process during HR in S/G2 phase. In contrast, this chapter describes the 
circumstances under which alt-EJ contributes to the misrejoining of distant DSB ends and how 
alt-EJ differs compared to res-cNHEJ, especially in the resection process. In chapter 4.2.1, the 
way in which alt-EJ takes over in the absence of KU or 53BP1 was described (Figures 3.7 B, C, 
3.13 C, D). Although some aspects of repair by alt-EJ in the absence of KU have been 
investigated, the main focus of this study was how alt-EJ as it occurs in 53BP1-depleted cells 
differs from res-cNHEJ (Figure 4.5). The alt-EJ mechanism relies on PARP1 in both KU and 
53BP1-depleted cells (Figures 3.7 B, C, 3.13 C, D). However, this dependency on PARP1 is 
different to res-cNHEJ (chapter 4.2.6). While PARP1 is required for the misrejoining of distant 
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DSB ends by res-cNHEJ, cells are still able to repair DSBs in its absence (Figures 3.7 A, B). In 
contrast, the overall repair of I-SceI-induced DSBs is entirely dependent on PARP1 in the 
absence of KU80 or 53BP1 (Figures 3.7 B, C, 3.13 C, D). This indicates that the role of PARP1 
in alt-EJ is different than in res-cNHEJ. This is likely because, in alt-EJ, PARP1 is required to 
recruit downstream alt-EJ factors that are necessary for repair 404.  
The situation in KU and 53BP1-depleted cells differs greatly; the absence of KU leaves the DSB 
ends unprotected. Therefore, all it takes for the initiation of resection is the recruitment of 
resection factors. The misrejoining of distant DSB ends in KU-depleted cells was largely 
dependent on EXO1 in preliminary data. However, the observation that misrejoining of distant 
DSB ends still partially occurs in the absence of EXO1, suggests that further nucleases are 
involved or can take over in the absence of EXO1. Radiation-based studies confirmed that 
resection in KU-depleted cells is associated with EXO1 382. In contrast, the DSB ends are still 
protected by KU in 53BP1-depleted cells. Nevertheless, 53BP1-depleted cells show excessive 
resection, not only in S/G2 phase 292 but also in the G1-specific misrejoining of distant DSB ends 
148,154. Thus, the absence of 53BP1 somehow allows resection despite the protection of the DSB 
ends by KU and the resection is much larger than observed in res-cNHEJ.  
In contrast to res-cNHEJ, the resection in 53BP1-depleted cells was not dependent on EXO1 
(Figure 3.30 C). Instead, resection in 53BP1-depleted cells relied on the endonuclease and 
exonuclease functions of MRE11 (Figures 3.29 A, B) as well as the endonuclease function of 
CtIP (Figures 3.22 A). When compared to resection during S/G2 phase in HR, this indicates that 
resection in 53BP1-depleted cells resembles the short-range resection process, where MRE11 
introduces an endonucleolytic cut internally to the DSB end and then resects the DNA in a 3′ to 
5′ direction 354. This might explain why the endonuclease activity of CtIP is required for alt-EJ 
but not res-cNHEJ (Figures 3.22 A, B). CtIP is responsible for removing the flap produced by 
MRE11 during 3′ to 5′ resection and likely they assist with the removal of KU 74,229. Since 
resection in 53BP1-depleted cells was not depend on EXO1 (Figure 3.30 C), the resection 
process might be limited to the 3′ to 5′ direction and executed in a stepwise manner to produce 
large resected regions, as was observed in biochemical studies 10. Radiation-based studies 
confirmed that resection in 53BP1-depleted cells depends on MRE11 but not EXO1 22. In 
addition, the MMEJ reporter assay, which was observed by Truong et al. (2013) to be S/G2-
specific, is also dependent on MRE11 and its nuclease function but not dependent on EXO1 
7,384. In contrast to the prevention of the endonucleolytic cut during res-cNHEJ, the importance 
of the MRE11 endonucleolytic cut in 53BP1-depleted cells is further emphasized by the 
following observation: after the inhibition of DNA-PK with the Nu7441 inhibitor, WT cells lack 
misrepair events (Figures 3.5 A), while the misrejoining of distant DSB ends is undisturbed in 
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53BP1-depleted cells (Figures 3.13 A, B). The DNA-PK inhibitor Nu7441 causes a block by the 
DNA-PK molecules at the DSB ends due to the inhibition of DNA-PKcs at its active site, which 
prevents autophosphorylation 99, and thus the release of DNA-PKcs and completion by c-NHEJ 
or res-cNHEJ. Therefore, an endonucleolytic cut by MRE11 can overcome this block, which is 
only observed in WT S/G2 phase cells. In this context, DNA-PK inhibition results in increased 
frequencies of HR 278. In addition, the DNA-PK block after Nu7441 inhibitor treatment was 
overcome in a reporter assay investigating MMEJ frequencies 278, which was similar to the S/G2-
specific reporter assay in Truong et al. (2013).  
These observations further explain how resection in res-cNHEJ is limited, while alt-EJ 
mechanisms produce larger resected regions. The interesting question remains how the 
endonucleolytic cut of MRE11 is prevented in WT human cells during G1 phase, as biochemical 
studies confirmed that the presence of the MRN complex in concert with CtIP-pThr847 is 
sufficient to perform the endonucleolytic cut 10. As the cut is possible in 53BP1-depleted cells, 
53BP1 or one of its downstream factors might be responsible. Moreover, BRCA1 is known to 
suppress the nuclease activity of MRE11 during G1 phase (also see chapter 4.2.3) 336,412. In the 
absence of 53BP1, BRCA1 was not required for the misrejoining of distant DSB ends (Figure 
3.15 B). The antagonism between CtIP-BRCA1 and 53BP1-RIF1 is believed to control the DSB 
repair pathway choice in a cell cycle-dependent manner 96,123,178. The CtIP-BRCA1 interaction, 
which requires phosphorylation of CtIP at Ser327, is crucial for res-cNHEJ (Figure 3.23 A) but 
not for MMEJ 429. Interestingly, this interaction is constitutively active during S/G2 phase but 
disrupted approximately 1 h post-damage induction by the hyper-phosphorylation of CtIP 
238,281,397. Furthermore, the lack of the CtIP-BRCA1 interaction impacts the resection rate and 
speed during S/G2 phase but not resection in general 93. Hence, this interaction in concert with 
53BP1 might not only ensure efficient and accurate resection but also specifically control the 
MRE11 nuclease function, and thus DSB repair pathway choice (Figure 4.5). In the MMEJ 
reporter assay, CtIP activity is dependent on S/G2-specific CDK complexes 384. In contrast, CtIP 
is activated by PLK3 in the G1-specific misrejoining of distant DSB ends (Figures 3.23 A, 3.26 C). 
This was also observed in the absence of 53BP1 (Figures 3.21 A, B, S8.16 e). Thus, resection in 
alt-EJ mechanisms is dependent on CtIP and PLK3 outside of S/G2 phase, which has also been 
observed in radiation-based studies 22,25. Of note, the overexpression of CtIP in 53BP1-depleted 
cells caused a significant increase in misrepair events (Figure 3.22 A), emphasizing that the 
imbalance of pathway choice proteins is a driving force for alt-EJ mechanisms. 
The misrejoining of distant DSB ends in 53BP1-depleted cells is dependent on ARTEMIS 
(Figures 3.14 A). The involvement of ARTEMIS in alt-EJ has also been observed by Moscariello 
et al. (2015). ARTEMIS might be required for the removal of either DNA-PK, the MRN complex, 
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and/or the flap generated by the MRE11 exonuclease activity after the 3′ to 5′ resection took 
place 74,164,229. Furthermore, the misrejoining of distant DSB ends in 53BP1-depleted cells was 
entirely dependent on POL (Figures S8.10 b, c). Several publications distinguish between alt-
EJ, which involves POL and uses MHs for rejoining (MMEJ) and an alt-EJ, which does not use 
MHs 102,116. Microhomology-mediated rejoining was observed after both KU and 53BP1 
depletion 7,155,414,427 and involved POL 414. However, Mansour et al. (2010) observed that in 
the absence of KU, the MHs were shorter, which indicates that the rejoining process differs 
under these two conditions. In contrast to ligation during res-cNHEJ, ligation in 53BP1-depleted 
cells is dependent on LIG1/LIG3 (Figures 3.13 C, D). As described in chapter 4.2.5, in the 
absence of LIG4, a fraction of distant DSBs, which misrejoin by res-cNHEJ can switch to a 
LIG1/LIG3-dependent ligation (Figure 3.8 A, B). Speculatively, this is possible because PARP1 
is involved in res-cNHEJ (as described in chapter 4.2.6 with a different function compared to 
alt-EJ) and its presence likely allows the recruitment of LIG1/3 in the absence of LIG4. 
Importantly, Dorsett et al. (2014) observed that resection in cells without LIG4 is still limited 
and the distribution of deletions in their study was similar to the distribution of additional 
deletions in WT GC92 cells herein (Figures 3.3 A). This indicates that the resection process in 
LIG4-depleted cells remains unaltered compared to alt-EJ in KU or 53BP1-depleted cells and 
therefore, res-cNHEJ still occurs in LIG4-depleted cells with only an alteration in the ligation 
step. Interestingly, Gelot et al. (2016) showed that in the absence of the pro-HR cohesin 
complex, the increase in misrejoining of distant DSB ends (in this case, no longer limited to G1 
phase, see chapter 4.3.1), is dependent on all three ligases, LIG1/3 and LIG4.  
This confirms that MMEJ functions as a backup mechanism for abrogated HR during S/G2 phase 
7,136,384 and indeed works differently than microhomology-mediated misrejoining in G1 phase by 
the res-cNHEJ pathway (Figure 4.5). Importantly, both are microhomology-mediated, and thus 
the use of MHs during res-cNHEH can be termed MM-cNHEJ (as opposed to MMEJ that 
describes the use of MHs during an alt-EJ mechanism). In conclusion, alt-EJ takes over in the 
absence of certain c-NHEJ factors and involves a variety of mechanisms to conduct repair and 
overcome the deficits imposed by the absence of a factor (Figures 4.5). In contrast, res-cNHEJ 
is a distinct repair pathway for certain DSBs in G1 phase of the cell cycle 36. Thus, two resection 
regulation mechanisms exist: DSBs that do not undergo resection or undergo limited resection 
(fast repair versus slow repair, which is dependent on location, structure, and complexity of the 
DSB end) and DSBs that undergo limited or excessive resection (WT human cells versus 
deficient cells; Figure 4.5). As there is an overlap of several repair factors in the different 
pathways, publications referring to alt-EJ and/or MMEJ need to be carefully examined, as the 
pathway they investigate in WT cells could be res-cNHEJ. 
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Figure 4.5 Alt-EJ in relation to WT end-joining pathways in G1 phase 
The fast repair component during all cell cycle phases is resection-independent c-NHEJ. In G1 phase, 53BP1 needs 
to be antagonized by BRCA1 to initiate res-cNHEJ, a pathway that rejoins breaks with or without MHs. The absence 
of 53BP1 or KU results in excessive resection and the use of alt-EJ mechanisms, which can entail microhomologies. 
Of note, this model, with some alterations, was part of Biehs et al. (2017). 
4.4. Rationale for res-cNHEJ 
In the previous chapters, res-cNHEJ was introduced and its role in misrejoining distant DSBs 
discussed in the context of other DSB repair pathways. However, the majority of experiments 
in this study was performed with reporter assays and therefore, not physiological. In this final 
chapter, the physiological relevance of res-cNHEJ will be discussed with a focus on open 
questions and future directions. Res-cNHEJ is an error-prone repair mechanism in WT human 
cells, which prevents worse mutagenic events. Thus, the mutagenic events associated with res-
cNHEJ can be considered collateral damage in preventing genomic havoc. However, under 
which circumstances is res-cNHEJ required? 
4.4.1. Relevance of the location, structure, and complexity of the DSB ends 
The DSB repair pathway choice is largely dependent on factors such as the cell cycle phase, the 
location, structure, and complexity of the DSB end 13,15,17,71,72,74,75,140,145,147,202,288,302,312,326,370. As 
res-cNHEJ is a G1-specific pathway, the choice of res-cNHEJ is likely connected to the other 
factors mentioned. In Biehs et al. (2017), slow repair of DSBs induced by X-IR in G1 phase was 
observed to be conducted by res-cNHEJ, as are DSBs induced by high-LET irradiation. While 
the prevention of resection resulted in a pathway switch after damage induction by X-IR, DSBs 
induced by high-LET irradiation required resection and subsequent res-cNHEJ or remained 
unrepaired 15,25,36. Importantly, the post-high-LET irradiation resection products were long 
enough to allow pRPA-binding, as was observed after high doses of X-IR (Figure 3.6 F). This 
indicates that the resection process in these situations was less limited than the resection 
observed at misrejoined break sites in GC92 cells (Figure 3.3 A). Thus, one biological reason 
for res-cNHEJ is the repair of complex DSBs after high-LET irradiation. In this case, complexity 
refers to clustered DSBs.  
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An interesting observation in the KU80 foci analysis in this study was that slowly repairing DSBs 
at 8 h post-4 Gy X-IR often showed a localized reduction in the DAPI intensity (Figure 3.6 A, 
C). This indicates a reduction in the chromatin density in the vicinity of these DSBs. Kruhlak et 
al. (2006) observed a local expansion, and thus reduced density of the chromatin immediately 
after DNA damage, which was also described as a local decondensation of heterochromatic 
regions in a study using heavy ion irradiation 1. This suggests that res-cNHEJ is employed in 
heterochromatic regions and/or regions where the chromatin structure needs to be altered. This 
was not surprising since DSBs in heterochromatic regions are known to be repaired with slow 
kinetics 23,34,145,411 and res-cNHEJ is the slow repair process during G1 phase 36. Indeed, this 
supports the claim that res-cNHEJ could require chromatin remodeling factors (chapter 4.2.6). 
In conclusion, DSBs that are repaired with slow kinetics during G1 phase employ res-cNHEJ. 
Resection and the use of res-cNHEJ is a necessity for DSBs, which cannot be repaired by 
resection-independent c-NHEJ during G1 phase due to their complexity. However, DSBs that 
are repaired even if resection of res-cNHEJ is not initiated (e.g. after X-IR), indicate that the 
speed of repair determines which DSBs are repaired by res-cNHEJ in WT cells. Thus, persisting 
DSBs are repaired by res-cNHEJ. Therefore, DSBs located in heterochromatic regions are 
repaired by res-cNHEJ, as they first require chromatin remodeling. The most challenging 
question is why two I-SceI-induced DSBs in the same reporter assay are repaired differently in 
different cells. Speculatively, the availability of slow repair factors plays a role. If a second I-
SceI cut is induced after the first accurately repaired and before the repair machinery 
disassembles, the cell might perceive a persistent DSB (for further details see chapter 4.3.2). 
4.4.2. How error-prone is res-cNHEJ? 
Res-cNHEJ is a DSB repair pathway, which specifically prevents extensive resection during G1 
phase of the cell cycle. In S/G2 phase, extensive resection is required for accurate repair by HR, 
which is not possible during G1 phase because HR in human cells requires the presence of a 
sister chromatid as a template for repair 138,200. A key step in preventing extensive resection is 
the prevention of short-range resection, which might sound counterintuitive at first. However, 
the internal endonucleolytic cut by MRE11, which induces short-range resection during HR 354 
and which is also required for alt-EJ (Figures 3.29 A, B), allows resection in both 3′ to 5′ (short-
range) and 5′ to 3′ (long-range) resection irrespective of the DSB ends being protected 10,354. 
Therefore, prevention of the endonucleolytic cut by MRE11 is the key step in ensuring that 
resection remains limited during res-cNHEJ. Preventing the endonucleolytic cut by MRE11 
during G1 phase comes at a price; RPA cannot protect the generated ssDNA since resection is 
too limited for stable RPA-binding 42. However, the absence of RPA-binding enables 
microhomology-mediated rejoining 264, which the cell uses to limit the sequence loss during res-
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cNHEJ and prevent worse mutagenic events. Importantly, this means that there could be 
differences in res-cNHEJ after high-LET irradiation because the ssDNA regions are large enough 
for RPA to bind 15,25,36. Indeed, the presence of RPA raises the question of how error-prone res-
cNHEJ truly is. In the reporter-based sequence analysis of the misrejoined break sites, the 
mutagenicity of res-cNHEJ was visualized (Table 8.1). However, in the reporter system, the 
cells are selected for misrepair events and therefore these data are biased toward error-prone 
repair results. Thus, the frequency and extent to which res-cNHEJ is error-prone, could not be 
answered in this study. 
Therefore, the mechanism by which res-cNHEJ might contribute to error-free repair events 
comes into question. One indication is that transcriptionally active regions in S/G2 phase are 
repaired with slow kinetics by HR 17,312. As described in chapter 4.4.1, slow DSB repair in G1 is 
performed by res-cNHEJ, and thus transcriptionally active regions might be repaired by res-
cNHEJ during G1 phase. Transcriptionally active regions are associated with RNA-DNA hybrids 
and with template-guided DSB repair 69,175,236. Chakraborty et al. (2016) found an error-free c-
NHEJ pathway, which uses RNA-DNA hybrids in transcriptionally active regions to ensure 
sequence integrity. In contrast, Ohle et al. (2016) associated RNA-DNA hybrids with HR in 
Schizosaccharomyces pombe and the stabilization of such hybrids impaired the recruitment of 
RPA. This implies that RNA-DNA hybrids form at short ssDNA regions to guide the resection 
process and RPA-binding. A major factor in template-guided repair by RNA-DNA hybrids is 
DDX1 (DEAD box 1) since it is crucial for the clearance of the RNA 236. DDX1 forms foci after 
irradiation-induced damage induction, which co-localize with H2AX, phosphorylated ATM, 
and RIF1 236,237. The accumulation of DDX1 requires RNA-DNA hybrids and ATM-mediated 
phosphorylation of DDX1 237. Importantly, RIF1 interacts with DDX1 to load BLM on chromatin 
(a 53BP1-independent role of RIF1), which is required at a subset of DSBs associated with 
transcriptionally active regions and/or where resection has been initiated 237. In this study, a 
likely interaction of ARTEMIS with DDX1 following DNA damage induction was discovered 
(Table 8.4). Therefore, DDX1 might play a role in res-cNHEJ, and thus could link template-
guided repair to res-cNHEJ. 
However, template-guided repair still does not provide evidence for an error-free DSB repair 
pathway, as RNA-DNA hybrids are in fact, associated with genomic instability 5,294. Therefore, 
even if res-cNHEJ would be associated with template-guided repair, it might still be error-prone. 
Interestingly, the repair of DNA damage associated with certain RNA-DNA hybrids requires 
BRCA1 163. In any case, the idea that res-cNHEJ might not be as error-prone as this study 
indicates remains highly speculative. Future studies will have to investigate if res-cNHEJ plays 
a role in the DSB repair of transcriptionally active regions and if there is any indication that res-
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cNHEJ might not be as mutagenic as observed in this study. Res-cNHEJ is involved in generating 
interchromosomal and intrachromosomal genomic rearrangements 25,36 that are reduced in the 
absence of res-cNHEJ. However, the sequence alterations of the remaining intrachromosomal 
rearrangements in the absence of res-cNHEJ were of worse quality than those formed by res-
cNHEJ (Figures 3.18 A, Table 8.1). Therefore, if inhibiting resection during G1 phase, and thus 
targeting res-cNHEJ could be a beneficial situation for the cell remains an open question. Less 
than 2% of the human genome codes for proteins and a biochemical function has been predicted 
for up to 80% of the genome (of note, this claim is highly disputed due to a very loose definition 
of the word function in the respective study; it is predicted that the actual number probably lies 
between 10 and 20%) 69,80,300. Thus, limiting the loss of genetic information by slightly error-
prone repair to reduce the probability of mutagenesis in a functional region might indeed be 
the physiological relevance for res-cNHEJ. 
4.4.3. Genetic recombination as the physiological origin of res-cNHEJ? 
The structure of the reporter construct containing two distant DSBs with 3′ overhangs is 
reminiscent of the situation in CSR (for details see chapter 2.2.5). CSR aims to misrejoin distant 
DSBs to allow immunoglobulin gene diversification in mature B cells 4,115. During CSR, lesions 
induced by AID are first transformed into SSBs and then into DSBs 24,196,365. The AID-induced 
lesions are limited to transcriptionally active guanine and cytosine-rich switch regions of 
repetitive DNA sequences and initiated by cytokine-activated promoters 4,115,365. Interestingly, 
such regions were associated with difficult to repair RNA-DNA hybrids 115,276, again proving that 
the presence of such structures does not necessarily imply error-free repair but is associated 
with deliberate misrepair during CSR (also see chapter 4.4.2). Importantly, the expression of 
the lymphoid-specific AID induces CSR in fibroblast cell lines 115,296,425. Thus, only the induced 
lesions are specific for mature B cells, while the CSR repair process is present in all cells.  
Since CSR aims to misrejoin distant DSB ends, this is a strong indication of where error-prone 
res-cNHEJ might originate. Indeed, many CSR factors were observed to be involved in res-
cNHEJ in this study (Figures 3.5 B, 3.10 A, 3.11 A, 3.12 A, 3.14 B, 3.17 A, 3.28 A, 3.30 A): 
EXO1 and POL are involved in generating the DSBs during CSR via the formation of 3′ 
overhangs 24,364,365,419; ATM and the MRN complex are involved in the stabilization of the broken 
DNA ends during CSR, along with H2AX 423; 53BP1 and RIF1 promote CSR and protect the 
DSB ends from resection, while 53BP1 and PTIP facilitate long-range chromatin interactions to 
favor long-range intrachromosomal rejoining and avoid intra-switch recombination 
47,48,97,157,324,344,392; the c-NHEJ factors KU70/80, DNA-PKcs, XLF/XRCC4/LIG4, and ARTEMIS 
are all involved in repair during CSR 4,46,254,328,330,331,391; CtIP is associated with CSR 226; and 
some junctions of the distant DSBs are rejoined using MHs during CSR 131,226,289,421. Therefore, 
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the repair process during CSR might not only be the origin or closely related to res-cNHEJ but 
indeed could represent res-cNHEJ. Thus, CSR might be a lymphoid-specific type of res-cNHEJ 
where the DSBs are induced endogenously by AID. 
CSR studies are also an important indicator for a difference in the repair outcome of 
interchromosomal (translocations) and intrachromosomal genomic rearrangements. Several 
studies on genetic recombination found different impacts on interchromosomal versus 
intrachromosomal genomic rearrangements. Genomic stability was linked to POL by 
preventing translocation formation and facilitating intrachromosomal rejoining to minimize the 
loss of genetic information 414,426. Differences in interchromosomal and intrachromosomal 
genomic rearrangements were also observed in 53BP1-deficient cells 48,107. Translocations are 
frequently observed in cells utilizing alt-EJ, which indicates that non-canonical repair pathways 
result in the imbalance of both genomic recombination outcomes 226,335,432. Therefore, res-
cNHEJ might be necessary to maintain the balance between interchromosomal and 
intrachromosomal genomic rearrangements since the disequilibrium causes a shift in one 
direction or the other.  
4.4.4. A role for res-cNHEJ in checkpoint control? 
After DNA damage, cell cycle checkpoints are initiated to allow the cell to repair the damage 
before progressing into the next cell cycle phase. The G1/S checkpoint is initiated by ATM in a 
p53-dependent and a p53-independent manner 246,349. Both result in an inactive CyclinE/CDK2 
complex, and thus prevent the progression in S phase. In S/G2 phase, large ssDNA regions are 
produced during DNA repair, which activates ATR. ATR also triggers p53-dependent and -
independent response 101,310,338. Therefore, ATM and ATR are the key factors of cell cycle 
checkpoint induction 2. TOPBP1 is important for ATR activation but also interacts with 53BP1 
to mediate the G1 DNA damage checkpoint 68,222,355. In addition, TOPBP1 is an established 
interaction partner of ARTEMIS 400, the interaction of which increased after DNA damage 
induction herein (Table 8.4). Furthermore, BRCA1 is required for the G1/S checkpoint 
activation 412. The link between these res-cNHEJ factors (ARTEMIS, BRCA1, and ATM; Figures 
3.11 A, 3.15 A, S9.14 a) and cell cycle checkpoint control in G1 post-DNA damage induction, 
raises the question of whether res-cNHEJ has a role in cell cycle checkpoint control during G1 
phase. Indeed, Gamper et al. (2013) showed that ATR is activated in irradiated G1 phase cells 
and this activation is associated with limited resection. The authors assume that CtIP is not 
required for this resection since the S/G2-specific CtIP-activating CDK complex is not available 
in G1 phase. However, by now CtIP was linked to small resection during G1 phase, and thus the 
resection during res-cNHEJ may be required for checkpoint control during G1 25,36. Another 
important aspect is the maintenance of cell cycle checkpoints 216,217,349. As Kousholt et al. (2012) 
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observed that CtIP is required for ATR-dependent checkpoint maintenance but not activation, 
the initiation of resection during res-cNHEJ might be linked to maintaining the G1/S checkpoint 
and allowing the cell more time to slowly repair DSBs before the DNA is replicated during S 
phase. 
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4.5. Final statement  
The significance of this work lies in the discovery of a novel error-prone resection-dependent c-
NHEJ pathway in WT human cells. Res-cNHEJ was characterized not only in its execution but 
also in its initiation. Thus, this work provides valuable insight into DSB repair pathway choice. 
Res-cNHEJ contributes to generating intrachromosomal genomic rearrangements by the repair 
of distant DNA DSBs during G1 phase. Together with the results from the publications Barton 
et al. (2014) and Biehs et al. (2017), res-cNHEJ was identified in functioning during the slow 
repair component in G1 phase, in repairing complex DSBs during G1 phase, and in contributing 
to translocation formation.  
Res-cNHEJ unifies the, until now, contradicting observations in other studies that genomic 
rearrangements arise from c-NHEJ 142,357 but require certain pro-resection factors, which were 
thus far associated with the loss of genetic information in alt-EJ 148,302,322. Indeed, the unique 
feature of this pathway is the limited resection in combination with c-NHEJ factors, which was 
hitherto thought to be mutually exclusive. Importantly, the resection process in res-cNHEJ 
differs from other known resection processes to limit resection. Thus, the characterization of 
res-cNHEJ also helped to distinguish it from error-prone repair by alt-EJ, the role of which was 
clarified in human cells as a variety of backup mechanisms to compensate for missing repair 
factors. Therefore, published studies need to be reevaluated to assess when an investigated 
error-prone end-joining mechanism was, in fact, res-cNHEJ and not alt-EJ. 
The absence of res-cNHEJ resulted in fewer genomic rearrangements. However, the remaining 
rearrangements featured more severe mutagenic sequence alterations at the misrejoined break 
site. Thus, it remains unclear if the inhibition of res-cNHEJ would be a beneficial situation for 
the cell to maintain genomic stability. Inhibiting res-cNHEJ in order to avoid genomic 
rearrangements in WT human cells is an interesting consideration for cancer patients 
undergoing radiation treatment. The question arises as to whether the inhibition of res-cNHEJ 
is more beneficial than harmful because res-cNHEJ indeed seems to be beneficial for genomic 
stability by limiting the loss of genomic information although at the cost of generating genomic 
rearrangements. Therefore, its characterization in comparison to alt-EJ and the resection 
process during HR is an important step for advanced tumor treatment options that target DNA 
repair proteins via inhibitors. When developing such inhibitors, the characterization of this 
novel repair pathway helps to specifically target tumor cells, which utilize alt-EJ, without 
interfering with WT cells and the repair pathways they utilize. In any case, the characterization 
of res-cNHEJ contributes to the broadening of therapeutic options to treat cancer patients in 
the future.  
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5. Materials & Methods 
5.1. Materials 
5.1.1. Consumable materials and appliances 
Blotting paper, 703   VWR 
Cell culture dishes (100 x 20 mm)   Biochrom 
Cell culture dishes (35 x 10 mm, 60 x 15 mm, 100 x 20 mm)  nunc VWR 
Cell culture flasks (25 cm2, 75 cm2)   TPP 
Cell culture well plates (96, 24, 12, 6 well)   TPP 
Coverslips (15 mm)   Roth 
Centrifuge tubes (15 ml, 50 ml)   Greiner, TPP 
Nunc cryogenic tubes   Thermo Scientific 
Disposable pipettes (5 ml, 10 ml, 25 ml)   Sarstedt 
Flow cytometry tubes with filter caps   Falcon 
MACS separation columns MS   Miltenyi Biotec 
SafeSeal reaction tubes (2 ml, 1.5 ml, 0.2 ml)   Roth 
Microscope slides, superfrost (76 x 26 mm)   Roth 
Pasteur pipettes, glass, plastic   Roth 
Pipette tips (10 µl, 200 µl, 1000 µl), filtered   Sarstedt, Roth 
Plastic cuvettes   Roth 
PVDF (polyvinylidene difluoride) membrane   Thermo Scientific 
Round bottom flow cytometry tubes   BD Bioscience 
Syringes (10 ml, 20 ml, 50 ml)   Braun 
Syringe filters (0.45 µm)   Roth 
Agarose gel electrophoresis set Horizon 58; 11-14 Life Technologies 
 Wide Mini-Sub GT cell Bio Rad 
Camera system AxioCam MRm Zeiss 
Centrifuge 5415 R; 5804 R Eppendorf 
 Biofuge pico Heraeus 
Cell counting chamber Neubauer Marienfeld 
Cell sorter S3e Cell Sorter Bio Rad 
Chemiluminescence detection ChemiSmart 5000 Vilber Lourmat 
 Fusion FX Vilber Lourmat 
Confocal laser scanning microscope TCS SP5 II Leica 
Electrophoresis set Mini-Protean Tetra Cell Bio Rad 
 Midi Hoefer 
Fluorescence microscope Axiovert 200M Zeiss 
 Imager.Z2 Zeiss 
 Observer.D1 Zeiss 
MACS system MultiStand; Separator Miltenyi Biotec 
Microscope Eclipse TS100 Nikon 
Micropipette 1000, 200, 100, 20, 10, 2 Gilson 
 1000, 200, 20, 10 Eppendorf 
Nano Photometer P-Class Implen 
pH detection pMX2000 WTW  
Power supply PowerPac HC Bio Rad 
 EV 243; EPS 3500 Pharmacia Biotech 
Scale TE 1502S; TE 153S-DS Sartorius 
Thermocycler peqStar VWR 
 C1000; T100 Bio Rad 
 T-personal 48 Biometra 
Thermomixer Comfort Eppendorf 
Ultracentrifuge Sorvall Thermo Scientific 
Ultrasound bath Sonorex Bandelin 
Western blotting system Mini Trans-Blot Cell Bio Rad 
 Midi Hoefer 
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Semi-dry blotting system Trans-Blot Bio Rad 
X-Ray biological irradiator MCN 165/796704 Philips 
 X-RAD 320 Precision X-Ray 
5.1.2. Software and external facilities  
AxioVision V4.6.3.0 Zeiss Imaging Solutions 
BLAST Open Source, NCBI 
ChemiCapt  Vilber Lourmat 
CLC Sequence Viewer 6 CLC bio A/S 
CXP Analysis Beckman Coulter 
CXP Cytometer V2.2 Beckman Coulter 
FusionCapt Advance FX7 Vilber Lourmat 
G*Power V3.1.9.2 Open Source 
ImageJ Open Source 
Isis MetaSystems 
LAS AF Lite Leica 
MEGA5.1 Open Source 376 
Micro-Manager Open Source 
Metafer4 V3.4.109 MetaSystems 
OriginPro 8.5 OriginLab Corporation 
Serial Cloner 2.6 Serial Basics 
Cytometry Core Facility     MD Anderson Cancer Center 
Cellular Imaging Core Facility    MD Anderson Cancer Center 
The Taplin Biological Mass Spectrometry Facility Harvard Medical School 
5.1.3. Chemicals 
Acetic acid (CH3COOH)      Roth 
Accutase       Sigma-Aldrich 
Agar       Roth 
Agarase       Thermo Scientific 
Agarose       Roth 
Ampicillin       Sigma-Aldrich 
APS (Ammonium persulfate, (NH4)2S2O8)    Roth 
-Mercaptoethanol (C2H6OS)     Sigma-Aldrich 
Biotin       Thermo Scientific 
Bromophenol blue (C19H10Br4O5S)    USB 
BSA (Bovine serum albumin)      AppliChem 
Calcium chloride (CaCl2)      Roth 
Coomassie brilliant blue R-250      Bio Rad 
DAPI (4',6-diamidino-2-phenylindole)    Sigma-Aldrich 
DMEM (Dulbecco's Modified Eagle Medium)   Sigma-Aldrich 
DMSO (Dimethyl sulfoxide, C2H6OS)    Sigma-Aldrich 
EDTA (Ethylenediaminetetraacetic acid, C10H16N2O8)  Roth 
Ethanol, pure (CH3CH2OH, ≥ 99.5%)    Roth 
Ethidium bromide (C21H20BrN3)     Bio Rad 
FBS (Fetal bovine serum; also FCS (Fetal calf serum))  Biochrom 
Formaldehyde (CH2O)      Roth 
G418 (Geneticin)      Sigma-Aldrich 
Glacial acetic acid (CH3COOH, ≥ 99.85%)   Roth 
Glycerol (C3H8O3)      Roth 
Glycine (C2H5NO2)      Roth 
Hydrogen chloride (HCl)     Roth 
Immersion oil       Zeiss 
IPTG (Isopropyl -D-1-thiogalactopyranoside, C9H18O5S)  Sigma-Aldrich 
Isopropanol (Isopropyl alcohol, C3H8O)    Roth 
Kanamycin       Sigma-Aldrich 
Low melting point agarose, UltraPure     Thermo Scientific 
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MEM (Minimum Essential Medium)    Sigma-Aldrich 
MES (2-(N-morpholino)ethanesulfonic acid, C6H13NO4S) Roth 
Methanol (CH3OH)      Roth 
Magnesium chloride (MgCl2)     Roth 
Magnesium sulfate (MgSO4)     Roth 
Manganese(II) chloride (MnCl2)     Roth 
Mounting medium       Vectashield 
NP-40 (Nonidet P-40)        Sigma-Aldrich 
Opti-MEM (Reduced serum MEM)    Life Technologies 
NEAA (Non-essential amino acids)    Biochrom 
Paraformaldehyde (OH(CH2O)n; n = 8-100)   Roth 
Peptone       Roth 
PIPES (piperazine-N,N′-bis(2-ethanesulfonic acid))  Roth 
Potassium acetate (CH3COOK)     Sigma-Aldrich 
Potassium chloride (KCl)      Roth 
Potassium dihydrogen phosphate (KH2PO4)   Roth 
ProLong gold antifade       Invitrogen 
PI (Propidium iodide, C27H34I2N4)    Sigma-Aldrich 
Puromycin       Sigma-Aldrich 
Rubidium chloride (RbCl)     Sigma-Aldrich 
RNase A       Sigma-Aldrich 
Roti-Safe GelStain       Roth 
Rotiphorese Gel 30 (37, 5:1)     Roth 
SDS (Sodium dodecyl sulfate, C12H25NaO4S)   Roth 
Skim milk (Non-fat dry milk)     Frema 
Sodium chloride (NaCl)       Roth 
Sodium deoxycholate (C24H39NaO4)    Roth 
Sodium hydrogen phosphate (Na2HPO4)   Roth 
Sodium hydroxide (NaOH)     Roth 
Sucrose (Saccharose, C12H22O11)    Roth 
TEMED (Tetramethylethylenediamine, C6H16N2)   Roth 
Tris-HCl (Tris hydrochloride)     Roth 
TritonX-100 (C14H22O(C2H4O)n)     Roth 
Trypsin       Roth 
Tryptone       Roth 
Tween20 (Polysorbate 20, C26H50O10)    Roth 
X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside) Roth 
Xylen-Cyanol FF (C25H27N2NaO6S2)    USB 
Yeast extract       Roth 
5.1.4. Solutions, buffers, and media 
PCR, enzymatic digestion, ligation, and agarose gel electrophoresis 
dNTP mix (10 mM)   Thermo Scientific 
10x Herc buffer    Agilent Genomics 
5x Phusion buffer HF   Thermo Scientific 
10x Phu turbo buffer   Agilent Genomics 
10x Thermopool buffer   BioLabs 
10x T4 ligase buffer   Thermo Scientific 
10x T4 ligation buffer with ATP  NEB 
50% PEG 4000 solution   Thermo Scientific 
10x Fast digest buffer   Fermentas 
6 x DNA loading dye    0.25% Bromophenol blue 
     0.25% Xylen-Cyanol FF 
     30% Glycerin 
TAE (Tris-acetate-EDTA)  4.84 g/l Tris-HCl   pH 8.0 
     1.142 g/l Acetic acid 
TE (Tris-EDTA)    10 mM Tris-HCl   pH 8.0 
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     1 mM EDTA 
Bacteria 
LB (lysogeny broth) medium  10 g/l Peptone 
     5 g/l Yeast extract 
     5 g/l NaCl 
LB agar     1.5% (w/v) Agar   in LB media 
SOB (super optimal broth) medium 2% (w/v) Tryptone 
     0.5% (w/v) yeast extract 
     10 mM NaCl 
     2.5 mM KCl 
     10 mM MgCl2 
     10 mM MgSO4 
Competent bacteria solution 1  30 mM Potassium acetate  pH 5.8 
     50 mM MnCl2 
     100 mM RbCl 
     10 mM CaCl2 
     15% (w/v) Glycerin 
Competent bacteria solution 2  10 mM RbCl    pH 6.8 
     75 mM CaCl2 
     10 mM MOPS 
     15% (w/v) Glycerin 
Cell culture, purification, and staining 
PBS (phosphate-buffered saline) 137 mM NaCl    pH 7.4 
     2.7 mM KCl  
     8 mM Na2HPO4 
     1.5 mM KH4PO4 
TBS (Tris-buffered saline)  20 mM Tris-HCl   pH 7.6 
     137 mM NaCl  
Trypsin/EDTA    0.5 M EDTA    pH 8.0 
     2.5% (v/v) Trypsin   in PBS 
CSK (cytoskeletal) buffer  10 mM PIPES pH 7 
     100 mM NaCl 
     300 mM Sucrose 
     3 mM MgCl2 
     0.7% TritonX-100 
     0.3 mg/ml RNase 
PI solution    10 µg/ml PI    in PBS 
     0.5 mg/ml RNase 
PBS-T     PBS 
     0.1% Tween20 
Fixative     3:1 Methanol/glacial acetic acid 
Biotin solution    2 mg/ml Biotin    in NETN buffer 
Coomassie blue staining solution 0.1% Coomassie brilliant blue R-250 
     50% Methanol 
     10% Glacial acetic acid 
Coomassie destaining solution 40% Methanol 
     10% Glacial acetic acid 
Cell lysis 
RIPA (radio-immunoprecipitation assay) buffer  
50 mM Tris-HCl   pH 8.0 
     150 mM NaCl  
     0.5% Sodium deoxycholate 
     1% TritonX-100 
     0.1% SDS 
Lysis buffer    20 mM Tris-HCl   pH 8.2 
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     150 mM NaCl 
     1% TritonX-100 
2x SDS loading buffer   100 mM Tris-HCl   pH 6.8 
     4% (w/v) SDS 
0.2% (w/v) Bromophenol blue 
     20% (v/v) Glycerol  
     200 mM -Mercaptoethanol 
NETN buffer    20 mM Tris-HCl   pH 8.0 
     100 mM NaCl 
0.5 mM EDTA 
     0.5% (v/v) Nonidet P-40 
Chelsky buffer    10 mM Tris-HCl   pH 7.5 
     10 mM NaCl 
     3 mM MgCl2 
     30 mM Sucrose 
NP-40 buffer    Chelsky buffer 
     0.5% Nonidet P-40 
SDS-PAGE (polyacrylamide gel electrophoresis) and immunoblotting 
Electrophoresis buffer   25 mM Tris-HCl   pH 8.8 
     0.2 M Glycine  
     0.5% (w/v) SDS 
5x SDS loading buffer (Laemmli) 60 mM Tris-HCl   pH 6.8 
     2% (w/v) SDS  
     5% (v/v) -Mercaptoethanol 
     10% (v/v) Glycerin 
     0.01% Bromophenol blue 
Stacking gel buffer   0.5 M Tris-HCl    pH 6.8 
     1% SDS 
Stacking gel (4 gels)   2.2 ml RotiphoreseGel30 
     3.8 ml Stacking gel buffer 
     9 ml Aqua dest. 
     100 µl 10% APS 
     40 µl TEMED 
Running gel buffer   1.5 M Tris-HCl    pH 8.8 
     1% SDS  
Running gel (4 gels)   7.5%  10%  12.5% 
RotiphoreseGel30  18 ml  12 ml  15 ml 
Running gel buffer  9 ml  9 ml  9 ml 
Aqua dest.   9 ml  15 ml  12 ml 
10% APS   200 µl  200 µl  200 µl 
TEMED    20 µl  20 µl  20 µl 
Transfer buffer    20 mM Tris-HCl   pH 8.3  
     150 mM Glycine 
TBS-T     0.1% Tween20    in TBS  
5.1.5. Reagents, kits, ladders, and enzymes 
Transfection reagents 
HiPerFect transfection reagent    Qiagen  
jetPEI transfection reagent    Polyplus  
PEI (Polyethylenimine)     Sigma-Aldrich  
MATra-A reagent     IBA 
Chemiluminescence detection reagents 
LumiLight western blotting substrate   Roche  
ChemiGlow      Biozym 
WesternBright Quantum    Advansta  
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WesternBright Sirius     Advansta  
Kits 
peqGold Xchange plasmid maxi EF kit   peqLab   
ZR plasmid mini prep classic    Zymo Research 
QIAPrep spin miniprep kit    Qiagen  
peqGold MicroSpin cycle pure kit   peqLab 
MasterPure Complete DNA & RNA Purification Kit Epicentre  
PureLink genomic DNA mini kit    Thermo Scientific  
Gateway cloning system     Life Technologies 
EdU Click-iT (Cy5, TexasRed)    baseclick  
MACS separation column    Miltenyi Biotec  
Protein and DNA ladders 
PageRuler plus prestained protein ladder  Fermentas 
HiMark prestained standard    Thermo Scientific 
ProSieve quad color protein ladder   biozym 
Precision plus protein all blue standards   Bio Rad  
GeneRuler 1kb DNA ladder    Thermo Scientific 
GeneRuler 100 bp plus DNA ladder   Thermo Scientific 
Enzymes 
Fast alkaline phosphatase    Fermentas 
Fast BsmBI      Fermentas 
Fast DpnI      Fermentas 
Fast SmaI      Fermentas 
Gateway BP clonase     Life Technologies 
Gateway LR clonase     Life Technologies 
Herc polymerase     Agilent Genomics 
KOD Hot Start DNA polymerase    Novagen 
Pfu turbo polymerase     Agilent Genomics 
Phusion polymerase     Thermo Scientific 
Proteinase K      Epicentre 
Q5 polymerase      Thermo Scientific 
RNase A      Epicentre 
RNase A      Sigma-Aldrich 
T4 DNA ligase      Thermo Scientific 
T4 PNK       NEB 
Taq polymerase      BioLabs 
5.1.6. Primers, siRNAs, and gRNAs 
Table 5.1 Primers 
Primers were maintained as 100 pmol/µl stocks and diluted to 10 pmol/µl as a working solution. 
Primer name Sequence 
ARTEMIS gRNA1 fw 5′-GAACTCTGGGCGACACAGCAAGACTCCATTTCACAA-3′ 
ARTEMIS gRNA1 rev 5′-ACAAGGAACATCTATTACAAACTGGGTAGCATCTC-3′ 
ARTEMIS gRNA3 fw 5′-AGATTTTACCAAATTCCAAGTCGGG-3′ 
ARTEMIS gRNA3 rev 5′-AGAATCAACAGACTGGGAACACTG-3′ 
BRCA1 gRNA9 fw 5′-TGAGTGGTTTTCCAGAAGTG-3′ 
BRCA1 gRNA9 rev 5′-GTTTGGTTAGTTCCCTGATT-3′ 
CD4int 5′-GCTGCCCCAGAATCTTCCTCT-3′ 
CMV2 5′-ATATATGGAGTTCCGCGTTACAT-3′ 
EXO1 mutP73P fw 5′-CTCATGGGATCAAGCCAATTCTCGTATTTGATGG-3′ 
EXO1 mutP73P rev 5′-CCATCAAATACGAGAATTGGCTTGATCCCATGAG-3′ 
T7 fw 5′-TAATACGACTCACTATAGGGCGA-3′ 
 
Table 5.2 siRNAs (small interfering RNAs) 
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siRNA Sequence/number Conc. Vendor 
53BP1 5′-GAGAGCAGATGATCCTTTA-3′ 25 nM Dharmacon 
53BP1 (construct) 5′-AGAACGAGGAGACGGUAAUAGUGGG-3′ 50 nM Qiagen 
ARTEMIS 5′-AACTGAAGAGAGCTAGAACAG-3′ 25 nM Qiagen 
BRCA1 5′-GGAACCTGTCTCCACAAAGTG-3′ 15 nM Qiagen 
BRCA1_14 5′-CAGGAAATGGCTGAACTAGAA-3′ 25 nM Qiagen 
BRCA1 (construct) 5′-AATCACAGTGTCCTTTATGTA-3′ 50 nM Qiagen 
BLM 5′-AAGCTAGGAGTCTGCGTGCGA-3′ 50 nM Qiagen 
CDK2 SI02654631 25 nM Qiagen 
CtIP 5′-TCCACAACATAATCCTAATTT-3′ 50 nM Qiagen 
CtIP (construct) 5′-AAGCTAAAACAGGAACGAATC-3′ 50 nM Qiagen 
Ctrl (negative) 5′-AATTCTCCGAACGTGTCACGT-3′ 10-50 nM Qiagen 
DNA2 5′-AAATAGCCAGTAGTATTCGAT-3′ 20 nM Qiagen 
DNA-PKcs 5′-CTCGTGTATTACAGAAGGAAA-3′ 15 nM Qiagen 
EXD2 L-020899-02 25 nM Dharmacon 
EXO1 (construct) 5′-CAAGCCTATTCTCGTATTTTT-3′ 50 nM Qiagen 
EXO1_7 5′-ATGGATGTACTTTACCTTCTA-3′ 20 nM Qiagen 
KU70 5′-GGAAGAGATAGTTTGATTTTT-3′ 20 nM Qiagen 
KU80 5′-AAGACAGACACCCTTGAAGAC-3′ 20 nM Qiagen 
LIG I 5′-GGCATGATCCTGAAGCAGA-3′ 25 nM Qiagen 
LIG III 5′-CCACAAAAAAAATCGAGGA-3′ 25 nM Qiagen 
LIG IV 5′-CAAGATGTTTACAGAAAGGAA-3′ 20 nM Qiagen 
MRE11 5′-ACAGGAGAAGAGATCAACTAA-3′ 20 nM Qiagen 
MRE11_2 5′-AAGAAAGGCTCTATCGAATGT-3′ 20 nM Qiagen 
PARP1 M-06656-01-0005 25 nM Dharmacon 
PLK1_2 SI00071624 20 nM Qiagen 
PLK1_6 SI02223837 20 nM Qiagen 
PLK3 5′-CTGCATCAAGCAGGTTCACTA-3′ 25 nM Qiagen 
PLK3_1 SI00059388 20 nM Qiagen 
PLK3_11 SI05056450 20 nM Qiagen 
POL  sc-43729 10 nM Santa Cruz 
POL µ sc-105304 10 nM Santa Cruz 
POL  S100090062 25 nM Qiagen 
RAP80 UMC1 (51720) 20 nM Dharmacon 
 
Table 5.3 gRNAs (guide RNAs) 
gRNA Sequence 
53BP1 gRNA #4 (kindly provided by Z. Gong) 5′-ATCGGAAAGCATCAGGAGA-3′ 
ARTEMIS gRNA #1 400 5′-GAGACTTCAGATTGGCGCA-3′ 
ARTEMIS gRNA #3 400 5′-GAGCCCGTACCATGTTGTG-3′ 
BRCA1 gRNA #3 (kindly provided by Z. Gong) 5′-GTAAGAATGATATAACCAAA-3′ 
BRCA1 gRNA #9 (kindly provided by Z. Gong) 5′-AGGCTTGCCTTCTTCCGAT-3′ 
CtIP gRNA #2 (kindly provided by Z. Gong) 5′-GTTAACGCCAGAAAATGAGA-3′ 
EXO1 gRNA #4 (kindly provided by Z. Gong) 5′-GGAAAGCAACTTCTTCGTGA-3′ 
PTIP gRNA #1 400  5′-TGTGAGGCTAGTGCATTGT-3′ 
REV7 gRNA #4 (kindly provided by Z. Gong) 5′-TGTGCTCTGCGAGTTCCTGG-3′ 
RIF1 gRNA #1 (kindly provided by Z. Gong) 5′-CACAAAAGGTACATTTGCG-3′ 
 
5.1.7. Inhibitors, nucleotides, and nucleotide analogues 
Table 5.4 Inhibitors 
Inhibitor (name) Conc. or dilution Vendor/Reference  
ATM (Ku60019) 0.5 µM Tocris Bioscience 
CDK1 (RO-3306) 1 µM, 10 µM Selleckchem 
CDK1/2 (Roscovitine) 2 µM, 25 µM Sigma-Aldrich 
DNA-PK (Nu7441) 7.5 µM Tocris Bioscience  
MRE11 (mirin) 500 µM Tocris Bioscience  
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MRE11 endonuclease (PFM01) 50 µM, 100 µM 354 
MRE11 exonuclease (PFM39) 100 µM, 300 µM 354 
Nocodazole 100 µg/ml Sigma-Aldrich  
PARP (PJ34) 15 µM Calbiochem  
PARP (Olaparib) 0.5 to 2.5 µM Selleckchem 
PhosphoStop 10x Roche 
PLK1/3 (GW843682X) 0.5 µM Tocris Bioscience  
Protease 25x Roche 
Protease (pepstatin) 1:500 Sigma-Aldrich 
Protease (aprotinin) 1:500 Sigma-Aldrich 
 
Table 5.5 Nucleotides and nucleotide analogs  
Inhibitor (name) Conc. or dilution Vendor 
BrdU (5-bromo-2-deoxyuridine) 10 µg/ml Sigma-Aldrich  
EdU (5-ethynyl-2-deoxyuridine) 1 µM Baseclick  
EdU 1 µM Invitrogen 
Thymidine 2 mM Sigma-Aldrich  
 
5.1.8. Antibodies and beads  
Table 5.6 Primary antibodies 
Primary antibodies (ABs) with vendor, dilution, and application. Where the AB was used for immunoblotting, the 
AB solution and the solvent is named instead of the application. 
Antibody Vendor (number) Dilution (application) 
mouse-anti-53BP1 (BP13) Millipore (#05-726) 1:1,000 (5% BSA) 
rabbit-anti-53BP1 Bethyl (A300-272A) 1:2,000 (5% BSA) 
mouse-anti--ACTIN Santa Cruz (sc47778) 1:1,000 (5% BSA) 
rabbit-anti-ARTEMIS Abcam (ab35648) 1:2,000 (5% BSA) 
rabbit-anti-ARTEMIS GenTex (GTX100128) 1:3,000 (5% milk) 
rabbit-anti-ARTEMIS Novus Biologicals (100-542) 1:1,000 (3% milk) 
rabbit-anti-ARTEMIS Thermo Scientific (14241) 1:1,000 (5% BSA) 
rabbit-anti-BLM Abcam (ab2179) 1:1,000 (5% BSA) 
mouse-anti-BRCA1 (MS13) Abcam (ab16781) 10 µg (IP) 
mouse-anti-BRCA1 (D9) Santa Cruz (sc6954) 1:100 (3% milk) 
rabbit-anti-BRCA1 (C20) Santa Cruz (sc642) 1:200 (5% BSA) 
rabbit-anti-BRCA1 (I20) Santa Cruz (sc646) 1:500 (5% BSA) 
mouse-anti-BrdU Becton Dickinson (347580) 1:500 (IFM) 
rabbit-anti-CDK2 (D12) Santa Cruz (sc6248) 1:400 (1% milk) 
rabbit-anti-CtIP Bethyl (A300-488A) 1:1,000 (5% BSA) 
rabbit-anti-CtIP Abcam (ab70163) 1:1,000 (3% milk) 
mouse-anti-CtIP (D-4) Santa Cruz (sc271339) 2 µg (IP) 
mouse-anti-CtIP (E-2) Santa Cruz (sc48415) 1:800 (5% BSA) 
rabbit-anti-phospho-CtIP-Ser327 Kindly provided by T. Paull 1:1,1000 (5% BSA) 
rabbit-anti-DNA2 Abcam (ab96488) 1:1,000 (5% BSA) 
rabbit-anti-DNA-PKcs Novus Biologicals (100658) 1:1,000 (1% milk) 
rabbit-anti-EXD2 Sigma (HPA005848) 1:1,000 (5% BSA) 
mouse-anti-EXO1 Abcam (ab3307) 1:800 (5% BSA) 
rabbit-anti-EXO1 Bethyl (A302-640) 1:1,000 (5% BSA) 
rabbit-anti-EXO1 Santa Cruz (sc33194) 1:400 (5% BSA) 
mouse-anti-FLAG (M2) Sigma (F3165) 1:1,000 (5% BSA) 
rabbit-anti-GAPDH Santa Cruz (sc25778) 1:1,000 (1% milk) 
mouse-anti-GFP Roche (11 814 460 001) 1:500 (1% milk) 
rabbit-anti-GFP Santa Cruz (sc8334) 1:500 (3% milk) 
rabbit-anti-GFP Abcam (ab6556) 1:500 (3% milk) 
mouse-anti-phospho-H2A.X-Ser139 Millipore (#05-636) 1:2,000 (IFM) 
rabbit-anti-phospho-H2A.X-Ser139 Abcam (ab81299) 1:1,000 (IFM) 
rabbit-anti-phospho-H2A.X-Ser139 Epitomics (mono 2212-1) 1:2,000 (IFM) 
mouse-anti-phospho-H3-Ser10 Cell signaling (9706) 1:200 (FACS) 
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mouse-anti-HA (HA.C5) Abcam (ab18181) 1:1,000 (5% BSA) 
mouse-anti-KU70 (A9) Santa Cruz (sc5309) 1:1,000 (1% milk) 
mouse-anti-KU80 (B4) Santa Cruz (sc515736) 1:1,000 (1% milk) 
mouse-anti-KU80 (B4) Santa Cruz (sc515736) 5 µg (IP) 
mouse-anti-KU80 (111) Abcam (ab79220) 1:100 (IFM) 
mouse-anti-LIG1 (1A9) Santa Cruz (sc47703) 1:1,000 (1% milk) 
mouse-anti-LIG3 Santa Cruz(sc56089) 1:1,000 (1% milk) 
rabbit-anti-LIG4 Acris (SP1275) 1:2,000 (5% BSA) 
mouse-anti-MRE11 Abcam (ab214) 1:1,000 (1% milk) 
mouse-anti-cMyc (9E10) Novus Biologicals (600302) 1:1,000 (5% BSA) 
mouse-anti-cMyc (9E10) Santa Cruz (sc40) 1:1,000 (5% milk) 
mouse-anti-OctA-Probe (H5) Santa Cruz (sc166355) 1:1,000 (1% milk) 
rabbit-anti-PARP1 Abcam (ab137653) 1:1,000 (5% BSA) 
rabbit-anti PLK1 AB online (ABIN1527406) 1:800 (1% milk) 
rabbit-anti-PLK3 Abcam (ab33119) 1:1,000 (2.5% milk) 
rabbit-anti-POLµ Abcam (ab157465) 1:1,000 (5% BSA) 
rabbit-anti-POL Abcam (ab82919) 1:1,000 (5% BSA) 
rabbit-anti-POL (M09) Abnova (H000107 21-M09) 1:500 (5% BSA) 
rabbit-anti-PTIP Generated by Z. Gong 1:1,000 (5% BSA) 
rabbit-anti-PTIP (H167) Santa Cruz (sc367459) 1:400 (5% milk) 
rabbit-anti-RAP80 Abcam (ab124763) 1:400 (5% BSA) 
rabbit-anti-tRFP Evrogen (AB233) 1:1,000 (1% milk) 
rabbit-anti-RIF1 Novus Biologicals (1001587) 1:1,000 (5% BSA) 
rabbit-anti-RPA2 (phosphoT21) Abcam (ab109394) 1:10,000 (IFM) 
rabbit-anti-RAD51 Abcam (ab63801) 1:15,000 (IFM) 
rabbit-anti-I-SceI (FL-86) Santa Cruz (sc98269) 1:1,000 (IFM) 
mouse-anti--TUBULIN (TU-02) Santa Cruz (sc8035) 1:2,000 (5% BSA) 
 
Table 5.7 Tagged primary antibodies 
Antibody Vendor (number) Dilution 
mouse-anti-CD4-FITC BioLegends (100510) 1.5 µg (IFM) 
FITC rat anti-mouse CD4 BD Pharmingen (553047) 1.5 µg (IFM, MACS) 
FITC rat anti-mouse CD8 BioLegends (100706) 2 µg (IFM) 
 
Table 5.8 Secondary antibodies 
Secondary ABs with vendor, dilution, and application. Where the AB was used for immunoblotting, the AB solution 
and the solvent is named instead of the application. 
Antibody Vendor (number) Dilution 
goat anti-mouse AlexaFluor 488 Molecular Probes (A11001) 1:1,000 (IFM) 
goat anti-rabbit AlexaFluor 488 Molecular Probes (A1008) 1:1,000 (IFM) 
goat anti-mouse AlexaFluor 594 Molecular Probes (A11005) 1:1,000 (IFM) 
goat anti-rabbit AlexaFluor 594 Molecular Probes (A1012) 1:1,000 (IFM) 
goat anti-mouse IgG-HRP Santa Cruz (sc2031) 1:10,000 (1% milk) 
goat anti-mouse IgG-HRP Generated by Z. Gong 1:4,000 (5% milk) 
goat anti-rabbit IgG-HRP Santa Cruz (sc2030) 1:30,000 (1% milk) 
goat anti-rabbit IgG-HRP Generated by Z. Gong 1:3,000 (5% milk) 
 
Table 5.9 Beads 
Antibody Vendor (number) Dilution 
Dynabeads protein G Thermo Scientific (10004D) 20 to 50 µl 
S protein agarose beads EMD Millipore (69704) 120 µl 
Streptavidin coupled Dynabeads Thermo Scientific (11206D) 300 µl 
anti-rat IgG MicroBeads Miltenyi Biotec (130-048-501) 20 µl 
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5.1.9. Plasmids 
HA-53BP1-WT: Plasmid encoding HA-tagged siRNA-resistant (A231G, A234G, A237C silent point 
mutations) human WT 53BP1 construct; pCMH6K-53BP1, 10.1 kb, ampicillin resistance, kindly provided 
by P. Jeggo 288. 
cMyc-ARTEMIS-WT, cMyc-ARTEMIS-D37N: Plasmid encoding cMyc-tagged siRNA-resistant (K376K, 
R377R, A378A) human WT ARTEMIS or ARTEMIS endonuclease mutant with Asp37 mutated to Asn; 
pClneo-cMyc-ARTEMIS-WT or -D37N, 7.43 kb, ampicillin resistance, original plasmid kindly provided by 
P. Jeggo 34, mutations for siRNA resistance by O. Barton. 
SFB-ARTEMIS: N-terminal triple epitope tag destination vector (S protein, FLAG epitope tag, and 
streptavidin-binding peptide tag) with human ARTEMIS WT; SFB-ARTEMIS-N-LR, 2079 bp, ampicillin 
and puromycin resistance, kindly provided by Z. Gong 400. 
FLAG-BRCA1-WT, FLAG-BRCA1-I26A, FLAG-BRCA1-C61G, FLAG-BRCA1-S1655A: Plasmid encoding 
FLAG-tagged siRNA-resistant (C186T, C187T, G189A, C191G, C192T) human WT BRCA1, BRCA1 
hypomorphic RING domain mutant with Ile26 mutated to Ala with residual E3 ligase activity 127, BRCA1 
RING domain mutant with Cys61 mutated to Gly, or BRCA1 BRCT mutant with Ser1655 mutated to Ala; 
FLAG-BRCA1-WT, -I26A, -C61G, or –S1655A, ampicillin resistance, kindly provided by A. Shibata 348. 
SFB-BRCA1: N-terminal triple epitope tag destination vector (S protein, FLAG epitope tag, and 
streptavidin-binding peptide tag) with human BRCA1 WT; SFB-BRCA1-N-LR, 5592 bp, ampicillin and 
puromycin resistance, kindly provided by Z. Gong. 
Cas9: Plasmid encoding Cas9; gRNA vector needs to be transfected simultaneously; hSpCas9-blast, 
blasticidin resistance, vendor: GeCKO. 
psPAX2 & pMD2.G: Envelope and packaging plasmids for second-generation lentiviral plasmid, gRNA-
V2 plasmid acts as transfer plasmid; psPAX2, vendor: AddGene (#12260). 
gRNA-V0: Plasmid encoding chimeric gRNA; lentiGuide-puro, 13 kb, kanamycin and puromycin 
resistance, vendor: GeCKO. 
gRNA-V2: Viral plasmid encoding hSpCas9 and the chimeric gRNA; the vector can be digested by BsmBI 
and a pair of annealed oligo nucleotides can be cloned into the region to alter the gRNA sequence; 
lentiCRISPRv2, 13 kb, ampicillin and puromycin resistance, vendor: GeCKO. 
FLAG-CtIP: N-terminal triple epitope tag destination vector (S protein, FLAG epitope tag, and 
streptavidin-binding peptide tag) with siRNA-resistant (C133T silent point mutation) human CtIP WT; 
SFB-CtIP-N-LR, 2691 bp, ampicillin and puromycin resistance, original plasmid kindly provided by Z. 
Gong. 
GFP-CtIP-WT, GFP-CtIP-S327A: Plasmid encoding C-terminal GFP-tagged siRNA-resistant (C133T, 
A135G, A138G silent point mutations) human WT CtIP or CtIP phospho-mutant with Ser327 mutated to 
Ala; pEGFP-CtIP-WT-C1 or -S327A-C1, 7416 bp, kanamycin and neomycin resistance, original plasmid 
kindly provided by S. Takeda 25. 
RFP-CtIP-WT, RFP-CtIP-S327A, RFP-CtIP-S327E, RFP-CtIP-T847A, RFP-CtIP-T847E: Plasmid 
encoding C-terminal RFP-tagged siRNA-resistant (C133T, A135G, A138G silent point mutations) human 
WT CtIP, CtIP phospho-mutant with Ser327 or Thr 847 mutated to Ala, or CtIP phospho-mimic mutant 
with Ser327 or Thr 847 mutated to Glu; ptagRFP-CtIP-WT-C1, -S327A-C1, -S327E-C1, -T847A-C1, or -
T847E-C1, 7416 bp, kanamycin resistance, generated by graduate student F. Lörch 25 from original GFP-
tagged version kindly provided by S. Takeda. 
RFP-CtIP-S327A/T847A, RFP-CtIP-S327E/T847E, RFP-CtIP-S327E/T847A, RFP-CtIP-S327A/T847E: 
Plasmid encoding C-terminal RFP-tagged siRNA-resistant (C133T, A135G, A138G silent point mutations) 
human CtIP phospho-mutant with Ser327 and Thr847 mutated to Ala, CtIP phospho-mimic mutant with 
Ser327 and Thr847 mutated to Glu, CtIP mixed phospho-mimic and phospho-mutant with Ser327 and 
Thr847 mutated to Glu or Ala; ptagRFP-CtIP-S327A/T847A-C1, -S327E/T847E-C1, -S327E/T847A-C1, 
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or -S327A/T847E-C1, 7416 bp, kanamycin resistance, generated by undergraduate student C. Ruder 
from original GFP-tagged version generated by O. Barton. 
RFP-CtIP-S664A/S745A, RFP-CtIP- S664E/S745E, RFP-CtIP-N289A/H290A: Plasmid encoding C-
terminal RFP-tagged siRNA-resistant (C133T, A135G, A138G silent point mutations) human CtIP 
phospho-mutant with Ser664 and 745 mutated to Ala, CtIP phospho-mimic mutant with Ser664 and 745 
mutated to Glu, CtIP nuclease mutant with Asn289 and His290 mutated to Ala; ptagRFP-CtIP-
S664A/S745A-C1, -S664E/S745E-C1, or -N289A/H290A-C1, 7416 bp, kanamycin resistance, generated 
by graduate student F. Lörch from original GFP-tagged version generated by O. Barton. 
SFB-CtIP: N-terminal triple epitope tag destination vector (S protein, FLAG epitope tag, and streptavidin-
binding peptide tag) with human CtIP WT; SFB-CtIP-N-LR, 2691 bp, ampicillin and puromycin resistance, 
kindly provided by Z. Gong. 
FLAG-EXO1-WT: C-terminal triple epitope tag destination vector (S protein, FLAG epitope tag, and 
streptavidin-binding peptide tag) with human siRNA-resistant (P73P) EXO1 WT; SFB-EXO1-C-LR, 
ampicillin resistance, original plasmid kindly provided by Z. Gong. 
SFB-EXO1: C-terminal triple epitope tag destination vector (S protein, FLAG epitope tag, and 
streptavidin-binding peptide tag) with human EXO1 WT; SFB-EXO1-C-LR, ampicillin and puromycin 
resistance, kindly provided by Z. Gong. 
GFP: C-terminal GFP plasmid for mammalian cells; pEGFP-C1, 4.7 kb, kanamycin and neomycin 
resistance, vendor: Clontech (#632470). 
CMV-EGFP: Plasmid encoding EGFP; suitable for viral production as positive control; pCMV-EGFP, 
vendor: AddGene (#19319). 
FLAG-PLK3-WT, FLAG-PLK3-PBD: N-terminal triple epitope tag destination vector (S protein, FLAG 
epitope tag, and streptavidin-binding peptide tag) with siRNA-resistant human WT PLK3 or PLK3 deletion 
mutant (aa 1 to 480); SFB-PLK3-WT-N-LR or -PBD-N-LR, ampicillin and puromycin resistance, original 
plasmid kindly provided by J. Wang 25, mutations for siRNA resistance by O. Barton. 
RFP: RFP expressing plasmid for human cells; ptagRFP-C1, 4643 bp, kanamycin resistance, vendor: 
Takara Bio Inc. 
I-SceI: Plasmid encoding the meganuclease I-SceI for expression in human cells; pBL464-pCBA-Sce, 
5661 bp, ampicillin resistance, kindly provided by W. Mansour 258. 
pGEM-T easy: Vector from pGEM-T easy vector system I, which is suitable for -complementation; vector 
is included in its linearized form (EcoRV); pGEM-T easy vector, 3015 bp, ampicillin resistance, vendor: 
Promega (#A1360). 
pUC19: Vector that is suitable for -complementation with a SmaI restriction site within the multiple 
cloning site; pUC19, 2686 bp, ampicillin resistance, vendor: New England Biolabs (#N3041S). 
5.1.10. Cell lines and bacteria 
82-6 hTERT: hTERT-immortalized human WT fibroblast cell line; cells were cultivated in MEM with 
20% FCS and 1% NEAA and passaged twice per week (1:8 or 1:10); kindly provided by P. Jeggo 327. 
GC92: SV40-transformed GM639 human fibroblast control cell line isolated from a 8-year-old female 
(National Institute of General Medical Sciences Human Genetic Mutant Cell Repository (Camden, NJ)) 
132 containing a stable intrachromosomal integrated reporter substrate (see Figures 3.1 A, S9.2 a); cells 
were cultivated in DMEM plus 10% FCS and 1% NEAA and passaged twice per week (1:10 or 1:15); 
kindly provided by B. Lopez 322. 
GC92 ARTEMIS KO: GC92 ARTEMIS knock-out cell line generated with CRISPR/Cas9; cells were 
cultivated in DMEM plus 10% FCS and 1% NEAA and passaged twice per week (1:10 or 1:15); 36. 
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GC92 BRCA1 KO: GC92 BRCA1 mutant cell line with a depleted BRCT domain generated with 
CRISPR/Cas9; cells were cultivated in DMEM plus 10% FCS and 1% NEAA and passaged twice per week 
(1:10 or 1:15). 
GCS5: Variant of the GC92 reporter cell line but with a second reporter substrate, which has G418 
resistance (see Figure 3.4 A); cells were cultivated in DMEM plus 10% FCS and 1% NEAA plus 
350 µg/ml G418 and passaged twice per week (1:8 or 1:10); kindly provided by B. Lopez 154. 
GCSH14: Variant of the GC92 reporter cell line with a second reporter substrate, which has G418 
resistance (see Figure 3.4 A); cells were cultivated in DMEM plus 10% FCS and 1% NEAA plus 
350 µg/ml G418 and passaged twice per week (1:8 or 1:10); kindly provided by B. Lopez 154. 
HEK293T: Human epithelial embryonic kidney cell line; cells were cultivated in DMEM plus 10% FCS or 
DMEM plus 10% FCS and 1% Glutathione and passaged twice per week (1:8 or 1:10); vendor: ATCC 
(#ATCC-CRL-3216). 
HeLa-S3: Human epithelial cervix tumor cell line isolated in 1951 from 31 year old Henrietta Lacks 
suffering from adenocarcinoma; cells were cultivated in DMEM plus 10% FCS and 1% NEAA and 
passaged twice per week (1:8 or 1:10); vendor: ATCC (#ATCC-CCL-2.2). 
HeLa pGC: HeLa cells containing a gene conversion reporter construct with puromycin resistance; cells 
were cultivated in DMEM plus 10% FCS and 1% NEAA plus 2 µg/ml puromycin and passaged twice per 
week (1:8 or 1:10); kindly provided by W. Mansour 258. 
Escherichia coli DH5: E. coli strain used for cloning; suitable for -complementation due to an 
incomplete lacZ gene, which makes blue-white colony screening possible after transformation with a 
vector coding for the missing lacZ- (N-terminal  fragment of -galactosidase) 
5.2. Cellular biological methods 
5.2.1. Cell culture, transfections, and treatments 
Cell culture 
Cells were cultured at 37°C in a 5% CO2 incubator in either 75 cm2 cell culture flasks or 10 cm 
cell culture dishes. Sterile solutions, media, and materials were used. For thawing, cells were 
taken from the liquid nitrogen storage and incubated for 1 min in a 37°C water bath. The cell 
suspension was mixed with 5 ml of medium and centrifuged for 3 min at 300 × g. The pellet 
was resuspended in 1 ml of fresh medium and incubated for 24 h in either 6 or 10 cm cell culture 
dishes. The first passage after thawing was executed at a 1:3 ratio. Passaging was performed at 
80 or 90% optical confluence. Medium was discharged and cells were washed with PBS. Cells 
were incubated with trypsin/EDTA solution until cells could be shaken off the cell culture dish 
or flask (after 3 to 10 min, depending on the cell line). Trypsinization was stopped by medium 
addition, cells were singularized by resuspension and transferred into new cell culture dishes 
or flasks containing fresh medium (for passaging ratios see chapter 5.1.13). Cells were 
harvested at 70% confluence, washed with PBS, trypsinized and transferred into a tube. The 
suspension was centrifuged at 300 × g for 3 min and cells were resuspended in fresh medium. 
After another centrifugation, cells from one 10 cm cell culture dish were resuspended in 2 ml 
FBS/10% DMSO and transferred into cryogenic tubes 1 ml each. Samples were frozen at -80°C 
or in liquid nitrogen tanks. 
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After stopping the trypsinization, cells were centrifuged at 300 × g for 3 min and resuspended 
in fresh medium. The cell number was determined with a Neubauer counting chamber and cells 
were seeded in cell culture dishes. For microscopy assays, cells were seeded in either 35 or 
60 mm cell culture dishes on coverslips with 1.5 x 105 cells in 2.2 ml medium or 2.5 x 105 cells 
in 5.5 ml medium, respectively. For protein analysis, 2.5 x 105 cells were seeded in 35 mm 
dishes with 2.2 ml medium. For cell sorting with flow cytometry, cells were seeded in 6-well 
plates in a 1:100 ratio. For cell sorting with MACS, 2 x 105 cells were seeded with 5.5 ml 
medium in 60 mm dishes. For immunoprecipitation and purification, cells were seeded in 10 cm 
dishes at a 1:10 ratio. Cells were first transfected with small interfering RNA (siRNA) during 
seeding and all additional transfections or other treatments took place between 24 and 72 h 
after seeding. 
RNA interference 
Transfection of siRNA was performed with HiPerFect transfection reagent (for target sequences 
and applied concentrations see Table 5.2). The composition was dependent on the desired 
siRNA concentration and the medium volume the cells were seeded in. For cells seeded in 2.2 ml 
medium, a total volume of 100 µl Opti-MEM with siRNA (1.2 to 3 µl) was mixed with 12 µl of 
HiPerFect in a 1.5 ml reaction tube and vortexed for 1 min. For cells seeded in 5.5 ml medium, 
a total volume of 250 µl Opti-MEM with siRNA (2.88 to 7.2 µl) was mixed with 28.8 µl of 
HiPerFect in a tube and vortexed for 1 min. After incubation for 10 min at RT, the solution was 
added dropwise under pivoting. The first siRNA transfection was executed during the seeding 
of the cells. A second siRNA transfection took place 24 to 36 h after the first. Downregulation 
was confirmed by immunoblotting and the strongest downregulation was detected 72 h after 
the first transfection. After a third siRNA transfection, which took place 72 h after cell seeding, 
protein levels remained low for an additional 72 h, providing enough time to conduct the 
experiments. 
Plasmid transfection 
Plasmid transfection was performed with gentle jetPEI transfection reagent for reporter assay 
experiments. For cells seeded in 2.2 ml medium, 1 µg plasmid DNA and 4 µl jetPEI were each 
mixed and briefly vortexed with 100 µl 150 mM NaCl. For cells seeded in 5.5 ml medium, 4 µg 
plasmid DNA and 8 µl jetPEI were each mixed and briefly vortexed with 250 µl 150 mM NaCl. 
The jetPEI solution was then added to the DNA solution and the mixture was briefly vortexed 
again. After 15 min incubation at RT, the solution was added dropwise under pivoting. The 
medium was changed 8 to 12 h after adding the plasmid DNA and the second or third siRNA 
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transfection was subsequently performed. Plasmid transfection was performed with PEI or 
MATra-A for all other experiments following the manufacturer’s instructions.  
Viral Transduction 
Viral transduction was used to establish gRNAs. HEK293T cells were seeded in 60 mm dishes 
with 3 ml medium and were transfected with PEI after 24 h, using 200 µl Opti-MEM with 40 µl 
PEI solution and 200 µl Opti-MEM containing 10 µg DNA. The DNA was mixed in a 4:3:1 ratio: 
4.8 µg gRNA-V2 vector, 3.6 µg psPAX2, and 1.2 µg pMD2.G. The virus was collected 48 h after 
transfection with a syringe and a 0.45 µm filter and 6 µl enhancer was added. 1 ml of virus 
solution was added to cells seeded 24 h prior in 6-well plates after medium was removed. 1 ml 
fresh medium was added. After 72 h, the medium was changed to selection medium containing 
2 µg/ml puromycin. Fresh selection medium was added after 24 h and cells were harvested 
after an additional 48 h for immunoblotting. Viral transduction was also used in some 
experiments instead of siRNA downregulation. 
Generation of KO cell lines 
CRISPR/Cas9 technology was used to generate knock-out (KO) cell lines. GC92 or MCF10A 
cells were simultaneously transfected with gRNA-V0 plasmids, a Cas9-encoding plasmid, and a 
GFP plasmid using PEI following the manufacturer’s instructions. GFP-positive cells were 
singularized in 96-well plates by cell sorting and transferred to two 24-well plates after reaching 
confluence. One 24-well plate was used to screen for knock-out at the protein level by 
immunoblotting. Clones were transferred to two 12-well plates and after reaching confluence, 
one 12-well plate was used to verify protein levels by immunoblotting. Potential KO cells were 
transferred to 6-well plates and genomic DNA was extracted with pure link genomic DNA mini 
kit following the manufacturer’s instructions. The targeted region was amplified by PCR using 
KOD hot start DNA polymerase (for primer sequences see Table 5.1). PCR products were cloned 
into pGEM-T easy vector and transformed into competent E. coli DH5. -complementation 
was used to identify colonies containing the plasmid. Plasmid preparation was performed with 
QIAPrep spin mini prep kit according to the manufacturer’s instruction. To confirm the KO, the 
isolated DNA of at least 10 colonies was sent for sequencing to verify frameshift mutations in 
the targeted region. 
Generation of stable cell lines 
HEK293T cells were seeded in 6-well plates and plasmid transfection with 3 µg DNA was 
performed after 24 h using PEI following the manufacturer’s instructions. After another 24 h, 
the transfected cells were seeded in 10 cm cell culture dishes with DMEM/15% FBS at 1:5, 1:10, 
and 1:40 ratios. After 48 h, the medium was changed to selection medium containing 2 µg/ml 
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puromycin. Fresh selection medium was added every 72 h and after a total of 12 to 15 days, 
single clones were picked and transferred to 24 or 12-well plates. After reaching confluence, 
cells were transferred into 6-well plates with coverslips. Cell-covered coverslips were used for 
immunofluorescence microscopy analysis to identify clones showing homogenous expression 
levels roughly equal to the endogenous protein level. Protein level was also tested by 
immunoblotting. 
Inhibitor treatment 
Chemical inhibitors were added 1 h before IR or 8 h after I-SceI transfection in reporter assay 
experiments when the medium was changed. To maintain inhibition over the entire repair time 
for reporter assay experiments, the medium and inhibitor were replaced 24 h after initial 
treatment. Negative controls were treated with DMSO. For concentrations used see Table 5.4.  
Cell synchronization 
For synchronization, proliferating GC92 cells were treated with 2 mM thymidine. 16 h after the 
first treatment with thymidine, cells were washed 3x with PBS and incubated in medium to 
release the cells from their block in S phase and at the G1/S transition. To fully synchronize all 
cells at the G1/S transition, thymidine was re-added 10 h after release. After 14 h pulse 
treatment with thymidine, cells were washed 3x with PBS and fresh medium was added. To 
obtain synchronized G2 cells, experiments were conducted 8 h after release and to obtain 
synchronized G1 cells, experiments were conducted 16 to 18 h after release. Cell 
synchronization was controlled using propidium iodide flow cytometry analysis. 
To maintain GC92 cells synchronized in G1 phase for the duration of the entire repair time in 
reporter assay experiments, serum-free medium (or starvation medium with 0.5% FCS) was 
added to the cells 12 h after release from the second thymidine block. Additionally, EdU was 
added. To maintain GC92 cells in G2 phase for the duration of the repair time, the CDK1 
inhibitor RO-3306 was added 8 h after the second thymidine release to keep cells from 
progressing from G2 into G1 phase. Additionally, EdU was added. EdU incorporation was used 
to exclude the small number of cells which continued to progress in the cell cycle. Of note, both 
procedures without previous thymidine block were unsuccessful in GC92 cells. 
DSB induction 
Damage induction by I-SceI expression was initiated in cells containing a reporter substrate by 
transient transfection of an I-SceI plasmid. The first sign of I-SceI expression was detected in 
very few cells after 12 h and was observed in roughly 30% of all cells after 48 h. In the first step 
of I-SceI DSB induction, the two -sheets interact directly with the DNA to recognize the 18 bp 
I-SceI recognition site on one DNA strand. Next, the endonucleolytic cut is performed by the 
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Asp-rich active region cradled between the two -sheets 205,279. The N-terminal loop of I-SceI is 
coiled around the DNA to maintain position while the nuclease moves to also disrupt the second 
DNA strand, which produces a DSB with a 4 nt 3′ ssDNA overhang (also see Table 9.1). 
Damage induction by X-IR was performed at 90 kV and 39 mA for immunoprecipitation and 
purification experiments and at 90 kV and 19 mA for all other experiments. The dose doubling 
effect was taken into account when cells were seeded on glass coverslips, thus exposure times 
were reduced to obtain the indicated dose 206. The X-ray machine uses a tungsten anode and a 
beryllium window and the samples were irradiated on a 1 mm aluminum plate which filters 
low energy X-rays. 
5.2.2. Flow cytometry and magnetic-activated cell sorting (MACS) 
For flow cytometry experiments, cells were washed twice with PBS then trypsinized for 5 min 
at 37°C. Trypsinization was stopped with medium. All further steps were conducted on ice and 
with cold solutions. Cells were resuspended and transferred into falcon tubes or reaction tubes. 
After centrifugation at 300 × g for 3 min at 4°C, cells were resuspended in 1 ml of PBS and 
transferred to a fresh 1.5 ml reaction tube. After another centrifugation, cells were fixed by 
dropwise addition of -20°C cold ethanol under constant vortexing of the cell pellet. Fixed cells 
were stored at -20°C. Cells were centrifuged at 400 × g for 3 min at 4°C. After two washing 
steps with PBS, cells were permeabilized with 0.25% TritonX-100/PBS by incubation for 15 min 
on ice. After centrifugation, cells were washed twice with 1% BSA/PBS. Cells were incubated 
for at least 1 h at RT or overnight at 4°C in 1% BSA/PBS. Cells were resuspended in primary 
antibody diluted in 1% BSA/PBS and incubated at 4°C overnight. After centrifugation at 400 × g 
for 3 min at 4°C, cells were washed twice with 1% BSA/PBS. Following secondary antibody 
treatment in 1% BSA/PBS for 1 h at RT in the dark, cells were centrifuged and washed once 
more. Cells were resuspended in PI solution and incubated for 30 min at RT in the dark. Cells 
were detected by flow cytometry after gating on forward and side scatter to exclude cell debris. 
Cells were scanned and plotted for secondary antibody signal and PI signal. Data were analyzed 
using CXP analysis software. 
MACS was used to enrich CD4-positive cells for sequence analysis. Cells were washed twice 
with PBS and incubated in 50 mM EDTA solution for 10 min at 37°C. All further steps were 
conducted on ice and with cold solutions. Cells were carefully resuspended in PBS to singularize 
them. After centrifugation at 300 × g for 3 min at 4°C, cells were stained and separated on 
miniMACS MS columns following the manufacturer’s instructions. 
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5.2.3. Immunofluorescence 
For immunofluorescence experiments, cells were grown on coverslips. In experiments where 
the endogenous protein was depleted, transfection with plasmids coding for exogenous protein 
occurred 24 h after cell seeding and transfection with the I-SceI plasmid took place 60 h after 
cell seeding to initiate DNA damage induction from roughly 72 h after cell seeding. In 
experiments where downregulation of an endogenous protein was not necessary, I-SceI 
transfection occurred 24 h after cell seeding. Cells were harvested 72 h after I-SceI was first 
detected. Cells were treated with EdU and nocodazole 30 min prior to IR or cell harvest. EdU is 
a thymidine analog, and thus marks cells that progress through S phase, while nocodazole 
disrupts the spindle apparatus, and thus prevents cells from successfully completing mitosis and 
therefore progressing into G1 phase. This procedure permits the analysis of cells damaged 
during G1 phase and maintained in G1 throughout repair time in IR-based experiments and the 
recognition of G1 phase cells in reporter assay-based experiments. 
For KU foci detection, cells were pre-extracted twice for 3 min with CSK buffer supplemented 
with 0.3 mg/ml RNase. Cells were then fixed for 15 min at RT with 2.5% formaldehyde/PBS or 
4% paraformaldehyde and washed 3x with PBS. Cells were permeabilized for 10 min at 4°C 
with 0.2% TritonX-100/PBS/1% FCS and washed 3x with PBS/1% FCS. Cells were blocked for 
at least 1 h in 3% BSA/PBS/1% FCS or overnight in 0.5% BSA/PBS-T for detection of KU foci. 
Cells were stained with the primary AB in humid chambers overnight at 4°C or 2 to 4 h at RT 
for KU foci analysis (for primary antibody dilutions see Table 5.6, 5.7) in blocking solution. 
After 3x washing with PBS/1% FCS or 0.5% BSA/PBS-T, cells were stained for 1 h at RT in the 
dark with the secondary AB in PBS/1% FCS or 0.5% BSA/PBS-T (see Table 5.8). For KU foci, 
the stained samples were fixed with 2% paraformaldehyde for 10 min at RT to fix the secondary 
AB. Cells were washed 3x in PBS/1% FCS or 0.5% BSA/PBS-T. EdU incorporation was detected 
with EdU click kit following the manufacturer’s instructions using Cy5 diluted at a 1:40 ratio. 
Cells were washed 3x in PBS and once in Aqua dest. before DAPI staining with 
0.4 µg/ml DAPI/PBS for 4 min at RT. The coverslips were transferred to a microscope slide with 
mounting medium and sealed with nail polish. For KU foci analysis, mounting was performed 
with ProLong gold and images were captured within 48 
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Figure 5.1 Workflow for reporter assay experiments 
The first siRNA transfection took place during cell seeding. The exogenous protein plasmid was 
transfected 24 h after cell seeding. To reduce toxicity from the transfection reagent, the medium was 
changed and a second siRNA treatment was conducted to ensure downregulation of the endogenous 
protein. The I-SceI plasmid was transfected at 60 h after cell seeding and the first signs of I-SceI were 
detected 12 h later in a few cells. Cells were harvested for immunoblotting experiments to confirm 
downregulation by siRNA since DSB induction begins at this point. For all other experiments, the medium 
was changed 8 h (red) after I-SceI plasmid transfection and a third siRNA transfection and/or the first 
inhibitor treatment occurred. In experiments with inhibitor treatment, another medium change plus 
second inhibitor treatment was conducted 36 h (red) after I-SceI transfection. I-SceI expression peaked 
at 48 h (red) after I-SceI plasmid transfection and was observed in roughly 30% of cells. Cells were 
harvested 72 h after I-SceI transfection.  
Cells were analyzed with a Zeiss microscope and Metafer software. The DAPI and EdU content 
were scanned and plotted, making it possible to select G1 phase cells for further analysis. In 
experiments with exogenous tagged protein, cells were also scanned for the tag to facilitate the 
analysis of G1 cells positive for the tagged protein. For foci analysis, the number of foci per cell 
was analyzed in at least 40 G1 cells per sample. For reporter assay data, up to 10,000 cells (with 
a minimum of 2,000 cells) were scanned per condition. The intensities of DAPI, RFP (or a tag), 
and CD4 were detected and the quantity of cells positive for the reporter protein was analyzed 
in plasmid-transfected cells (see chapter 3.1.1). Alterations due to experimental conditions are 
mentioned where applicable. Images were captured with Metafer Isis or AxioVision software 
and analyzed with ImageJ. For KU foci, Z stacks were acquired by confocal laser scanning 
microscopy using a 100x immersion objective. Co-localization of KU80 with H2AX, pRPA, or 
RAD51 foci was analyzed using LAS AF lite software (dx < 20 nm for co-localization of signal 
intensity in line profile). 
5.3. Biochemical methods 
5.3.1. Protein extracts, immunoprecipitation, and immunoblotting 
Protein extracts 
All steps were conducted on ice and with cold solutions. Cells were washed twice with PBS, 
harvested with a cell scraper, and transferred into a falcon or reaction tube after resuspension. 
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After centrifugation at 300 × g for 3 min at 4°C, cells were lysed using RIPA buffer to confirm 
knockdown efficiency and exogenous protein levels or lysis buffer for immunoprecipitation 
experiments together with sonification in an ultrasound bath twice for 1 min. The buffers were 
mixed with PhosphoStop and protease inhibitor following the manufacturer’s instructions. The 
supernatant was transferred into a new reaction tube after centrifugation at 16,000 × g for 
30 min at 4°C. Protein concentration was determined using Bradford protein assay (absorption 
at 595 nm). Alternatively, 2x SDS buffer was used for cell lysis when testing the protein levels 
in generated KO cell lines. 
Immunoprecipitation 
30 µl of protein G Dynabeads were washed with PBS and then incubated with 2 to 10 µg AB for 
2 to 4 h at 4°C. The beads-AB complex was washed 3x with 0.1% BSA/PBS. After incubation 
with the cell extracts for 2 to 4 h at 4°C, the suspension was washed 3x with 
0.1% Tween20/PBS, transferred to a new tube and washing buffer was removed after brief 
centrifugation. The beads-AB-protein complex was resuspended in 20 µl RIPA buffer with 
PhosphoStop and protease inhibitor and Laemmli buffer was added. Proteins were eluted by 
boiling at 99°C for 10 min. After brief centrifugation, the supernatant was used in SDS-PAGE. 
Immunoblotting 
Samples were prepared with 5x Laemmli buffer (unless they were harvested with 2x SDS 
buffer) and boiled for 5 min at 95°C or for 10 min at 80°C for large proteins (> 250 kDa). SDS-
PAGE was performed to separate the proteins according to size. Electrophoresis buffer was used 
and gels were run at 180 V or alternatively at 25 to 50 mA. For western blotting, a PVDF 
membrane was activated in methanol and then equilibrated in transfer buffer. After completion 
of the SDS-PAGE, the gel was fixed on a membrane and placed in between filter paper and 
sponges soaked in transfer buffer. The stack was sealed after removing air bubbles and the 
blotting aperture was assembled with the membrane facing the anode. The western blot was 
conducted at 300 mA for 90 min, 3 h, or 4 h or at 80 mA overnight depending on the size of the 
target protein. When using the semi-dry western blot aperture, blotting was performed at 0.8 A 
for 1 to 2 h. The membrane was blocked in 5% milk/TBS-T for experiments where knockdown 
efficiencies and exogenous protein levels were confirmed or for immunoprecipitation 
experiments. After brief washing in TBS-T, the membrane was incubated in primary AB (AB 
solutions see Table 5.6) in 1, 3, or 5% milk/TBS-T or 5% BSA/TBS-T overnight at 4°C. After 
3 wash steps, the membrane was incubated in secondary IgG-HRP-coupled AB in 1% milk/TBS-
T for 1 h at RT. The membrane was washed 3x. For detection, western blotting substrates were 
mixed and incubated on the membrane following the manufacturer’s instructions. The emitted 
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chemiluminescent signal was detected using ChemiSmart5000 or Fusion FX imaging system. 
Images were analyzed using ImageJ. 
5.3.2. Tandem affinity purification mass spectrometry (TAP-MS) 
HEK293T cells stably expressing exogenous SFB-tagged protein were collected on ice with cell 
scrapers and centrifuged at 400 × g for 4 min at 4°C. The pellet was washed with PBS and 
centrifugation repeated. Cells were lysed in NETN/pepstatin/aprotinin for 30 min with rotation 
at 4°C. The suspension was centrifuged at 22,000 × g for 20 min at 4°C. The supernatant was 
transferred into a clean falcon tube and the chromatin fraction was collected in 1.5 ml reaction 
tubes and frozen at -80°C. Streptavidin beads were washed twice with NETN buffer, added to 
the supernatant and incubated overnight at 4°C on a shaker. The suspension was centrifuged 
at 400 × g for 3 min, beads were resuspended in 1 ml of fresh lysis buffer, and transferred to a 
1.5 ml reaction tube. Samples were centrifuged at 1,000 × g for 1 min and beads washed twice 
with the buffer. After the remaining buffer was completely removed, the bound protein was 
eluted by incubation of the beads in 1 ml of 2 mg/ml biotin in lysis buffer on a shaker at 4°C for 
2 h. After centrifugation at 1,000 × g for 2 min, the supernatant was transferred to a fresh tube 
and the elution step was repeated with another 800 µl of biotin solution. 120 µl of S beads were 
washed twice with NETN buffer, the first eluate was added and beads were incubated at 4°C 
for 2 h with rotation. The second eluate was added and S beads were incubated again at 4°C 
for 2 h with rotation. Beads were centrifuged at 1,000 × g for 1 min and washed 4x with lysis 
buffer. The lysis buffer was completely removed and 30 µl 2x SDS buffer was added to elute 
the protein from the beads with boiling for 10 min at 99°C. Samples were briefly run on SDS-
PAGE for a quarter of the running gel. The gel was stained overnight with Coomassie blue 
staining solution and subsequently destained for several hours with Coomassie destaining 
solution. Protein bands were excised and transferred to a fresh 1.5 ml reaction tube for analysis 
at the Taplin Mass Spectrometry Facility, Harvard Medical School.  
For phosphorylation MS data, the statistical analysis (Ascore calculation) was performed by the 
Taplin Mass Spectrometry Facility 27 and the provided probabilities were analyzed to determine 
certain (Ascore = 1,000), likely (Ascore > 18), unlikely (Ascore > 0), and no phosphorylation 
at Ser, Thr, and Tyr sites. For analysis, sites showing no phosphorylation under a certain 
condition were given the value 0.1 (rationale: no phosphorylation is less than the smallest value 
Ascore of 1 but even when no phosphorylation was detected, phosphorylation is still generally 
possible). For each condition, the highest provided Ascore was used. For interaction MS data 
84, associated proteins and likely interaction partners were determined. The number of 
minimum interacting peptides of a protein identified by MS to have been co-precipitated with 
the purified protein of interest was used for analysis because the maximum interacting peptide 
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number can be highly inaccurate (especially for large proteins). Conditions where no 
interaction was observed were assigned 0.1 for further analysis (rationale: no interaction is 
smaller than 1 interacting molecule). Next, the ratio of the irradiated sample compared to the 
unirradiated condition was calculated. The calculated ratios were used to compare conditions 
and to observe the development of an interaction depending on the different experimental 
conditions. 
5.4. Molecular biological methods 
5.4.1. DNA purification, amplification, digestion, and ligation 
DNA extraction, PCR, and agarose gel electrophoresis 
DNA isolation and purification after MACS enrichment of CD4-positive cells was performed 
using a MasterPure complete DNA & RNA purification kit, following the manufacturer’s 
instructions. All other DNA isolation was conducted using the PureLink genomic DNA mini kit. 
To amplify the DNA, polymerase chain reaction (PCR) was conducted using polymerase kits 
following the manufacturer’s instructions. Phusion polymerase or Q5 polymerase were used for 
error-free DNA amplification after MACS with annealing temperatures ascertained using the 
software on the vendor’s homepage. Taq polymerase was used for colony PCR screening. Pfu 
turbo or Herc polymerases were used for mutagenesis PCR at annealing temperatures of 54°C 
and 56°C, respectively. KOD hot start polymerase was used for all other applications with 
annealing temperatures ranging from 50°C to 56°C. Agarose gels of 1% were used to separate 
DNA fragments according to their size. After heating 100 ml TAE buffer with 1 g agarose in the 
microwave, 5 µl RotiSafe or ethidium bromide was added. Electrophoresis was performed at 
10 V per 1 cm of gel length. ChemiSmart5000 aperture was used for the detection of DNA 
bands. 
Mutagenesis, digestion, ligation, and Gateway cloning 
Mutagenesis PCR was performed using Pfu turbo polymerase following the manufacturer’s 
instructions. After mutagenesis PCR, template plasmid was removed by Dpn1 digestion for 1 h 
at 37°C. For linearization of vectors, dephosphorylation and digestion were performed 
simultaneously with restriction enzymes and alkaline phosphatase following the manufacturer’s 
instructions. Ligation was performed using T4 DNA ligase or pGEM-T easy cloning system 
following the manufacturer’s instructions. The molar insert/vector ratio of 3:1 was used to 
calculate the components of the ligation for most ligation reactions but was adjusted to a higher 
insert amount if necessary. The gateway cloning system was used following the manufacturer’s 
instructions. BP donor vectors were created for ARTEMIS, BRCA1, CtIP, and EXO1. C-terminal 
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SFB-tagged LR plasmids were generated for CtIP, BRCA1, and ARTEMIS. An N-terminal SFB-
tagged LR plasmid was generated for EXO1. 
Interchanging gRNA sequences in the GeCKO CRISPR/Cas9 system 
The CRISPR gRNA plasmid was digested with BsmBI and the 11 kb plasmid was purified using 
agarose gel electrophoresis. Oligonucleotides encoding the target gRNA sequence were 
phosphorylated and annealed with T4 PNK in the thermocycler at 37°C for 30 min, then at 95°C 
for 5 min with a ramp down to 25°C (5°C per min). Linearized plasmid and annealed 
oligonucleotides were ligated with T4 ligase for at least 2 h at RT. 
5.4.2. Bacteria preparation, transformation, plasmid isolation, and sequence 
analysis 
Competent E. coli DH5 were prepared by the rubidium chloride method. RbCl-competent 
DH5 cells were grown overnight at 37°C with rotation at 220 rpm in 5 ml SOB medium. 1 ml 
of overnight culture was used to inoculate 100 ml SOB medium. During incubation at 37°C and 
rotation at 220 rpm, absorption at 550 nm was regularly measured until an OD of 0.5 was 
reached. All further steps were conducted on ice using ice-cold solutions. Cells were centrifuged 
at 2,000 × g for 10 min at 4°C and the pellet was resuspended in 12.5 ml solution 1. After a 
second centrifugation step, the pellet was resuspended in 8 ml solution 2. 1.5 ml reaction tubes 
were prepared with 100 µl cell suspension and snap frozen in liquid nitrogen for storage at 
80°C. 
For bacteria transformation, DH5 were thawed on ice and 10 ng plasmid DNA or 10 µl ligation 
sample were added, resuspended, and incubated on ice for 30 min. After 90 sec heat shock at 
42°C, a 5 min incubation on ice followed. 900 µl LB medium was added and the cells were 
incubated for 1 h at 37°C with rotation at 220 rpm or in a water bath. After centrifugation for 
1 min at 10,000 × g, the medium was removed. Cells were resuspended in 25 µl 0.4 M IPTG 
and 20 µl 50 µg/µl X-Gal in DMSO was added for -complementation or cells were resuspended 
in 50 µl LB medium for all other experiments. Cells were plated on 30 mg/ml kanamycin or 
50 mg/ml ampicillin agar and incubated at 37°C overnight. Colonies were picked and incubated 
in 10 µl LB medium at 4°C for short-term storage or a glycerol stock was prepared with 850 µl 
30% glycerol and 150 µl of a 10 ml bacterial culture grown overnight at 37°C with rotation at 
220 rpm for long term storage at 80°C. Plasmid maxi-preparation was conducted using 
peqGold Xchange plasmid maxi EF kit and plasmid mini-preparation was conducted using either 
ZR plasmid mini prep classic or QIAPrep spin mini prep kit following the manufacturer’s 
instructions. DNA concentration was determined at absorption of 260 nm with Implem’s nano 
photometer. 
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For sequencing, samples were mixed with the corresponding primer according to instructions 
and sent for sequencing to Eurofins. For sequencing after cloning into pGEM-T easy vector, the 
T7 forward primer was used. The sequences were analyzed with MEGA5.1 for sequence analysis 
after MACS separation or with BLASTN for CRISPR/Cas9 generated KOs. 
5.5. Analysis 
For general analysis, procedure, and presentation of the results, the guidelines of Cumming et 
al. (2007) were followed. All plots were created with Origin8.5. Key experiments are shown in 
the results part of this thesis (chapter 3) while supporting data, preliminary experiments, and 
raw data can be found in the appendix (chapters 9.1). Experiments within one cell line were 
treated as independent in statistical analyses because cellular biology on the laboratory scale 
aims to propose a model based on the findings within a cell line 390. Therefore, the experimental 
procedure was performed independently: experiments were performed at least one week apart, 
fresh chemicals/reagents were prepared, cells were used at different passaging stages, and cell 
lines were freshly thawed regularly for experiments.  
5.5.1. Quantification and descriptive statistics 
For reporter assay analysis, between 2,000 and up to 10,000 cells were scanned with the 
microscope software Metafer4 and only damage-induced cells were analyzed (meaning I-SceI-
positive cells, identified by RFP or a tagged protein; for details see chapters 3.1.1, 5.2.5). Each 
experiment was performed in duplicate to counteract the variability frequently observed in 
reporter assay experiments. For foci assay analyses, at least 40 cells were analyzed per 
experiment (for details see chapters 3.1.2, 5.2.5). 
The majority of the data in this study compares untreated and treated samples. To describe the 
magnitude of the effect between a treated and an untreated sample, the effect size was utilized 
284,372. The effect size was determined by Cohen’s d with GPower 3.1, which was calculated to 
estimate the difference of the means over the common standard deviation (SD) of two samples. 
Additionally, the effect size was used to estimate the sample size a priori (power > 0.9) with 
data obtained during the master’s thesis 35, preliminary data, and published data utilizing the 
same reporter assay 322(for further details see chapter 3.1.1). According to the a priori sample 
size calculations, all reporter assay data were obtained from n = 8 or n = 16 independent 
experiments. For foci analysis, data were obtained from n = 5 independent experiments. 
Sequence analysis was conducted with data from n = 4 or n = 5 experiments and a total of at 
least 39 sequences per condition. All other data were derived from at least n = 3 independent 
experiments.  
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The majority of the data are displayed in dot plots, which show the mean value of all 
independent experiments as well as the individual data points. Error bars in the dot plots show 
the confidence interval at the 95% confidence level (95% CI) or the SD. Background data were 
generally not subtracted (for details see chapter 3.1.2). For n > 20 samples, the data were 
additionally displayed in box plots to allow easy interpretation of the distribution 220. The 
boxplots show the median, mean, and 25th and 75th quartile. The whiskers represent the 1st and 
99th percentile, while plotted data points are the outliers. Additionally, histograms were used 
for large sample sizes to visualize normal distribution.  
5.5.2. Inferential statistics 
Origin8.5 was used for all inferential statistic calculations. The confidence interval of the mean 
was calculated with a confidence level of 95% using the t-distribution. All confidence intervals 
were calculated this way, even if the data was not normally distributed. Wang (2001) shows 
that this approach is still advantageous for small sample sizes compared to the Bootstrap 
method, which would typically be used for confidence interval calculations of non-normally 
distributed data. For small sample sizes, the Shapiro-Wilk test was performed to test data for a 
normal distribution, which would allow the usage of a parametric test. Analysis of all WT data 
obtained during this work revealed that the data generally follow a normal distribution (e.g. 
Figure S9.5 a). However, some samples at the significance level of 0.05 were not from a 
normally distributed population. Usually, this could be attributed to either one outlier in a data 
set or due to the application of a siRNA with varying efficiencies, which resulted in a bimodal 
distribution. Another reason for a non-normal distribution was an experimental condition 
where no positive events occurred. In any of these cases, nonparametric tests could not be 
performed either because such data sets were compared with normally distributed data sets. 
Therefore, statistical analysis was forgone for such samples, except to involve them in the 
overall analysis by ANOVA (see below) when comparing the WT to more than one normally-
distributed condition to prevent an increase in -error. 
To compare the means of two independent normally distributed samples, two-sample Student’s 
t-test was performed. For other normally distributed data sets of groups larger than two, a one-
way ANOVA was performed to assess the relative size of variance among group means 210. 
ANOVA was used for such groups larger than two to prevent an -error increase relative to the 
pre-set -level, which repeated multiple tests would lead to. Subsequently, Levene’s test was 
performed to establish the homogeneity of the population variances. In many cases, the 
population variances were different at the 0.05 significance level. As ANOVA is robust to 
differing variances if n is equal 436, the sample sizes in the experiments were always identical 
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within a group. The one-way ANOVA was followed by stringent Bonferroni correction to 
examine which group means were significantly different. 
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7. Directories 
7.1. Abbreviations 
Abbreviations for chemical compounds and buffers not included in this abbreviation list, can be found in 
chapters 5.1.3 and 5.1.4.  
53BP1  tumor suppressor p53-binding protein 1 
95% CI  confidence interval at the 95% confidence level 
 
aa  amino acid 
AB  antibody 
ABRAXAS BRCA1-A complex subunit Abraxas 1 
AID activation-induced cytidine deaminase 
Ala (A)  alanine 
alt-EJ  alternative end-joining 
APLF aprataxin and PNK-like factor 
ARTEMIS DCLRE1C, DNA cross-link repair 1C protein 
Asn (N)  asparagine 
Asp (D)  aspartate 
ATM  ataxia telangiectasia mutated 
ATR  ATM- and Rad3-related 
-TUBULIN Tubulin alpha-1A chain 
 
-actin  Actin, cytoplasmic 1 
BARD1  BRCA1-associated RING domain protein 1 
BLM  Bloom syndrome protein 
bp  base pair 
BRCA1  breast cancer susceptibility protein 1 
BRCT BRCA1 C-terminal domain 
BrdU  5-bromo-2’-deoxyuridine 
 
CD4  T cell surface glycoprotein CD4 
CDK  cyclin-dependent kinase 
CHD2 chromodomain-helicase-DNA-binding protein 2 
CHK  checkpoint kinase 
CLSM  confocal laser scanning microscopy  
c-NHEJ  canonical non-homologous end-joining 
CSR  class switch recombination 
CtIP CtBP-interacting protein 
Cys (C)  cysteine 
 
d  effect size (Cohen) 
DAPI  4',6-diamidino-2-phenylindole 
DDX1  ATP-dependent RNA helicase DEAD box protein 1 
DMSO  dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
DNA2 DNA replication ATP-dependent helicase/nuclease DNA2 
DNA-PK DNA-dependent protein kinase  
DNA-PKcs DNA-dependent protein kinase catalytic subunit 
DSB  double-strand break 
dsDNA  double-stranded DNA 
 
E. coli  Escherichia coli 
EdU  5-ethynyl-2’-deoxyuridine 
EJ  end-joining 
EXD2  exonuclease 3'-5' domain-containing protein 2 
EXO1  exonuclease 1  
 
FITC  fluorescein isothiocyanate 
 Directories v 
 
G1  gap phase 1 
G2  gap phase 2 
GAPDH  glyceraldehyde-3-phosphate-dehydrogenase 
GC  gene conversion 
GFP  green fluorescent protein 
H2AX   gamma H2AX; phosphorylated histone variant H2AX 
Gln (Q)  glutamine 
Glu (E)  glutamate 
Gly (G)  glycine 
gRNA  guide RNA 
Gy  Gray 
 
h  hour 
H4 Lys20me2 Lys 20-dimethylated histone H4 
HELB DNA helicase B 
His (H)  histidine 
HR  homologous recombination  
HRP  horseradish peroxidase 
hTERT  human telomerase reverse transcriptase 
 
IC50  half maximal inhibitory concentration 
IgG  immunoglobulin G 
Ile (I)  isoleucine 
INO80  DNA helicase INO80 
 
KAP1 KRAB domain associated protein 1; TRIM28, transcription intermediary factor 1-beta 
kb  kilo base 
kDa  kilo Dalton 
Ki  inhibitory constant 
KU70/80 XRCC6/5, X-ray repair cross-complementing protein 6/5 
 
LET  linear energy transfer 
Leu (L)  leucine 
LIG DNA ligase 
Lys (K)  lysine 
 
M mean 
MACS magnetic-activated cell sorting 
MDC1  mediator of DNA damage checkpoint protein 1 
me  methylated 
MH  microhomology  
MMEJ  microhomology-mediated end-joining 
MRE11  meiotic recombination 11  
MRN  MRE11, RAD50, NBS1 complex 
MS  mass spectrometry 
 
n  sample size 
NBS1  Nijmegen breakage syndrome 1 
NONO non-POU domain-containing octamer-binding protein 
nt (N) nucleotide 
 
p  phosphorylated 
p21  cyclin-dependent kinase inhibitor 1 
p53  cellular tumor antigen p53 
PARP1 poly(ADP-ribose) polymerase 1 
PAXX paralogue of XRCC4 and XLF 
PBAF chromatin remodeling complex 
PBD  polo-box domain 
PEI polyethylenimine 
Phe (F)  phenylalanine 
 vi 
PI  propidium iodide  
PIKK  phosphatidylinositol 3-kinase-related kinases 
PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 
PLK3  Serine/threonine-protein kinase PLK3 
POH1 PSMD14, 26S proteasome non-ATPase regulatory subunit 14 
POL  DNA polymerase lambda 
POLµ  DNA-directed DNA/RNA polymerase mu 
POL  DNA polymerase theta 
Pro (P)  proline 
PTIP  PAXIP1, PAX interacting protein 1 
 
RAD50  radiation repair protein 50 
RAD51 DNA repair protein RAD51 homolog 1 
RAG1/2 recombination activating gene 
RAP80 BRCA1-A complex subunit RAP80 
res-cNHEJ resection-dependent c-NHEJ  
RFP  red fluorescent protein  
RIF1  RAP1-interacting factor homolog 
RING  really interesting new gene 
RNA  ribonucleic acid 
RNF  E3 ubiquitin protein ligase RING finger protein 
RPA replication protein A 
RT  room temperature 
 
S  synthesis phase 
S. cerevisiae Saccharomyces cerevisiae 
SD  standard deviation 
Ser (S)  serine 
SFPQ splicing factor, proline- and glutamine-rich 
siRNA  small interfering RNA 
SMARCAD1 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A 
containing DEAD/H box 1 
SMART  single molecule analysis of resection tracks 
SNM1B  5' exonuclease Apollo; DCLRE1B: DNA cross-link repair 1B protein 
SSB  single-strand break 
ssDNA  single-stranded DNA 
 
TAP-MS  tandem affinity purification mass spectrometry 
TexRed, TR Texas Red; sulforhodamine 101 acid chloride 
Thr (T)  threonine  
TOPBP1  DNA topoisomerase 2-binding protein 1 
Tyr (Y)  tyrosine 
 
U  enzymatic activity unit 
ub  ubiquitinated 
 
VCP valosin-containing protein 
V(D)J variable, diversity, joining 
 
WRN Werner syndrome ATP-dependent helicase 
WT  wild-type  
 
X-IR  X-ray irradiation 
XLF XRCC4-like factor; Cernunnos 
XRCC1 X-ray repair cross-complementing protein 1 
XRCC4 X-ray repair cross-complementing protein 4  
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8. Appendix 
8.1. Supplemental figures and raw data 
 
Figure S8.1 Supplement to Figures 3.2 A 
(a) I-SceI protein levels in GC92 cells over time. GC92 cells were harvested at various timepoints post-I-SceI 
transfection and protein levels were analyzed by immunoblotting. Of note, this experiment was part of the master’s 
thesis 35. (b, c) Data displayed in Figure S8.3 b in relation to all cells (b) and the RFP transfection efficiency of all 
experiments displayed in Figure S8.3 b (c). 
 
Figure S8.2 Supplement to Figure 3.2 A, B 
(a) Representative image for Figure S8.3 b was captured with a 63x objective using Metafer Isis software. The scale 
bar represents 10 µm. (b, c) Multiple transfections at various timepoints in GC92 cells. GC92 cells were transfected 
either 24 h, 36 h, or 48 h apart with either the I-SceI plasmid plus a plasmid coding for the tagged 102 kDa 
protein (b) or with the RFP and GFP plasmids (c). Cells were harvested at the indicated timepoints post-plasmid 
transfection and either stained for RFP, the tag, I-SceI and the tag, or with anti-RFP and anti-GFP AB plus DAPI. 
Samples were scanned and analyzed using Metafer software. Data represent the mean of 4 independent experiments 
performed in duplicate (n = 4). Error bars show the SD.  
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Figure S8.3 Supplement to Figure 3.2 A 
(a) Histogram of data displayed in Figure S8.3 b revealing the data are derived from a normally distributed 
population (n = 124). (b) Misrepair events in GC92 cells. GC92 cells were co-transfected with the RFP and I-SceI 
plasmids and harvesting occurred 72 h post-I-SceI transfection. Cells were stained with anti-CD4, anti-RFP AB, and 
DAPI. Samples were scanned using Metafer software and plasmid-transfected cells were analyzed. (c) Cell cycle-
dependent analysis of misrepair events in GC92 cells. GC92 cells were synchronized with double thymidine block 
and cells were subsequently held in G1/G0 by serum starvation or in G2 by CDK inhibitor treatment (RO-3306). EdU 
was added and harvest took place 72 h post-co-transfection with the I-SceI and RFP plasmids. Cells were stained 
with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected 
EdU-negative cells were analyzed. The treatment was very harmful to the cells and therefore only between 500 and 
1,000 cells could be analyzed per experiment. (b, c) RFP was used as a marker for cells with damage induction (see 
chapter 3.1.1). Data represent the mean of 8 or 124 independent experiments performed in duplicates (for b n = 124; 
for c n = 8). (c) Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by 
one-way ANOVA with Bonferroni correction. (b) Box plot shows the mean, median, 25th and 75th percentile (whiskers 
1st and 99th percentile). Several data points were part of the analysis in Barton et al. (2014) or Biehs et al. (2017). 
 
Figure S8.4 Cell cycle-dependent H2AX foci analysis in plasmid-transfected cells 
(a, b) Cell selection by Metafer software. GC92 cells were treated with EdU and nocodazole 30 min prior to harvest. 
Harvest took place 72 h post-co-transfection with I-SceI and RFP plasmids. Cells were stained with anti-RFP, anti-
H2AX ABs, and DAPI. Cells were scanned with Metafer software to select and analyze only RFP-positive cells (red 
box) in all experiments (b, n = 1; 3,291 cells) and to additionally select and only analyze G1 phase cells (a, n = 1; 
3,276 cells) in the H2AX foci assay (blue circle).  
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Figure S8.5 Supplement to Figure 3.2 A 
(a) Background H2AX foci (RFP-negative), overall repair in plasmid-transfected cells (RFP-positive), and H2AX in 
cells that underwent misrepair (CD4-positive). (b) Overall repair in GC92 cells. (a, b) GC92 cells were co-transfected 
with the RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest took place 
72 h post-plasmid transfection. Cells were stained with anti-RFP or anti-CD4 plus anti-H2AX AB and DAPI. Samples 
were scanned using Metafer software and non-transfected, plasmid-transfected, and/or CD4-positive G1 cells were 
analyzed. RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Data represent the mean 
of 5 or 30 independent experiments (for a n = 5, for b n = 30). (a) Error bars show the 95% CI. Effect size was 
obtained by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni correction. (c) 5 exemplary 
experiments from data displayed in Figure S8.5 b. In each experiment at least 40 cells were analyzed. (b, c) Box 
plots show the mean, median, 25th and 75th percentile (whiskers 1st and 99th percentile). (a, b, c) Several data points 
were part of the analysis in Biehs et al. (2017). 
 
Figure S8.6 Supplement to Figure 3.5 
(a, b, c) Impact of inhibition or depletion of core c-NHEJ factors on misrepair in GCS5 (a) or overall repair in GC92 
(b, c) cells. GCS5 or GC92 cells were treated with inhibitors or siRNAs against DNA-PK (Nu7441), LIG4, KU70/80, 
or DNA-PKcs. As a control, cells were treated with DMSO or control siRNA. (a) Cell harvest occurred 72 h post-co-
transfection with I-SceI and RFP plasmids. Cells were stained with anti-GFP, anti-RFP AB, and DAPI. Samples were 
scanned using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 
8 independent experiments performed in duplicate (n = 8). (b, c) GC92 cells were co-transfected with RFP and I-
SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvesting occurred 72 h post-plasmid 
transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using Metafer 
software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 5 independent 
experiments (n = 5). (a, b, c) RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Error 
bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with 
Bonferroni correction (a,c) or by two-sample Student’s t-test (b). (c) Several data points were part of the analysis in 
Biehs et al. (2017). 
 xii 
Table 8.1 Overview of the sequence analyses in GC92 cells 
Overview of all sequences from Tables 8.2, 8.3, 8.5. Experiment 1 and 2 were conducted during the master’s thesis 
(named M1 or M2) and experiments 2 to 6 (named 1 to 4) were conducted after the master’s thesis. The laboratory 
part of experiment 6 was executed by C. Alvarado. All sequences except for those from experiment 6 were part of 
the analysis in Biehs et al. (2017). 
 
Table 8.2 Sequence analysis in GC92 cells 
All 40 sequences analyzed after control siRNA treatment from 4 independent experiments (n = 4) with the I-SceI 
recognition site (bold), the I-SceI restriction site (red), MHs (yellow), and insertions (blue). The numbers indicate if 
sequences were observed more than once. Most sequences were part of the analysis in Biehs et al. (2017). 
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Figure S8.7 DNA-PK is required throughout the slow repair mechanism in G1 
(a) 82-6 hTERT cells were treated with EdU and nocodazole 30 min prior to 7 Gy X-IR. DMSO or DNA-PK inhibitor 
(Nu7441) treatment took place at 6 h, 8 h, 10 h, or 12 h post-X-IR and cells were harvested at the indicated 
timepoints. Cells were stained with anti-H2AX AB and DAPI. Samples were scanned using Metafer software and 
only G1 cells were analyzed, as identified by EdU intensity and DAPI content (b, n = 1; 4,191 cells). Data represent 
the mean of 4 independent experiments (n = 4). Error bars show the SD. Experiments were conducted together with 
R. Weimer and analysis was shared. (a) The kinetics were included in Biehs et al. (2017).
 
Figure S8.8 Supplement to Figure 3.7 and 3.8 
(a, b, c) Impact of inhibition or depletion of alt-EJ factors on misrepair in GCS5 (a) or overall repair in GC92 (b, c) 
cells. GCS5 or GC92 cells were treated with inhibitors and/or siRNAs against PARP (Olaparib), PARP1, LIG1/3, 
and/or LIG4. As a control, cells were treated with DMSO or control siRNA. (a) GCS5 cells were harvested 72 h post-
co-transfection with I-SceI and RFP plasmids. Cells were stained with anti-GFP, anti-RFP AB, and DAPI. Samples 
were scanned using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 
8 independent experiments performed in duplicate (n = 8). (b, c) GC92 cells were co-transfected with RFP and I-
SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvesting occurred 72 h post-plasmid 
transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using Metafer 
software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 5 independent 
experiments (n = 5). (a, b, c) RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Error 
bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with 
Bonferroni correction.  
 
 
 
Table 8.3 Sequence analysis after depletion of LIG1/3 in GC92 cells 
 xiv 
All 39 sequences analyzed after depletion of LIG1/3 from 4 independent experiments (n = 4) with the I-SceI 
recognition site (bold), the I-SceI restriction site (red), MHs (yellow), and insertions (blue). The numbers indicate if 
sequences were observed more than once. Most sequences were part of the analysis in Biehs et al. (2017). 
 
 
 
 
Figure S8.9 Supplement to figure 3.11 
(a, b, c) Impact of the absence of ARTEMIS on the misrepair in GC92 (a, c) or GCSH14 (b) cells. GC92 or GCSH14 
cells were treated with inhibitors and/or siRNA against ARTEMIS. As a control, cells were treated with DMSO or 
control siRNA. (a) Based on data published in the master’s thesis 35. The protocol during these experiments did not 
allow sufficient time for ARTEMIS downregulation (48 h instead of 72 h) although downregulation by siRNA 
measured by immunoblotting showed a strong reduction in ARTEMIS protein levels. Each experiment was 
normalized to cells treated with control siRNA and all cells were analyzed. (b, c) Cells were harvested 72 h post-co-
transfection with the I-SceI and RFP plasmids. Cells were stained with anti-GFP or anti-CD4 plus anti-RFP AB and 
DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were analyzed. (a, b, c) Data 
represent the mean of 4 or 8 independent experiments performed in duplicate (n = 4 for a, c; n = 8 for b). (b, c) 
RFP was used as a marker for cells with damage induction and exogenous protein (see chapter 3.1.1). Error bars 
show the 95% CI (b, c) or the SD (a). Effect size was calculated by Cohen’s d and p-value was obtained by two-
sample Student’s t-test. (d) Generation of GC92 ARTEMIS KO cells by CRISPR/Cas9 technology with gRNAs #3 and 
#1 (red boxes). KO was confirmed by sequencing. Both GC92 ARTEMIS KO cell lines show a 1 nt insertion resulting 
in a premature termination of the amino acid sequence. Of note, in all experiments labeled ARTEMIS KO, GC92 
ARTEMIS KO cells generated with gRNA #3 were used. 
Table 8.4 ARTEMIS-associated factors 
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SFB-ARTEMIS-WT was precipitated and purified from stably-transfected HEK293 cells with streptavidin beads. 
Precipitation took place in unirradiated controls, 30 min, or 2 h post-5 Gy X-IR (all conditions n = 1). MS was 
performed by the Taplin Mass Spectrometry Facility, Harvard Medical School. Conditions where no interaction was 
observed were given a value of 0.1 for further analysis. The minimum amount of interacting peptides of a potential 
interaction partner was used to calculate the ratio of the irradiated sample compared to the unirradiated condition. 
Therefore, values greater than 1 show an interaction increase while values less than 1 show an interaction decrease 
following X-IR. Interesting possible novel interacting proteins and some established interacting proteins are included 
in this table. Of note, observed interactions may be unspecific or may not only result from a direct interaction, but 
also an indirect protein-protein or indirect DNA-protein interaction. 
 
 
Figure S8.10 Supplement to Figures 3.12, 3.13 and 3.14 
(a, b, c, d) Impact of 53BP1 CRISPR/Cas9 viral transduction (a) or co-depletion of polymerases with 53BP1 (b, c) 
on the misrepair (a, b) or overall repair (c, d) in GC92 cells. (a) GC92 cells were virally transduced with CRISPR/Cas9 
and 53BP1 gRNA #4 plasmids and selected by selection medium. Downregulation by CRISPR/Cas9 was confirmed 
by immunoblotting. (b, c, d) GC92 WT or ARTEMIS KO cells were treated with siRNAs against POL, POL/µ, and/or 
53BP1. (a, b) Cells were harvested 72 h post-co-transfection with I-SceI and RFP plasmids and stained with anti-
CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were 
analyzed. Data represent the mean of 8 independent experiments performed in duplicate (n = 8). (c, d) Cells were 
co-transfected with RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest 
took place 72 h post-plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were 
scanned using Metafer software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 
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5 independent experiments (n = 5). (a, b, c, d) RFP was used as a marker for cells with damage induction (see 
chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by 
one-way ANOVA with Bonferroni correction (for b, c) or by two-sample Student’s t-test (for a, d).  
 
Figure S8.11 Supplement to Figure 3.15 and 3.16 
(a) Generation of GC92 BRCA1 KO cells by CRISPR/Cas9 technology with gRNA #9 (red box). KO was confirmed 
by sequencing. The GC92 BRCA1 KO cell line entails an 8 nt deletion resulting in premature termination of the amino 
acid sequence. Of note, due to the position of the gRNA, the RING domain is still fully present but the BRCT domain 
is completely depleted. (b, c, d, e) Impact of BRCA1 impairment (b, c, d) or overexpression (e) on misrepair (b, c, 
e) or overall repair (d) in GC92 (b, d, e) or GCS5 (c) cells. GCS5, GC92 WT, or ARTEMIS KO cells were treated with 
siRNAs against BRCA1. As a control, cells were treated with control siRNA. (b) GC92 cells were virally transduced 
with CRISPR/Cas9 and BRCA1 gRNA #3 plasmids and selected by selection medium. Downregulation by 
CRISPR/Cas9 was confirmed by immunoblotting. (b, c) Cells were harvested 72 h post-co-transfection with I-SceI 
and RFP plasmids. Cells were stained with anti-CD4 or anti-GFP plus anti-RFP AB and DAPI. (d) Cells were co-
transfected with RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest took 
place 72 h post-plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were 
scanned using Metafer software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 
5 independent experiments (n = 5). (e) GC92 cells were transfected with the RFP or SFB-BRCA1 plasmid. 36 h after 
plasmid transfection, cells were transfected with I-SceI and harvest took place after an additional 72 h. Cells were 
stained with anti-RFP or anti-FLAG plus anti-CD4 AB and DAPI. (b, c, e) Samples were scanned using Metafer 
software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent experiments 
performed in duplicate (n = 8). Overexpression was confirmed by microscopy in a facility without a microscope 
camera. (b, c, d, e) RFP and FLAG were used as markers for cells with damage induction and exogenous protein (see 
chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by 
one-way ANOVA with Bonferroni correction (for b, d) or by two-sample Student’s t-test (for c).  
 Appendix xvii 
 
Figure S8.12 BRCA1-CtIP interacts in G1 phase after damage induction and is dependent on CtIP 
phosphorylation at S327 
(a) Cell cycle distribution of G1-synchronized HEK293 cells. HEK293 cells were transfected with the GFP-CtIP-WT 
plasmid which resulted in G1 synchronization in GFP-positive cells 24 h post-transfection. Cells were harvested and 
stained with anti-GFP AB and PI. Samples were analyzed by flow cytometry. Data represent the mean of 
3 independent experiments (n = 3). Error bars show the SD. (b) BRCA1-CtIP co-immunoprecipitation from G1-
synchronized HEK293 cells. Exogenous GFP-CtIP-WT, GFP-CtIP-S327A, or endogenous BRCA1 was 
immunoprecipitated from HEK293 cells 30 min post-5 Gy X-IR or from unirradiated controls with anti-GFP or anti-
BRCA1 ABs. Protein levels were analyzed after immunoblotting of the samples.  
 
Figure S8.13 Supplement to Figure 3.17 and 3.19 
(a, b, c) Impact of CtIP CRISPR/Cas9 viral transduction (a) or co-depletion of ligases (b) or polymerases (c) with 
CtIP on the misrepair (a, b) or overall repair (c) in GC92 cells. (a) GC92 cells were virally transduced with 
CRISPR/Cas9 and CtIP gRNA #2 plasmids and selected using selection medium. Downregulation by CRISPR/Cas9 
was confirmed by immunoblotting. (b, c) GC92 cells were treated with siRNA against PARP (Olaparib), LIG4, LIG1/3, 
POL, POL/µ, and/or CtIP. (a, b) Cell were harvested 72 h post-co-transfection with the I-SceI and RFP plasmids. 
Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer software and only 
plasmid-transfected cells were analyzed. Data represent the mean of 8 independent experiments performed in 
duplicate (n = 8). (c) Cells were co-transfected with RFP and I-SceI plasmids and treated with EdU and nocodazole 
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30 min prior to harvest. Harvest took place 72 h post-plasmid transfection. Cells were stained with anti-H2AX, anti-
RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected G1 cells were 
analyzed. Data represent the mean of 5 independent experiments (n = 5). (a, b, c) RFP was used as a marker for 
cells with damage induction (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s 
d and p-value was obtained by one-way ANOVA with Bonferroni correction (for b, c) or by two-sample Student’s t-
test (for a). 
Table 8.5 Sequence analysis after depletion of CtIP in GC92 cells 
All 41 sequences analyzed after depletion of CtIP from 5 independent experiments (n = 5) with the I-SceI recognition 
site (bold), the I-SceI restriction site (red), MHs (yellow), and insertions (blue). The numbers indicate if sequences 
were observed more than once.  
 
Table 8.6 CtIP-associated factors 
SFB-CtIP-WT was precipitated and purified from stably-transfected HEK293 cells with streptavidin beads. 
Precipitation took place in unirradiated controls and 30 min post-5 Gy X-IR (all conditions n = 1). MS was performed 
by the Taplin Mass Spectrometry Facility, Harvard Medical School. Conditions where no interaction was observed 
were given a value of 0.1 for further analysis. The minimum amount of interacting peptides of a potential interaction 
partner was used to calculate the ratio of the irradiated sample compared to the unirradiated condition. Therefore, 
values greater than 1 show an interaction increase while values less than 1 show an interaction decrease following 
X-IR. Interesting possible novel interacting proteins and some established interacting proteins are included in this 
table.  
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Figure S8.14 Supplement to Figure 3.22 and 3.23 
(a) Impact of ATM inhibition on misrepair in GC92 cells. GC92 cells were treated with an inhibitor against ATM 
(Ku60019). As a control, cells were treated with DMSO. Cells were harvested 72 h post-co-transfection with I-SceI 
and RFP plasmids. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples were scanned using Metafer 
software and only plasmid-transfected cells were analyzed. Data represent the mean of 8 independent experiments 
performed in duplicate (n = 8). (b) Impact of CtIP complementation with phospho-mutants S327A and T847A on 
overall repair in CtIP-depleted GC92 WT and ARTEMIS KO cells. Cells were treated with siRNA against CtIP and 
transfected with the RFP or siRNA-resistant RFP-CtIP-WT, RFP-CtIP-S327A, or RFP-CtIP-T847A plasmid. 36 h after 
plasmid transfection, cells were transfected with I-SceI and treated with EdU and nocodazole 30 min prior to harvest. 
Harvest took place 72 h post-I-SceI plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. 
Samples were scanned using Metafer software and only plasmid-transfected G1 cells were analyzed. Data represent 
the mean of 5 independent experiments (n = 5). (a, b) RFP was used as a marker for cells with damage induction 
and exogenous protein (see chapter 3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and 
p-value was obtained by one-way ANOVA with Bonferroni correction (b) or by two-sample Student’s t-test (a). 
 
Figure S8.15 Both CtIP S327 and T847 phosphorylation sites need to be phosphorylated for misrepair in 
GC92 cells 
(a) Impact of CtIP complementation with phospho-mimic- and phospho-mutants on misrepair in CtIP-depleted GC92 
cells. GC92 cells were treated with siRNA against CtIP. Cells were transfected with the RFP or siRNA-resistant RFP-
CtIP-WT, RFP-CtIP-S327E, RFP-CtIP-T847E, RFP-CtIP-S327E/T847E, RFP-CtIP-S327E/T847A, or RFP-CtIP-
S327A/T847E plasmid. 36 h after plasmid transfection, cells were transfected with I-SceI and harvest took place 
after an additional 72 h. Diagrams of the exogenous CtIP WT, the S327E and/or T847E phospho-mimic-mutants and 
the mixed phospho-mimic-/phospho-mutants are not drawn to scale. Cells were stained with anti-CD4, anti-RFP AB, 
and DAPI. Samples were scanned using Metafer software and only plasmid-transfected cells were analyzed. Data 
represent the mean of 8 independent experiments performed in duplicate (n = 8). RFP was used as a marker for cells 
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with damage induction and exogenous protein (see chapter 3.1.1). Error bars show the 95% CI. Effect size was 
calculated by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni correction. 
 
Figure S8.16 Supplement to Figure 3.24 and 3.25 
(a, b, c, d, e) Impact of CDK impairment (a, d), PLK3 inhibition or depletion (b, d, e), PLK1 depletion (c), or PLK3 
depletion in combination with PARP or 53BP1 impairment (e) on gene conversion (a, b) or misrepair (c, d, e) in 
HeLa pGC (a, b), GC92 (c, e), or synchronized GC92 (d) cells. GC92 or HeLa pGC cells were treated with inhibitors 
and/or siRNAs against CDK1/2 (roscovitine), CDK2, PLK1/3 (GW843682X), PLK1, PARP (Olaparib), 53BP1, and/or 
PLK3. As a control, cells were treated with DMSO or control siRNA. (a, b, c, e) Harvest took place 72 h post-
transfection with the RFP and/or I-SceI plasmids. Cells were stained with anti-GFP and DAPI or anti-CD4, anti-RFP 
AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected GC92 cells or all HeLa 
pGC cells were analyzed. (d) GC92 cells were synchronized with double thymidine block and subsequently 
maintained in G1/G0 by serum starvation or in G2 by CDK inhibitor treatment (RO-3306). EdU was added and cells 
were harvested 72 h post-co-transfection with the I-SceI and RFP plasmids. Cells were stained with anti-CD4, anti-
RFP AB, and DAPI. Samples were scanned using Metafer software and only plasmid-transfected EdU-negative cells 
were analyzed. The treatment was very harmful to the cells and therefore only between 500 and 1,000 cells could 
be analyzed per experiment. (a, b, c, d, e) Data represent the mean of 8 independent experiments performed in 
duplicate (n = 8). RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Error bars show 
the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with Bonferroni 
correction. (a, b) Several data points were part of the analysis in Barton et al. (2014). 
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Table 8.7 PLK3-dependent CtIP phosphorylation sites 
(a, b) CtIP sites in vitro phosphorylated by recombinant PLK3 (a) or phosphorylated by PLK3 in a damage-inducible 
manner (b). SFB-CtIP-WT was precipitated and purified from stably-transfected HEK293 cells with streptavidin 
beads. (a) SFB-CtIP-WT was incubated with recombinant PLK3 in vitro where indicated (n = 2). (b) Precipitation 
took place 30 min or 2 h after X-IR with or without PLK inhibitor (GW843682X) treatment 1 h prior to irradiation 
(n = 1). (a, b) The numbers represent the Ascore. An Ascore < 19 is an unlikely phosphorylation, while values ≥ 19 
indicate a likely phosphorylation. Sites that did not provide any data under a specific condition were given the value 
0.1. An Ascore of 1,000 represents a certain phosphorylation signal in this experiment. For each detected 
phosphorylation site, the highest observed Ascore was used. The experimental procedure was conducted by J. Wang. 
MS and Ascore calculations were performed at the Taplin Mass Spectrometry Facility, Harvard Medical School. 
Several phosphorylation sites have not been described previously to Barton et al. (2014). Of note, lack of observation 
of a phosphorylation in this analysis does not mean that this phosphorylation does not exist in general. (a) This CtIP 
phosphorylation site analysis (without the ratios) was included in Barton et al. (2014). 
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Figure S8.17 Supplement to Figure 3.28 
(a, b) Impact of MRE11 inhibition, EXD2 (a), MRE11, and/or CtIP (b) depletion on misrepair in GC92 cells (b) or 
gene conversion in HeLa pGC cells (a). GC92 or HeLa pGC cells were treated with inhibitors and/or siRNAs against 
MRE11 endonuclease activity (PFM01), MRE11 exonuclease activity (PFM39, Mirin), MRE11, CtIP, 53BP1, DNA-PK 
(Nu7441), or EXD2. As a control, cells were treated with DMSO or control siRNA. Harvest took place 72 h post-
transfection with RFP and/or I-SceI plasmids. Cells were stained with anti-CD4, anti-RFP AB, and DAPI (for GC92 
cells) or with anti-GFP and DAPI (for HeLa pGC cells). Samples were scanned using Metafer software and only 
plasmid-transfected GC92 cells or all HeLa pGC cells were analyzed. Data represent the mean of 8 independent 
experiments performed in duplicate (n = 8). RFP was used as a marker for cells with damage induction (see chapter 
3.1.1). Error bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way 
ANOVA with Bonferroni correction. (a) Several data points were part of the analysis in Biehs et al. (2017).  
 
Figure S8.18 Supplement to Figure 3.30 
(a, b) Impact of EXO1 CRISPR/Cas9 viral transduction (a) or EXO1-CtIP co-depletion (b) on misrepair in GC92 cells. 
(c) Impact of EXO1 complementation in combination with other factors on overall repair in GC92 WT or ARTEMIS 
KO cells. (a) GC92 cells were virally transduced with CRISPR/Cas9 and EXO1 gRNA #4 plasmids and selected using 
selection medium. Downregulation by CRISPR/Cas9 was confirmed by immunoblotting. (b, c) GC92 WT or ARTEMIS 
KO cells were treated with inhibitors and/or siRNAs against MRE11 exonuclease activity (PFM39), 53BP1, CtIP, 
and/or EXO1. As a control, cells were treated with control siRNA. (a, b) Cells were harvested 72 h post-co-
transfection with the I-SceI and RFP plasmids. Cells were stained with anti-CD4, anti-RFP AB, and DAPI. Samples 
were scanned using Metafer software and only plasmid-transfected cells were analyzed. Data represent the mean of 
8 or 16 independent experiments performed in duplicate (n = 8 for a; n = 16 for b). (c) Cells were co-transfected 
with RFP and I-SceI plasmids and treated with EdU and nocodazole 30 min prior to harvest. Harvest took place 72 h 
post-plasmid transfection. Cells were stained with anti-H2AX, anti-RFP AB, and DAPI. Samples were scanned using 
Metafer software and only plasmid-transfected G1 cells were analyzed. Data represent the mean of 5 independent 
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experiments (n = 5). (a, b, c) RFP was used as a marker for cells with damage induction (see chapter 3.1.1). Error 
bars show the 95% CI. Effect size was calculated by Cohen’s d and p-value was obtained by one-way ANOVA with 
Bonferroni correction (c) or by two-sample Student’s t-test (a).  
Table 8.8 EXO1-associated factors 
SFB-EXO1-WT was precipitated and purified from stably-transfected HEK293 cells with streptavidin beads. 
Precipitation took place in unirradiated controls and 30 min post-5 Gy X-IR (all conditions n = 1). MS was performed 
by the Taplin Mass Spectrometry Facility, Harvard Medical School. Conditions where no interaction was observed 
were given a value of 0.1 for further analysis. The minimum amount of interacting peptides of a potential interaction 
partner was used to calculate the ratio of the irradiated sample compared to the unirradiated condition. Therefore, 
values greater than 1 show an interaction increase while values less than 1 show an interaction decrease following 
X-IR. Interesting possible novel interacting proteins and some established interacting proteins are included in this 
table.  
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